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Abstract
High risks and costs are associated with infections caused by antibiotic-resistant or-
ganisms. The continued development of antibiotic resistance in pathogenic organisms
means that in order to maintain our current standards in health care and disease treat-
ment, new antibiotics need to be sourced. Such was the ultimate goal of this project.
Endophytic fungi, due to their broad diversity, unique habitats and ease of acquisition,
have been shown to be an important source of bioactive natural products, including
novel antibiotics. Thus, the effort of this project was concentrated on the isolation of
endophytic fungi associated predominantly with native plants, and the evaluation of
the secondary metabolites they produced.
Tissues were harvested from 61 individual plant hosts representing 15 plant species.
Tissue segments were prepared and incubated on two different media formulations. As
fungal growths became apparent, they were subcultured in order to obtain pure fungal
isolates. A total of 133 fungal cultures were progressively isolated, covering over 100
fungal species.
Ultimately, 77 of these isolates were screened for antimicrobial activity against a panel
of 7 bacterial strains. Three isolates subsequently demonstrated repeatable antimicro-
bial action. They were identified as Schizophyllum commune, a species of Penicillium
and Sporormiella isomera, and their bioactivity further evaluated.
During the course of the project, activity originally detected in the S. isomera became
indiscernable. The Penicillium species demonstrated some activity, being able to in-
hibit the growth of Staphylococcus aureus at a dilution of 1:2. It was also found to
be mildly toxic to murine fibroblast L929 cells at a dilution factor of between 1:16
and 1:32, depending on the cytotoxicity assay used. Of the three isolates S. commune
possessed the highest level of activity. A 1:256 dilution inhibited the growth of staphy-
lococci, including an MRSA strain. A 1:32 dilution was bactericidal against E. coli.
However, while it demonstrated useful antimicrobial activity, its toxicity would prevent
its immediate development as such – a dilution factor of 1:1024, the highest dilution
tested in the cytotoxicity assay, was capable of killing over 50% of L929 cells.
Further analysis of this isolate’s products may reveal multiple products, with varying
levels of activity and toxicity, novel modes of action, or novel structures. Separation of
the active products could allow for further investigations, and if combinatorial chem-
istry is utilised, their structures may be manipulated in order to reduce the levels of
i
toxicity.
As long as bacteria continue to develop resistance to the antibiotics we use to treat their
infections, we will need to source new antibiotics. The continued isolation, screening
and evaluation of endophytic fungi and their secondary metabolites can only be of
benefit to all higher life forms on Earth.
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Chapter 1
Introduction
1.1 Antibiotics
In 1929, the bacteriologist Alexander Fleming reported the observation of inhibition
of Staphylococcus aureus growth by a substance produced by a contaminating mould,
identified at the time as Penicillium rubrum. Experiments conducted by Fleming indi-
cated the fungus produced a compound that was bactericidal to certain bacteria, whilst
also appearing to be non-toxic in animals. While he could see some application for it as
a treatment of infection in humans, Fleming suggested this compound, which he called
penicillin, would be most useful in the clinical isolation of non-penicillin-sensitive mi-
crobes from penicillin-sensitive microbes when present in a mixed clinical culture such
as in sputum samples and nasal swabs (Fleming 1929). Small experimental treatments
were conducted on human cases using the crude penicillin broth – unsuccessfully by
Fleming in 1929, and successfully by Dr C. G. Paine, one of Fleming’s former univer-
sity students. However, these trials were never officially documented (Wainwright &
Swan 1986). Chain et al. (1940) suggested the product, produced by the mould now
identified as P. chrysogenum (also previously known as P. notatum), could be used
as a chemotherapeutic agent, especially in the potential treatment of gas gangrene.
In experiments conducted by Chain et al. (1940), an almost 100% survival rate was
achieved when mice infected with penicillin-susceptible organisms were treated with a
programme of subcutaneous injections of a penicillin solution. All the infected control
mice not treated with penicillin, died. Chain, Florey and Abraham conducted the first
therapeutic trials of penicillin in humans during 1941 (Katz 2002).
In the United States, a penicillin solution was first used in 1942 on a patient close
to death from a streptococcal blood infection. Within days of treatment with the peni-
cillin, she had virtually fully recovered (Henry 2005, Grossman 2008). After becoming
involved in World War II, the US government declared the production of penicillin a
priority (Henry 2005). By the fifth month of 1943, a total of 400 million units of
penicillin had been produced (Grossman 2008), and the US military commenced large
scale use of the drug in North Africa. By 1944, 100 billion units were being pro-
duced monthly (Henry 2005), increasing to 650 billion units towards the end of 1945
1
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(Grossman 2008).
Other antibiotic discoveries had also been made by the start of World War II. In 1936,
details of the antibiotic properties of the dye Prontosil Rubrum (sulfamidochrysoi-
dine), were reported. In 1932 it was used successfully to save the life of Franklin
Roosevelt’s son from a severe streptococcal infection (S. haemolyticus). As a group,
sulphonamides became another antibiotic important in the prevention of infections in
open wounds of American soldiers (Stork 2005). In 1944, the first aminoglycoside
antibiotic, streptomycin, was discovered (Davis 1987).
The prognosis for patients was greatly enhanced by the discovery of antibiotics (Lowy
2003). For example, prior to their introduction, staphylococcal bacteraemia resulted in
the death of 80% (Lowy 2003, Cruickshank & Ferguson 2008) to up to 90% of cases
(Nimmo et al. 2007), as metastatic infections developed in most patients. The early
use of antibiotics reduced these affects (Lowy 2003).
Until 1957, penicillin was solely produced in fermented culture (Henry 2005, Gross-
man 2008). Thereafter, a chemist named John C. Sheehan, developed a process to
semi-synthesize penicillin. Semi-synthetic derivatives have since been developed which
have improved various characteristics of the drug such as the ability to absorb peni-
cillin orally (Henry 2005) or enhance resistance to the enzyme penicillinase, produced
by some penicillin-resistant bacteria (Lowy 2003).
Antibiotics function in a number of ways. The penicillins are a member of the β-lactam
group of antibiotics, all of which include a β-lactam ring in their structure. They are ef-
fective against a wide range of gram-positive and gram-negative bacteria, each antibac-
terial sub-group having a slightly different spectrum of activity. The β-lactams, which
also includes cephems (cephalosporins), penems and monobactams (CLSI 2006), in-
hibit bacterial cell wall synthesis (Yocum et al. 1980, Yotsuji et al. 1988, CLSI 2006).
However, some bacteria produce the enzyme β-lactamase which inhibits the antibi-
otic. Therefore, to be useful, either the antibiotic needs to be β-lactamase-resistant
(Yotsuji et al. 1988), or administered simultaneously with a β-lactamase inhibitor such
as clavulanic acid (CLSI 2006). For penicillin to reach its full bactericidal potential,
the sensitive-bacteria must be actively multiplying (Lee et al. 1944).
While the sulphonamide group of antibiotics were popular until the 1950’s (Stork
2005), today they are currently prescribed predominantly for the treatment of urinary
tract infections (CLSI 2006). They are generally bacteriostatic, inhibiting the further
growth of bacteria rather than killing the organism (Henry 1944). They act by prevent-
ing the formation of folic acid in the bacteria (Alovero et al. 1998, CLSI 2006), and
are often used in combination with trimethoprim, which inhibits a second step in the
folate pathway (CLSI 2006).
Aminoglycosides bind to the bactrial ribosome, blocking protein synthesis (Davis
1987, CLSI 2006), as do the macrolides, chloramphenicol, clindamycin (Schlu¨nzen
et al. 2001, CLSI 2006) and several other single-drug classes (CLSI 2006). Each group
performs this task in a unique manner (Schlu¨nzen et al. 2001), and has a differing spec-
trum of activity (CLSI 2006).
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Unfortunately, increasing antibiotic usage has not always had a positive outcome.
Super-infections (secondary infections) following antibiotic treatment are common,
especially with the use of broad spectrum antibiotics. These antibiotics may not only
affect a pathogenic organism. They can also have an adverse effect on the normal flora
of the body, and so allow subsequent infection by opportunistic, resistant organisms.
In the early years of antibiotic use and resistance, these tended to be organisms that
had not been previously encountered (Rantz 1954), undoubtedly creating delays and
difficulties in identification and treatment.
However, perhaps the greatest problem has been the development of antibiotic resis-
tance in previously sensitive organisms, a continued predicament foreseen by Fleming
in a statement he made in 1945 (Henry 2005).
1.1.1 Antibiotic resistance
The development of antibiotic resistance in Staphylococcus aureus is very well docu-
mented, and serves as an excellent example of this phenomenon.
Staphylococci resistant to penicillin were actually encountered in hospitals as early as
1942 (Lowy 2003), with the frequency of resistant clinical isolates increasing to 50 to
90% in the mid-fifties (Rantz 1954) to 80% of clinical and community isolates by the
late sixties (Lowy 2003). In 1960-61, methicillin was introduced as a new antibiotic to
treat penicillin-resistant S. aureus. Methicillin-resistant isolates were detected within
the year (Lowy 2003, Cruickshank & Ferguson 2008).
Australian isolates of methicillin-resistant Staphylococcus aureus (MRSA) were de-
tected in the late sixties (Nimmo et al. 2007, Cruickshank & Ferguson 2008), but were
usually treatable with non-β-lactams or gentamicin. By 1976, strains resistant to these
additional antibiotics were detected, becoming endemic in hospitals in the Eastern
states around the end of the 1980’s (Nimmo et al. 2007).
Vancomycin subsequently became the treatment of choice for serious cases of MRSA
infection (Nimmo et al. 2007). Reports of reduced susceptibility to vancomycin in
MRSA followed in 1997 (Lowy 2003, Cosgrove et al. 2004, CLSI 2006). Linezolid is
one of the few antibiotics available today for the treatment of multiple-resistant MRSA
(mMRSA), and cases of resistance have already been reported (Newman et al. 2003,
Nimmo et al. 2007).
The most frequently encountered multiresistant organism today is MRSA (Cruick-
shank & Ferguson 2008). A study conducted by the Australian Group for Antimi-
crobial Resistance (AGAR) found that 31.9% of clinical S. aureus isolates obtained
throughout Australia were MRSAs (Nimmo et al. 2007).
The development of antibiotic resistance has always followed a basic pattern – emer-
gence and detection in hospitals, followed by dissemination into the community (Lowy
2003, Nimmo et al. 2006, 2007, Cruickshank & Ferguson 2008). Consequently, community-
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acquired infections caused by antibiotic resistant organisms are on the rise (Nimmo
et al. 2006, 2007).
Treatment options for infections caused by antibiotic resistant organisms can be prob-
lematic. Alternative chemotherapeutic agents can be more expensive (Cruickshank &
Ferguson 2008) and, as suggested by the World Health Organization (WHO) more
toxic than the original antibiotic (Anon. 2002a), or there may be none readily available
(Lowy 2003, Cosgrove et al. 2004).
According to the WHO, development of resistance is a natural process based on evo-
lutionary or selective pressure (Anon. 2002a). It starts when there is not a 100% suc-
cess rate in the elimination of bacteria following an antibiotic treatment, and continues
as the antibiotic-resistant bacteria replicate and transfer their resistance genes to the
next generation. The process is swift due to the bacteria’s propensity for rapid mul-
tiplication. However, bacteria also have the ability to transfer resistance genes into
other related species through conjugation and on transduction (Anon. 2002a, Lowy
2003). Lowy (2003) mentions two incidents involving vancomycin-resistant S. au-
reus (VRSA), where the resistant gene was obtained via conjugal transfer from a
vancomycin-resistant Enterococcus faecalis (VRE).
Human activity is considered by the WHO to play a major role in the development of
antibiotic resistance (Anon. 2002a). In health-care settings, issues such as the incorrect
use of antibiotics involving insufficient treatment time, dose or potency (Henry 2005);
inappropriate use of antibiotics (Lowy 2003, Henry 2005), including the treatment of
viral diseases (Henry 2005), incorrectly diagnosed disease or in absence of disease
(Anon. 2002a); and the use of broad-spectrum antibiotics rather than narrow-spectrum
(Rantz 1954, Cruickshank & Ferguson 2008) encourage the selection and survival of
antibiotic resistant bacteria. Health-care associated environments are also ideal for
the development and spread of antibiotic resistance, due to prolonged (Cosgrove et al.
2004, Nimmo et al. 2007) and widespread antibiotic use and a concentrated population
of highly susceptible patients (Cruickshank & Ferguson 2008).
The use of antibiotics in food production has also been linked with the formation of
antibiotic resistant organisms (Laich et al. 2002, Lowy 2003). In North America and
Europe, antibiotics used for prophylaxis or growth enhancers in animals and poultry
accounted for approximately half the tonnage of antimicrobial products (Anon. 2002a)
They are frequently administered at sub-therapeutic levels, and the antibiotic resistant
bacteria can be subsequently spread to humans through the food chain. Antibiotic re-
sistance in the normal flora of the human colon can develop following the ingestion of
improperly cured fermented foods containing antibiotic resistant bacteria – their resis-
tance can be transferred to the residing gut bacteria through the process of conjugation
(Laich et al. 2002).
In addition to these direct causes, the WHO suggested the spread of antibiotic resistant
organisms is enhanced due to urbanisation (Anon. 2002a) and international trade and
travel (Anon. 2002a, Lowy 2003).
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1.2 Nosocomial pathogens
Nosocomial pathogens are defined by the Australian Infection Control Association
(AICA) as the disease causing bacteria, fungi and viruses found specifically in hos-
pitals, and can cause infections in patients subsequent to admission (Anon. 2005a).
In terms of infection, the term nosocomial is gradually being replaced with health-
care associated, so as to include any infections obtained in an environment in which
health care is received, such as aged-care facilities. It also includes infections which
do not appear until after discharge, but were incurred as a result of the health care
treatment previously received (Anon. 2003). Health-care associated infections are the
most frequently encountered complication affecting patients in hospital (Cruickshank
& Ferguson 2008).
In 2003, it was roughly estimated that up to 150 000 healthcare associated infections
occurred in Australia (Anon. 2003, Joint Expert Technical Advisory Committee on
Antibiotic Resistance (JETACAR) 2003), a figure which increased to an estimated
200 000 occurrences in 2008 (Cruickshank & Ferguson 2008). The greatest risk of
infection occurs in intensive care units, where up to 30% of nosocomial infections
develop (Cruickshank & Ferguson 2008).
Surgical sites and the bloodstream are the most frequently affected sites of infection
(Cruickshank & Ferguson 2008). According to AICA, up to 13% of surgical patients
contract an infection at the surgical site (Anon. 2003). Of all bloodstream infections
(bacteraemia), it has been estimated that approximately half are associated with noso-
comial infections (Nimmo et al. 2007, Cruickshank & Ferguson 2008), while another
third are associated with healthcare procedures (Cruickshank & Ferguson 2008).
Every day spent as a patient in a hospital environment increases the risk of acquiring a
nosocomial infection by 6% (Cruickshank & Ferguson 2008).
In Australia, Clostridium difficile (Cruickshank & Ferguson 2008) and Staphylococcus
aureus are the most frequently encountered causes of nosocomial infections (Lowy
2003, Nimmo et al. 2007, Cruickshank & Ferguson 2008). S. aureus is the most preva-
lent cause of infection following coronary artery bypass graft surgery and knee and hip
arthroplasty, and is responsible for from 20% (Klevens et al. 2007) to up to 33% of
cases of bacteraemia (Cruickshank & Ferguson 2008). In 1989 in the United States,
27% of bacteraemia cases were caused by coagulase-negative Staphylococcus species
(John & Harvin 2007).
However of greater concern, is the presence of antibiotic resistant organisms. In the
United States in 2003, over half of the S. aureus bacteraemia cases incurred in the hos-
pital were attributed to methicillin resistant strains (MRSA) (Klevens et al. 2007). An-
other American study conducted in a single hospital found 31% of cases were caused
by multiresistant MRSA (Cruickshank & Ferguson 2008). In the majority of Aus-
tralian hospitals, both antibiotic-sensitive and methicillin resistant Staphylococci are
endemic, with the antibiotic-sensitive strain being more prevalent (Cruickshank &
Ferguson 2008). MRSA has been cited as being responsible for 40% of health-care
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associated bacteraemia (Nimmo et al. 2007).
Other antibiotic resistant bacterial strains encountered in hospitals include vancomycin
resistant enterococci (VRE), multi-resistant Gram negative bacteria (MRGN) (Cruick-
shank & Ferguson 2008), multiple resistant Acinetobacter, extended-spectrum β-lactamase
(ESBL) Klebsiella pneumoniae (Anon. 2003, 2005b), and reduced vancomycin sus-
ceptibility S. aureus strains (vancomycin-intermediate S. aureus – VISA) (Anon. 2005c).
While not of current concern in developed countries, multiresistant Mycobacterium tu-
berculosis is an increasing world-wide problem (Cruickshank & Ferguson 2008).
These organisms are spread via contact transmission – via contaminated equipment,
from patient to patient, or particularly, on the hands of health care workers (Cosgrove
et al. 2004). Many healthcare workers are colonised with antibiotic resistant organisms
(Rantz 1954, Cruickshank & Ferguson 2008). While the spread of antibiotic-resistant
bacteria into the community, particularly MRSA, is of concern, it currently appears
the capacity for person-to-person transmission of these strains within the community
is lower than that in health care settings (Nimmo et al. 2006).
While antibiotics can be administered to infected individuals, they may occasionally
be of limited value, especially where antibiotic-resistant organisms are involved. How-
ever, even with the availability of suitable antibiotics, deaths may still occur (Lowy
2003). New antimicrobials are required, and are being developed (Lowy 2003, John &
Harvin 2007), but their use must be managed and reduced in order to slow the devel-
opment of resistance to the new drugs (Cruickshank & Ferguson 2008).
However, the AICA states that many healthcare associated infections may be prevented
by the implementation of infection control programmes (Anon. 2003). Hand washing
(Anon. 2005c, Cruickshank & Ferguson 2008), and, as suggested by the WHO, using
fresh gloves for each patient (Anon. 2002a) are two important measures. In the case of
MRSA, screening, followed by appropriate management of those patients found to be
colonised or infected, is essential (Anon. 2005c) though this should be followed in the
case of any antibiotic-resistant organism. In 2007, an Australian newspaper reported
that a major hospital in Brisbane, Australia, closed 2 medical wards following the
positive screening in 21 patients for vancomycin resistant enterococci (VRE). While
most of the patients were asymptomatic, the measures were taken to prevent its spread
to other areas of the hospital (Anon. 2007).
Surveillance also plays an important role in the control and prevention of healthcare as-
sociated infections, (Joint Expert Technical Advisory Committee on Antibiotic Resis-
tance (JETACAR) 2003, Cruickshank & Ferguson 2008). Information gathered can be
used to improve infection control (Joint Expert Technical Advisory Committee on An-
tibiotic Resistance (JETACAR) 2003), improve procedures, and improve the response
to these issues (Joint Expert Technical Advisory Committee on Antibiotic Resistance
(JETACAR) 2003, Cruickshank & Ferguson 2008).
Currently in Australia, there is no national surveillance system, leading to unreliable,
limited information, which ultimately prevents a coordinated response to the problems
caused by healthcare associated infections and antimicrobial resistance (Cruickshank
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& Ferguson 2008).
Apart from the initial problems created by the infection, healthcare associated infec-
tions have a substantial impact in different ways – longer hospital stays, increased pain
and suffering, and additional risk of further complications potentially leading to death
are faced by infected individuals (Cruickshank & Ferguson 2008); increased work-
loads and stretched resources in hospitals (Joint Expert Technical Advisory Committee
on Antibiotic Resistance (JETACAR) 2003); increased risk of exposure of antibiotic-
resistant organisms to the community (Lowy 2003, Klevens et al. 2007, Cruickshank
& Ferguson 2008); and increased financial costs for all involved (Klevens et al. 2007,
Nimmo et al. 2007, Cruickshank & Ferguson 2008).
Endocarditis, osteomyelitis and septic arthritis are some of the additional complica-
tions incurred by those who develop Staphylococcal bacteraemia (Cruickshank & Fer-
guson 2008), and 20 to 40% of these people will die (Lowy 2003, Nimmo et al. 2007).
When all causative agents of bacteraemia are considered, 17 to 29% of cases will re-
sult in death. When infections of surgical sites are also included, this figure increases
to 33% (Cruickshank & Ferguson 2008). In 2003, healthcare associated infections
were implicated in the deaths of up to 4.6% of those afflicted – approximately 7000
deaths annually (Joint Expert Technical Advisory Committee on Antibiotic Resistance
(JETACAR) 2003).
In 1984, nosocomial infections in Australia resulted in costs of around $180 million.
According to AICA, by 2001, these costs had risen substantially, with annual costs
of surgical site infections alone up to $268 million (Anon. 2003). In 2007, it was
estimated that Staphylococcal bacteraemia costs around $150 million (Nimmo et al.
2007).
Generally, higher risks and costs are associated with infections caused by antibiotic-
resistant organisms (Joint Expert Technical Advisory Committee on Antibiotic Resis-
tance (JETACAR) 2003, Klevens et al. 2007, Nimmo et al. 2007), particularly those
caused by MRSA (Cruickshank & Ferguson 2008). Even in the prevention of infection,
such as that mentioned previously in the Brisbane hospital, extra costs were incurred
as additional nursing staff undertook the labour intensive cleaning and disinfection of
the two affected wards (Anon. 2007).
It is expected that due to Australia’s aging population, levels of nosocomial infections
will increase – the elderly face reduced immunity levels, higher exposure to antibiotics,
more frequent stays in hospital and close contact within aged-care facilities increasing
the risk of developing infections (Cruickshank & Ferguson 2008).
1.3 The search for novel antibiotics
Antibiotic discovery primarily relies on the mass screening of suitable products. Ini-
tially, the bulk of these products were obtained from natural sources such as fungi,
bacteria and plants. The importance of natural-product screening has abated due in
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part to difficulties for pharmaceutical companies to secure intellectual property rights
(Anon. 2002b) and the effort and expense incurred in finding and developing products
(Strobel & Daisy 2003). In addition, combinatorial chemistry (Strobel & Daisy 2003)
and enhanced target-based biochemical screening processes (Lowy 2003) became the
preferred method for developing new antibiotics, as this largely automated process in-
creased the numbers of products which could be synthesised and screened (Newman
et al. 2003, Strobel & Daisy 2003, Koehn & Carter 2005).
However, due to the natural diversity in chemical structure (Schulz et al. 2002, Strobel
& Daisy 2003, Koehn & Carter 2005) and wide biological spectrum (Anon. 2002b),
natural products have proved more successful in providing novel substances than com-
binatorial chemistry (Schulz et al. 2002, Newman et al. 2003, Strobel & Daisy 2003,
Newman & Cragg 2007). However, when natural products are used to provide the
lead structure, and combinatorial chemistry is used to manipulate and enhance that
structure, the results are further improved (Katz 2002, Newman et al. 2003, Strobel
& Daisy 2003, Koehn & Carter 2005, Newman & Cragg 2007). The manipulation of
penicillin’s structure to improve its resistance to various enzymes (Katz 2002, Lowy
2003), its stability (Katz 2002) and its oral bioavailability (Henry 2005) provides a
suitable example.
Over an 11 year period, over 62% of the antimicrobial products submitted to the Amer-
ican Food and Drug Association (FDA) for analysis were associated with natural prod-
ucts. More than 77% of these were semi-synthetic forms (Suffredini et al. 2004). A
review conducted by Newman & Cragg (2007) revealed that 76.5% of new and ap-
proved antibacterials from the time spanning January 1981 to June 2006 were based
on natural products, with over 65% of these being semi-synthetic. In 1991, drugs based
on natural products constituted almost half of the most popular drugs sold (Cragg et al.
1997).
For approximately 40 years since the identification of penicillin, the discovery of new
antimicrobials flourished. The WHO suggests a misplaced belief that treatment of
pathogens no longer posed a problem was partially to blame for the decline in further
research and development of new antibiotics (Anon. 2002a). Costs, differences be-
tween in vitro and in vivo behaviours of antibiotics, and a failure to rapidly develop
new efficient products have reduced corporate involvement in the search for novel
antibiotics. In 2002, it was suggested by the World Health Organisation that within
10 years there would be no effective treatment available for some infectious diseases
(Anon. 2002a). Katz (2002) lamented the lack of significant antibiotic discovery in
the preceding 20 years. This is compounded by the fact that it can take approximately
12 years and significant costs to develop a new discovery into a clinically available
product (Schulz et al. 2002). To maintain the fight against bacterial infection, novel
antibiotics need to be sourced as a matter of urgency.
8
CHAPTER 1. INTRODUCTION
1.3.1 Fungi as a potential source of antibiotics
Fungi have been shown to be one source of a variety of useful natural products (Davis
et al. 2008). Important discoveries other than antibiotics have included cyclosporin,
an immunosuppressive drug used to prevent rejection of transplanted organs, produced
by Tolypocladium inflatum; citric, gluconic and itaconic acids from several Aspergillus
species and alcohol produced by Saccharomyces cerevisiae (Hyde 1996).
The anticancer agent paclitaxel (trademarked as Taxol) provides an interesting case.
Initially thought to be produced solely in the bark of Taxus brevifolia Nutt (Pacific
yew tree), it was later found to also be produced by the fungus Taxomyces andreanae,
isolated from the inner bark of the same tree species. However, it provided an easier,
less time-consuming and less costly source of this important drug than from harvesting
the bark, or from creating it through artificial means (Katz 2002, Strobel & Daisy
2003).
Since the discovery of penicillin, fungi are possibly best known as a potential source
of novel antibiotics. Other fungal-based antibiotic discoveries include Cephalosporin
produced by Cephalosporium sp., Griseofulvin from Penicillium griseofulvin (Hyde
1996) and Usnic acid, produced by a lichen, and used topically in the treatment of
human skin diseases (Katz 2002).
By 2002, of the 20 medicines most commonly prescribed, six originated from fungal
sources (Schulz et al. 2002).
It has been estimated that between 74 000 (Rodrigues et al. 2000, Hawksworth 2001,
Suryanarayanan et al. 2003), to 75 000 (Deacon 2006) to 100 000 (Strobel & Daisy
2003) fungal species have been described, yet this may only account for around 5%
of all fungal species in existence (Hyde 1996, Schulz et al. 2002, Deacon 2006). It is
conservatively estimated that the total number of species could number as high as 1
million (Strobel & Daisy 2003), or even higher (Rodrigues et al. 2000, Hawksworth
2001, Suryanarayanan et al. 2003). It is difficult to determine a more accurate figure
due to differences in sampling methods (Paulus et al. 2006).
Plants provide an easily identifiable habitat for fungi, so a ratio of plant host to fungal
species is frequently included in the calculations of total fungal species (Hawksworth
2001). However, the suggested ratios vary from 1:6, which was used for the initial
estimate (Hawksworth 2001) to 1:10 used to determine that Australia is estimated to
contain 250 000 fungal species (Hyde 1996). Yet work conducted by Hyde (1996)
demonstrated a much higher ratio of palm hosts to fungal species than the latter figure.
Nonetheless, basing the calculation of fungal species on an estimated 300 000 plant
species (Strobel & Daisy 2003) and using the ratio of 1:10 results in an estimate of
some 3 million fungal species.
Fungi exist in a diverse range of habitats, including, but not limited to, soil (Schulz
et al. 2002), freshwater and marine environments (Hyde 1996, McKenzie 2001), in-
sects (McKenzie 2001, Paulus et al. 2006) and in plants (Arnold et al. 2001, Strobel &
Daisy 2003, Arnold & Lutzoni 2007).
9
CHAPTER 1. INTRODUCTION
Their previous successes in yielding useful natural products, their extensive habitat
range and number of species yet to be discovered, imply that fungi will continue to be
a promising source of novel antibiotics.
1.3.2 Endophytic Fungi
Endophytic fungi are fungi which for at least a portion of the life cycle, reside within
the healthy tissues of plants without causing the plant to display any symptoms or
signs of infection (Bills 1996, Petrini 1996, Johnston 1998, Pela´ez et al. 1998, Fro¨hlich
et al. 2000, Dingle & McGee 2003, Strobel & Daisy 2003, Suryanarayanan et al. 2003,
Arnold & Lutzoni 2007). While not all plant species have been surveyed, it is expected
that all plant species harbour at least one endophytic fungus (Strobel & Daisy 2003),
including the algae and mosses (Arnold et al. 2001). Therefore, a substantial volume
of fungal biodiversity can be attributed to the endophytic fungi (Arnold et al. 2001,
Suryanarayanan et al. 2003, Arnold & Lutzoni 2007).
It has been suggested the relationship between plant host and fungal endophyte may
be symbiotic (Petrini 1996, Dingle & McGee 2003, Strobel & Daisy 2003), mutual-
istic (Schulz et al. 1995, Petrini 1996, Johnston 1998, Strobel & Daisy 2003, Arnold
& Lutzoni 2007) or saprophytic (Bills 1996, Strobel & Daisy 2003). It may also in-
clude opportunistic pathogens (Johnston 1998, Strobel & Daisy 2003) involved in a
fine balance between fungal virulence and plant defence (Schulz et al. 2002) or well
known plant pathogens capable of demonstrating an asymptomatic relationship in a
non-susceptible plant species (Schulz et al. 1995, Arnold & Lutzoni 2007). Endo-
phytic fungi can enter a plant host by transfer between individual plants via horizontal
transmission, such as airborne delivery or via the seed and so to following genera-
tions (vertical transmission) (Bayman et al. 1998, Arnold & Lutzoni 2007). The latter
method in particular could enhance the co-evolution of endophytic fungi with its host
plant (Bayman et al. 1998).
The role of endophytic fungi is not yet fully understood (Strobel & Daisy 2003). It has
been suggested the fungi can assist in the protection of the host from insect predators,
disease (Johnston 1998, Schulz et al. 2002, Dingle & McGee 2003, Arnold & Lutzoni
2007) or improve plant growth (Schulz et al. 2002, Dingle & McGee 2003). Studies
reported by Arnold & Lutzoni (2007) indicated improved tolerance to drought, heavy
metals and salinity in several hundred grass species could be directly attributed to the
endophytes present. However, they reported other studies which showed a decrease
in photosynthetic efficiency in maize and bananas, and decreased resistance to severe
drought.
Due to their broad diversity (Pela´ez et al. 1998, Strobel & Daisy 2003), unique and
varying growth environments (Strobel & Daisy 2003) and relatively easy acquisition
(Pela´ez et al. 1998), endophytic fungi are considered as an important source in the dis-
covery of bioactive natural products (Pela´ez et al. 1998, Rodrigues et al. 2000, Schulz
et al. 2002, Strobel & Daisy 2003), including novel antibiotics. In fact, research con-
ducted by Schulz et al. (2002) revealed fungal endophytes isolated from plants demon-
10
CHAPTER 1. INTRODUCTION
strated a greater number of antimicrobial inhibitions than pathogenic, epiphytic, algal
or soil isolates.
1.4 Project outline
The purpose of this project was the discovery and evaluation of novel antimicrobial
agents affective against nosocomial pathogens, and entailed four distinct areas of in-
vestigation:
1.4.1 Acquisition of Fungal Isolates
The goal of the first phase of the project was the acquisition of a sufficient number and
variety of fungal isolates. While fungi are ubiquitous, it was decided to concentrate ef-
forts on the collection of endophytic fungi from a variety of mostly native plant hosts.
Harvested plant tissues were washed, surface sterilised and portions transferred to suit-
able growth media. As isolates grew, they were subcultured until pure cultures were
obtained, cultured onto slants for short term use, and longer term storage preparations
made.
1.4.2 Screening for Antimicrobial Activity
The second stage of the project involved the screening of the fungal isolates collected
during the first phase, against a panel of selected nosocomial pathogens. Two screen-
ing methods were initially trialled, testing the response of Staphylococcus aureus and
Escherichia coli to substances produced in culture by the fungus Penicillium chryso-
genum. As it was known the substances produced would potentially include penicillin,
the two test microbes offered a sensitive and resistant response to the antibiotic. After a
suitable screening method was determined, the fungal isolates were progressively sub-
cultured from the slants, and if successfully grown, screened for antimicrobial activity
against a broader range of microbes.
1.4.3 Identification of Selected isolates
Fungi which demonstrated antimicrobial activity against one or more of the test bac-
teria were selected for further study. This firstly required the determination of their
scientific classification, so as not to re-evaluate a fungus which had been previously
described and assessed. Morphological characteristics, both macroscopic and micro-
scopic, were initially studied, and were sufficient to determine the genus of one of the
isolates obtained. Molecular techniques were required to obtain identification of the
remaining isolates.
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1.4.4 Evaluation of Activity
The final part of the project involved the evaluation of the antimicrobial activity and the
assessment of potential toxicity of crude preparations from the selected isolates. The
Minimum Inhibitory Concentration (MIC) was determined for the fungal preparations
against several of the bacteria used for the initial screening. Once these results were
obtained, the Minimum Bactericidal Concentration (MBC) could be determined. Toxic
effects of the crude preparations were tested on murine fibroblasts and evaluated using
the MTT Cell Viability and Crystal Violet Dye Exclusion (CVDE) assays.
The ultimate goal of this project was the discovery of novel antibiotics. Results from
the final part of the project will determine the future direction of any discoveries.
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Acquisition of Fungal Isolates
2.1 Introduction
The goal of the first phase of the project was the acquisition of a sufficient number
and variety of fungal isolates for screening, and as such, was considered the largest
and most important part of the project. Without a large number of isolates to screen
for antimicrobial activity, the chances of finding an isolate with antimicrobial activity
would be limited. While fungi are ubiquitous, it was decided to concentrate efforts on
the collection of endophytic fungi from a variety of mostly native plant hosts.
Plant samples from two sites were harvested, washed, surface sterilised and sectioned.
The sectioned tissues were transferred to one of two types of media and incubated.
As hyphae appeared around the edges of the tissue, a portion of hyphae and agar was
transferred to a fresh plate, incubated and subcultured until pure growth was obtained.
Fungal isolates were placed into storage until required for phase two of the project, the
screening for antimicrobial activity.
2.1.1 Strategy
In order to improve the chance of discovering novel antibiotics, novel fungal endo-
phytes need to be studied (Gloer 1997, Schulz et al. 2002, Strobel & Daisy 2003).
Therefore, some thought needs to be applied to host selection (Pela´ez et al. 1998, Stro-
bel & Daisy 2003). In particular, plants restricted to certain areas (Pela´ez et al. 1998,
Strobel & Daisy 2003), surviving in unique environments, or possessing unusual biol-
ogy or history, are expected to provide an important source of novel fungal endophytes
(Strobel & Daisy 2003).
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Host source
The greatest diversity in land-dwelling biological species can be found in the worlds
tropical and temperate rainforests (Strobel & Daisy 2003). One leaf alone, from a
lowland, tropical rainforest played host to 17 endophytic fungi (Arnold & Lutzoni
2007). A high species diversity is associated with the palms of tropical and temperate
rainforests (Fro¨hlich et al. 2000). Studies have shown that forests of both regions have
similar rates of host specificity (Arnold & Lutzoni 2007).
However, studies have generally shown that tropical rainforests contain a greater fun-
gal diversity (Hawksworth 2001, Suryanarayanan et al. 2003, Arnold & Lutzoni 2007)
and higher incidence of endophytic colonisation (Arnold et al. 2001) than the rain-
forests of temperate regions. Research cited by Hawksworth (2001) found this was
particularly so in the large forests, mountain tops and humid island forests of the trop-
ics. Research conducted by Arnold & Lutzoni (2007) found as the latitude increased,
the rate of endophytic fungal colonisation and diversity decreased – almost all leaf sec-
tions obtained from a tropical study site bore endophytic isolates, whereas only 1% of
arctic leaf sections were productive.
Due to their contribution to fungal diversity, studies into the fungal endophytic assem-
blages of tropical plants were included in the prediction of total world fungal species
(Suryanarayanan et al. 2003).
Regardless of the geographical zone, different forests have demonstrated unique endo-
phytic assemblages (Arnold & Lutzoni 2007), and a great number of fungi are yet to be
described (Hyde 1996, Hawksworth 2001, McKenzie 2001, Arnold & Lutzoni 2007).
Due to limited resources, increased competition, and increased selection pressure, rain-
forests are expected to be an important source of diverse, novel fungal endophytes able
to produce a range of novel antimicrobially active compounds (Strobel & Daisy 2003).
It is expected tropical rainforests in particular, host many of these currently unknown
endophytes (Hawksworth 2001, Strobel & Daisy 2003, Arnold & Lutzoni 2007), but
unfortunately, the rapid diminishment of the world’s rainforests means there will be re-
duced opportunity to discover them, and the natural products which they can produce
(Strobel & Daisy 2003).
Sample selection
Endophytic fungi appear to fall into two populations: one group appearing in many
host species (Fro¨hlich et al. 2000, Suryanarayanan et al. 2003, Strobel & Daisy 2003),
the other displaying some degree of host specificity (Bills 1996, Petrini 1996, Pela´ez
et al. 1998, Fro¨hlich et al. 2000, Arnold et al. 2001, Suryanarayanan et al. 2003, Paulus
et al. 2006). Fro¨hlich et al. (2000) found over half of the fungal endophytes isolated
from three Australian palm species came from a single palm species, while only 23%
were common to all three palms. A similar pattern was encountered in Brunei, with
46% of isolates demonstrating a preference for one host species and 32% being com-
mon to all three palm species studied.
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Even species in close proximity can play host to differing endophytic communities.
Results related to Petrini (1996) showed out of 70 isolates obtained from both mistle-
toes and the fir trees on which they grew, less than ten were common to both host
species.
In addition to host specificity, there appear to be elements of tissue specificity amongst
the endophytic fungi (Petrini 1996, Johnston 1998, Fro¨hlich et al. 2000, Paulus et al.
2006). Studies on the manuka (Leptospermum scoparium) (Johnston 1998) and palms
(Fro¨hlich et al. 2000), showed both hosts were found to have variations in the endo-
phytic assemblages between different leaf tissue types. The petiole in particular has
been associated with unique species (Petrini 1996) and greater numbers of isolates
(Fro¨hlich et al. 2000) when compared with other areas of the leaf.
Differences in endophyte assemblages can also occur between identical host species
in different environments (Bayman et al. 1998, Johnston 1998, Taylor et al. 1999). In
their study on the endophytes of the manuka, Johnston (1998) found major differences
between manuka stands established from seedlings raised in a nursery compared with
naturally established stands. When the endophytes of the palm Trachycarpus fortunei
were studied by Taylor et al. (1999), they found similar numbers of taxa, but different
species and a poorer population of endophytic fungi in the palm outside its natural
range when compared with those obtained from the host in its natural habitat.
Tissue age can also have an impact on endophytic sampling (Taylor et al. 1999), with
older leaves generally having a higher population of endophytes than younger leaves
(Bills 1996, Johnston 1998, Fro¨hlich et al. 2000, Arnold et al. 2001, Arnold & Lutzoni
2007). While Fro¨hlich et al. (2000) found few differences between the taxa encoun-
tered in younger compared with older palm fronds, isolation rates were higher in the
older tissues.
Other factors can have an influence on the distribution of endophytes, including re-
source competition (Paulus et al. 2006), host density (Johnston 1998, Arnold et al.
2001, Suryanarayanan et al. 2003), host species (Fro¨hlich et al. 2000), air quality
(Johnston 1998) climactic conditions (Johnston 1998, Arnold et al. 2001, Paulus et al.
2006) and season (Taylor et al. 1999, Arnold et al. 2001, Paulus et al. 2006).
2.1.2 Isolation Techniques
A variety of techniques have been employed in the isolation of endophytic fungi. A
summary of some of those techniques is described below.
In all cases examined, an excess of material was collected for processing, with the
harvested plant tissues sampled for endophytes within 4 hours (Arnold et al. 2001) to
96 hours (Taylor et al. 1999, Arnold & Lutzoni 2007) after collection. By comparing
leaves from the same site plated on the day with those plated 24 hours after collec-
tion, Johnston (1998) determined while the numbers of isolates did not fluctuate, the
species isolated were affected. In particular, the isolation frequency of the dominant
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endophytic species decreased with the delay, while other species were isolated more
frequently.
Whole leaves were generally washed thoroughly in running tap water prior to sur-
face sterilisation (Bayman et al. 1998, Arnold et al. 2001, Dingle & McGee 2003,
Suryanarayanan et al. 2003, Paulus et al. 2006, Arnold & Lutzoni 2007). For leaves
containing latex, Bayman et al. (1998) included approximately 0.05% Tween 80 in the
water.
Surface sterilisation of plant tissue appears to be predominantly by the sequential im-
mersion of the tissue in ethanol followed by sodium hypochlorite followed by ethanol.
Various concentrations and times were used, and these are summarised in Table 2.1.
Other studies have utilised a single treatment in either 5% sodium hypochlorite (Paulus
et al. 2006) or 70% ethanol (Strobel & Daisy 2003). Where ethanol was used as the
sole agent, it was either allowed to naturally evaporate or the material and ethanol were
flamed (Strobel & Daisy 2003).
Table 2.1: Summary of timings of chemical surface sterilisation of plant tissue.
Reference
Ethanol Sodium hypochlorite Ethanol
Conc. Time Conc. Time Conc. Time
Bayman et al. (1998) 75% 1 min 3.4% 10 min 75% 30 sec
- - 0.5% 20 min - Note1, 2
Johnston (1998) 95% 1 min 29.4% 3 min 95% 30 sec2
Taylor et al. (1999) 95% 1min 3.25% 10 min 95% 30 sec
Fro¨hlich et al. (2000) 96% 1 min 3.25% 10 min 96% 30 sec
Guo et al. (2000) 70% 1 min 3.25% 10 min 75% 30 sec3
Arnold et al. (2001) - - 0.525% 2 min 70% 2 min2, 3
Dingle & McGee
(2003) 96% 1 min 4.2% 25 min 96% 30 sec
Suryanarayanan et al.
(2003) 70% 5 sec 4% 90 sec - Note
2
Arnold & Lutzoni
(2007) 95% 10 sec 10%
4 2 min 70% 2 min3
1 For leaves with a latex content.
2 Tissues were finally rinsed in sterile water
3 Tissue was either dried or allowed to dry before continuing
4 Percentage of chlorine bleach provided
Flat leaves were mostly cut into segments no bigger than 0.5cm2 (Arnold et al. 2001,
Dingle & McGee 2003, Suryanarayanan et al. 2003, Arnold & Lutzoni 2007), or
punched with a hole punch to produce disks (Pela´ez et al. 1998, Taylor et al. 1999,
Guo et al. 2000, Fro¨hlich et al. 2000). A particulate filtration process was followed by
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one research group, where leaf particles measuring between 105 to 210 µm were ob-
tained and plated (Paulus et al. 2003, 2006). Strobel & Daisy (2003) carefully excised
and cultured the inner tissues of the leaf, while whole leaves were plated by Johnston
(1998). Needle-like leaves (Bayman et al. 1998), and twigs or stems were sliced into
small segments (Pela´ez et al. 1998, Fro¨hlich et al. 2000).
Over half of the studies examined stated the plant material was sectioned prior to sur-
face sterilisation (Pela´ez et al. 1998, Taylor et al. 1999, Fro¨hlich et al. 2000, Guo et al.
2000, Arnold et al. 2001, Dingle & McGee 2003, Suryanarayanan et al. 2003, Arnold
& Lutzoni 2007).
Malt Extract Agar (MEA) was the most frequently utilised medium for the initial cul-
turing of endophytic fungi from the plant tissue (Johnston 1998, Taylor et al. 1999, Guo
et al. 2000, Arnold et al. 2001, Arnold & Lutzoni 2007), followed by PDA (Fro¨hlich
et al. 2000, Dingle & McGee 2003, Suryanarayanan et al. 2003). Bayman et al. (1998)
used a half strength preparation of each medium, while Pela´ez et al. (1998) and Paulus
et al. (2006) used MEA with added yeast extract. The latter also utilised Bandoni’s
medium, corn meal agar and dichloran rose bengal chloramphenicol agar. Water agar
plates were used by Strobel & Daisy (2003). Most media were supplemented with
one or more antibiotics to prevent bacterial contamination, and included streptomycin
(Bayman et al. 1998, Pela´ez et al. 1998, Taylor et al. 1999, Fro¨hlich et al. 2000, Guo
et al. 2000), chloramphenicol (Bayman et al. 1998, Suryanarayanan et al. 2003), ter-
ramycin (Pela´ez et al. 1998) and tetracycline (Dingle & McGee 2003). In addition to
the antibiotics, 3/4 of the media used by Pela´ez et al. (1998) contained a fungicide –
either benomyl, cyclosporin or cyclohexamide. Low levels of cyclosporin can restrict
the radial growth of ascomyctes and prevent sporulation in mucoraceous fungi, with-
out preventing the growth of any species; low levels of benomyl and cyclohexamide
will inhibit some species, thus allowing selective growth of others (Bills 1996). Rose
bengal was included to slow the growth of rapidily growing fungi in media utilised by
Bayman et al. (1998), Taylor et al. (1999) and Guo et al. (2000).
Incubation temperatures ranged from a minimum of 18oC (Johnston 1998) to 26oC
(Suryanarayanan et al. 2003), for 3 weeks (Johnston 1998, Arnold et al. 2001, Surya-
narayanan et al. 2003, Paulus et al. 2006) to up to one year (Arnold & Lutzoni 2007).
Throughout the incubation period, plates were checked regularly for the appearance
of fungal hyphae. Once detected, hyphae were generally transferred to media without
supplements, usually PDA (Bayman et al. 1998, Johnston 1998, Pela´ez et al. 1998,
Fro¨hlich et al. 2000, Dingle & McGee 2003, Strobel & Daisy 2003, Paulus et al.
2006) or MEA (Bayman et al. 1998, Guo et al. 2000, Paulus et al. 2003). To encour-
age sporulation, additional media were employed, including oatmeal agar (Johnston
1998), or agar incorporating a strip of autoclaved host-plant material (Taylor et al.
1999, Fro¨hlich et al. 2000, Guo et al. 2000, Paulus et al. 2003). Media used for the
latter included MEA with (Taylor et al. 1999) or without antibiotics (Fro¨hlich et al.
2000), Potato Carrot Agar (Paulus et al. 2003) and PDA, corn meal agar and tap water
agar (Guo et al. 2000).
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2.2 Materials and Methods
2.2.1 Trialling Isolation Methods
Initially, a brief trial was conducted to determine the best methods for surface sterili-
sation and sectioning of the plant material. Due to a personal curiosity and extensive
availability, the exotic bush Lantana camara was selected to provide the test material
for the trial.
Prewash
A branch of lantana was cut from a healthy bush, and selected leaves washed by plac-
ing them into beakers of clean tap water and stirring. The water in each beaker was
replaced twice. Washing lasted approximately 1.5 hours at room temperature. The
washed leaves were then transferred to a beaker of sterile reverse osmosis (RO) water
in the Biological Safety Cabinet (BSC), where they were held until treated. To deter-
mine the impact of the pre-wash step on the population of epiphytic micro-organisms,
both surfaces of a washed and an unwashed leaf were gently pressed onto the surface
of separate Sabouraud Dextrose Agar (SDA) plates. The leaves were discarded, and
the plates incubated in the dark at 25oC for seven days.
To determine the necessity of the pre-wash step, an unwashed leaf was flamed as de-
scribed below, and a test plate prepared as described above.
Surface sterilisation
Individual pre-washed leaves were submitted to one of two surface sterilisation treat-
ments – an ethanol-bleach-ethanol treatment as described by Dingle & McGee (2003)
and flaming as suggested in Bills (1996). A pair of flame sterilised forceps were
utilised for all stages of handling the leaves. Both treatments commenced by allowing
excess water from the final rinse to drip back into the beaker, before the leaves were
placed into a beaker containing 96% ethanol.
The ethanol-bleach-ethanol treatment continued after the leaf was submerged in the
alcohol for one minute. It was subsequently transferred to a beaker containing bleach
which had been diluted to a concentration providing two percent available chlorine.
After 25 minutes, it was transferred to a second beaker containing 96% ethanol, where
it remained for 30 seconds before being rinsed in sterile water and held until required.
For the flaming treatment, excess alcohol was allowed to drip back into the container
and the leaf passed quickly through the blue flame of a bunsen burner to burn off the
alcohol remaining.
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Both surfaces of each treated leaf were gently pressed on to the surface of an SDA
plate, and the leaf discarded. All plates were incubated in the dark at 25oC for seven
days.
Leaf sampling
Several leaves were surface sterilised using the ethanol-bleach-ethanol procedure as
described above. Sections of each leaf were then taken using different methods:
Method 1 A sterile scalpel was used to cut a leaf into quarters, each of which was
placed on one half of an agar plate
Method 2 A sterile scalpel was used to cut two small squares out of the center of one
leaf, and each placed on one quarter of an agar plate.
Method 3 A single hole punch was sterilised by dipping into 95% ethanol, followed by
passage through the flame of a bunsen burner to burn off the alcohol. Two holes were
punched into the center of one leaf, and the punched-out disks placed on to the other
two quarters of the preceding agar plate
Method 4 Two disks from one leaf were obtained using the hole punch. Each disk
was placed in a sterile microcentrifuge tube containing 0.5ml sterile water. A sterilised
pestle was used to break up the disk, and expose its contents to the water. The entire
liquid content of one tube was spread onto a single agar plate. 0.1ml aliquots from the
other tube were spread on multiple agar plates.
The leaves and sections were kept in sterile Petri dishes during sectioning. SDA plates
which had been previously prepared as per the manufacturer’s instructions were used
for all tests. All plates were incubated at 25oC for 14 days.
2.2.2 Isolate Collection
Formulations and recipes of all media can be found in Appendix B.
15g/1000ml solutions of streptomycin and tetracycline were prepared by dissolving
0.15g of antibiotic into separate vials containing 10ml RO Water. Both were filter
sterilised through a 0.22µm syringe filter into several sterile microcentrifuge tubes.
Streptomycin solutions were stored at 4oC and the tetracycline at -20oC.
Four-hundred millilitre volumes of PDA and MEA were prepared and autoclaved ac-
cording to the manufacturer’s instructions. Once cooled to approximately 55oC, the
molten agar without antibiotics was poured directly into twenty sterile 90mm Petri
dishes and allowed to set. For media containing antibiotics, 400µl of the streptomycin
and tetracycline solutions were added and gently mixed into the cooled media before
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pouring into plates. All plates were labelled and stored upside down in plastic bags in
the refrigerator, and used within one month.
Five-hundred millilitre volumes of RO Water in Schott Bottles were autoclaved on a
Fluids cycle at 121oC for fifteen minutes.
Blotting paper strips were placed into autoclavable paper bags and autoclaved on a
Porous Cycle at 121oC for fifteen minutes.
Pyrex beakers (250 – 500ml) were topped with foil and autoclaved on a Hard Goods
cycle at 121oC for fifteen minutes or autoclaved with either of the other items.
Plant Sample Collection
Two areas local to Toowoomba were selected for collection of plant specimens – a dry
sclerophyll forest to the South of the city at Preston, and a dry rainforest at Redwood
Park in the North-Eastern suburbs of Toowoomba. A permit was granted from the
Queensland Parks and Wildlife Service for collection of plant samples from Redwood
Park. Collections at Preston were on private land.
A minimum of three plant specimens of each species were located in the sample area,
ensuring some distance was kept between each plant specimen (i.e. they were not next
to each other, but were separated by other plants). Secateurs were used to remove a
small (but excess) sample of the plant, which was placed immediately into its own
plastic or paper bag and labelled. At the completion of collection, the samples were
returned to the laboratory for the next stage of the process.
Samples were stored in cool areas or in a refrigerator if they were unable to be pro-
cessed on the day of collection. A list of plants sampled from each location can be
found in Table 2.2.
Plant Sample Sectioning
Initial washing of the plant material was performed in non-sterile conditions. The final
wash, and all subsequent steps involved in sectioning were undertaken in the BSC and
aseptic techniques followed.
Two to three leaves or smaller samples of twigs, stems and roots were placed into small
plastic bags (one per plant sample) and filled with tap water. The bags were then sealed
and shaken in order to clean the sample material. The water was replaced twice more,
and the agitation repeated. The final prewash was performed in the BSC, where the
plant material was removed from the bag and placed into a sterile beaker containing
sterile RO water. From this point on, the plant material was handled as aseptically as
possible. Having been rinsed in the sterile water, the plant material was finally removed
to a sheet of sterile blotting paper and excess water gently removed. At this point of
20
CHAPTER 2. ACQUISITION OF FUNGAL ISOLATES
Table 2.2: Species of plants sampled from each location.
LOCATION SCIENTIFIC NAME COMMON NAME
Preston
Acacia fimbriata Brisbane Wattle
Alphitonia excelsa Red Ash
Smilax australis Smilax
Xanthorrhoea johnsonii Grass Tree
Lantana camara Lantana
Redwood Park
Alyxia ruscifolia Chain fruit
Aphananthe philippinensis Rough-leaved Elm
Austromyrtus bidwillii Python Tree
Bridelia leichardtii Bush Ironwood
Dendrobium rex King Orchid
Elattostachys xylocarpa White Tamarind
Hoya australis Native Hoya
Mallotus claoxylloides Green Kamala
Streblus brunonianus Whalebone
Cultivated Wollemia nobilis Wollemi Pine
A small, but excess amount of material was removed from each plant specimen
and bagged, before being transported to the laboratory for isolation of endophytic
fungi.
the procedure, the first control plate was prepared.
A piece of the washed plant material from the first plant sample of each species was
gently pressed to the surface of an antibiotic-free PDA plate, which was then set aside
for incubation. The same piece of plant material was then sterilised (as described be-
low), and a second antibiotic-free PDA plate inoculated as for the first control plate.
This provided a sample of the epiphytic micro-organisms present on the washed sam-
ple, so that the effectiveness of surface sterilisation could be estimated.
After removal of the excess water, the plant material was dipped briefly into 96%
ethanol, removed, and excess alcohol allowed to drip back into the container. The al-
cohol remaining on the surface of the plant material was then flamed off by passing
the sample quickly through the blue flame of a bunsen burner, thus sterilising the ma-
terial’s surface. The sterile material was transferred to a sterile Petri dish to allow for
ease of handling and for sectioning.
Flamed equipment (dipped into 96% ethanol then passed through blue flame of a bun-
sen burner and allowed to cool) was used to section the plant material. In the case of
flat leaves, a single hole punch was used to punch numerous holes into several leaves
(where possible) of each specimen. The pieces punched out were used as the sample
21
CHAPTER 2. ACQUISITION OF FUNGAL ISOLATES
section. For roots, stems and grass-like leaves, a sterile scalpel was utilised, to produce
numerous sliced sections. Four to eight sections (depending on number of sections ob-
tained) were aseptically transferred to each of a PDA and MEA plate, both containing
antibiotics. Plates were then placed into plastic bags and lightly sealed for ease of
handling and incubation.
The bagged plates were incubated at 25oC for up to one month, and routinely examined
for evidence of hyphae growth. A small amount of natural light was able to enter the
incubator via a small panel in the door. No artificial light was employed.
Endophyte Isolation and Collection
All manipulations of fungal cultures were performed on the bench, using a bunsen
burner to provide a small sterile environment. To reduce bacterial contamination, the
bench was pre-sprayed with 70% ethanol which was allowed to evaporate immediately
before work commenced.
As fungal growth was detected, small sections of agar containing the growing hyphae
were removed with a flamed and cooled agar cutter, and placed on fresh, antibiotic-free
PDA plates. One plate was used per fungal isolation. The plates were incubated as pre-
viously described, and the growth checked every several days. As colony form became
distinct, its morphology was compared with the growth obtained on the original plate.
Where this was obviously different, a second plate was prepared from the original.
In most cases, the initial endophyte isolation was sufficient to provide a pure culture,
and no further subculturing was required. In the few instances where this was not
the case, subculturing of each apparent isolate was performed until pure cultures were
obtained. In two cases, this required the use of a spread plating technique, as would be
performed with bacteria.
Once in pure culture, three methods of storage were employed to minimise the risk of
loss of an isolate, and ranged from short (up to 12 months) to longer term storage. All
three methods required cubes of agar containing hyphae, which were cut from the pure
isolate culture. A flame sterilised scalpel was used to slice at least ten cubes measuring
approximately 3 to 5mm square, from an area containing the isolate.
1. PDA Slopes – PDA was prepared as per the manufacturer’s instructions, and
boiled to dissolve the agar. 14ml of the liquid, cooled to approximately 55oC,
was dispensed into a number of wide-mouthed 25ml glass vials. Following ster-
ilisation in the autoclave, the vials were placed on to a board and allowed to
set in a sloped position. Once set, a single cube of agar containing hyphae was
placed in the centre of the agar slope, and the vial labelled. Inoculated vials
were incubated at 25oC and routinely examined for presence of sufficient, pure
isolate growth. Once obtained, the vial was transferred to a storage container
and stored at 4oC. This form of storage is suitable for short term storage, with
fungal viability lasting for up to one year (Smith 1988).
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2. Water storage – Cryovials containing 1ml of RO water were sterilised in the
autoclave on a Fluids cycle at 121oC for 15 minutes and allowed to cool. Several
cubes of agar containing hyphae were added to each cryovial and submerged
under the water. Labelled vials were placed into a storage box and placed into
a fridge at 4oC. It has been shown by McGinnis et al. (1974) that storage in a
similar manner at 25oC has a successful revival rate of at least 92% after 5 years;
3. Cryopreservation – Several cubes of agar containing hyphae were placed into
a sterile cryovial, and covered with a sterile, aqueous 25% glycerol solution.
Labelled vials were placed into a storage box which was placed into a -70oC
freezer. This method can provide long term viability (Bills 1996).
2.3 Results
2.3.1 Trialling Isolation Methods
Pre-wash
As can be seen in Table 2.3, washing the plant material reduced the number of epiphytic
organisms on the leaf surface. However, problems were encountered with the material
becoming entangled in the magnetic stirring bar, so an alternative method of agitation
needed to be developed.
Flaming an unwashed leaf also led to a reduction in surface organisms. However, when
compared with the results obtained when flaming is combined with a pre-wash, as seen
in Table 2.4, flaming on its own did not provide a suitable surface sterilisation result.
Surface sterilisation
Table 2.4 shows both methods of sterilisation reduced the population of surface organ-
isms. However flaming alcohol off the leaf surface proved to be the more successful of
the two, being quicker and more simplified. Occasionally the leaf matter continued to
burn after the alcohol had gone, but burnt areas were simply avoided during sampling.
Leaf Sampling
Table 2.5 shows the description of growth obtained from the leaf samples, and an in-
dicator of potential sub-culturing efficiency. The approach using homogenised disks
appeared to be unsuccessful, as no useful colony growth was obtained on any of the
plates. Fungal growth from the leaf quarters was excessive, reducing the ease of ob-
taining individual isolates. The larger leaf sections were also more difficult to handle
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Table 2.3: Results showing impact of pre-washing leaves on the fungal epiphytic or-
ganism population.
TREATMENT RESULTS
Unwashed Entire agar surface covered with diverse range
of fungal colonies
Washed
Entire agar surface covered, however with a re-
duced diversity of species compared with the
unwashed plate
Unwashed/flamed
Entire agar surface covered with two main
moulds and several smaller ones. Reduced
number of colonies compared with the washed
plate
Test leaves were either washed in several changes of non-sterile tap water, fol-
lowed by a final rinse in sterile RO water, or left unwashed. Flamed leaves were
immersed in ethanol before being passed through the flame of a bunsen burner.
Both surfaces of each test leaf were subsequently pressed onto a SDA plate, the
leaf discarded, and the plate incubated.
than the smaller disk or square sections. Disks or small leaf squares proved to be the
most efficient way of obtaining discreet endophytic colonies. Using the hole punch was
much quicker and easier than using the scalpel, and would be the preferred method of
providing sections from flat leaves.
Therefore, based on observations and results of the trial, it was decided that plant
material collected for isolation of endophytic fungi would be washed and then flamed
before being punched with a hole punch where possible, to provide the sections.
2.3.2 Isolate Collection
Control Plates
All washed but pre-sterilised plant samples demonstrated the presence of a large num-
ber and diversity of fungal species colonising the external surfaces. Surface sterilisa-
tion of leaf samples generally resulted in the destruction of these potential contami-
nants. However, some apparent epiphytes remained on the root samples after sterilisa-
tion.
Flame sterilisation proved to be an effective method for the surface sterilisation of
the plant material - the leaves in particular. This can be seen in Figure 2.1(a) in the
photograph of the control plates prepared from the Streblus sp. leaf sample. The agar
plate exposed to the washed but unsterilised leaf became completely covered by growth
of fungal epiphytes. However, the plate exposed to the same leaf after surface flaming,
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Table 2.4: Results comparing two different surface sterilisation methods applied to
pre-washed leaves.
TREATMENT RESULTS
Ethanol-bleach-ethanol Bulk of agar surface covered by a single mould
species. Two other fungal species evident
Flamed No growth
The ethanol-bleach-ethanol method involved sequential soaking of the plant mate-
rial in 96% ethanol, bleach diluted to provide 2% available chlorine, followed by
immersion in another volume of 96% ethanol. Flaming involved immersing the
material into 96% ethanol, removing the excess, and passing the material through
the blue flame of a bunsen burner. Both surfaces of each test leaf were pressed
onto a SDA plate, the leaf discarded, and the plate incubated.
Table 2.5: Results of different leaf sampling techniques.
SECTION
TYPE RESULTS
Disks vs. cut
squares
Mycelial growth occurred at the edge of one of
each section type. Easy to sub-culture
Homogenised
disks
One compact yeast-like colony grew from the
plate with the 0.5ml aliquot. No growth from
the others
Quartered leaf
Entire surface of both plates covered by less
than ten fungal species. Difficult to isolate indi-
vidual colonies
Test leaves were washed and surface sterilised. Disks were punched out of the
leaf with a flame-sterilised hole punch. Cuts were made with a sterile scalpel.
grew nothing, which suggested the leaf surface had been effectively sterilised.
Figure 2.1(b)shows the same process but with a root sample from an Acacia fimbriata.
The washed but unsterilised root remained heavily contaminated, and this was exten-
sively reduced but not eliminated by flame sterilisation. However, in the majority of
cases, it was found that epiphytes remaining on the root surface appeared to be yeasts,
which were not a focus of this project, and so could be discounted.
Where epiphytic contamination remained possible after flame sterilisation, the mor-
phology of individual fungi was compared with the morphology of the isolates ob-
tained from the sections. Where morphological characteristics were found to be simi-
lar, those isolates were considered to be epiphytic contaminants.
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(a) Control plates – Leaf
(b) Control plates – Root
Figure 2.1: Examples of Sterilisation Control plates. Both figures show the growth
obtained after pressing the washed, but unsterilised plant tissue to the agar surface in
the left hand plate, while the plate on the right demonstrates the same tissue after flame
sterilisation. The upper set were from Streblus brunonianus leaf; the lower set were
from Acacia fimbriata root.
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Sample Plates
Fungi did not grow from all sections plated, while a small number of individual sec-
tions yielded two or three isolates. Both yeasts and moulds were recoverable from the
sections. However, due to the nature of the project, efforts were concentrated on the
endophytic moulds.
Some plates were overwhelmed by growth from one fast growing fungus. This re-
quired quick intervention, where unaffected sections were transferred to a fresh plate.
However, this did not always lead to a satisfactory result, where either the fast-growing
fungus persisted, or no new isolates grew at all.
Endophytic Isolates
Most sub-cultured isolates showed good resemblance to the cultures from the origi-
nal plates, and in addition, resulted in pure cultures without the need for further sub-
culturing. A total of 133 fungal cultures were grown with over 90% being moulds.
Macroscopic examination suggested that over 100 fungal species were represented,
including species of Fusarium, Epicoccum, Aspergillus and Penicillium.
Duplicate isolates tended to be from the same forest location but not from the same
plant species. One duplicate fungal species was isolated from both the Preston and
Redwood Park sites.
All plant species sampled provided at least one endophyte. Details of the total number
of fungal isolates and number of unique isolates obtained per plant host species can be
seen in Table 2.6. Within each plant host species, any multiple occurances of isolates
only occured within individual plant hosts.
Unfortunately, eleven of the cultures proved difficult to grow sufficiently to enable stor-
age, and so did not become part of the isolate collection. Each isolate was designated
a unique identifier, based on the plant sample of origin, and the number of isolates
obtained from that sample.
2.4 Discussion
It was determined during the initial trial that agitating the plant material in sequential
fixed volumes of water was sufficient to decrease the contaminant load, and thereby
increase the efficiency of the surface sterilisation method employed. Similarly, the
final part of the pre-wash was performed using sterile water and equipment, so as not
to introduce extra contaminants.
Flaming of the plant material appeared to provide a sufficient level of surface sterilisa-
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Table 2.6: Summary of Isolates obtained from each plant species.
PLANT NAME SAMPLETYPE
PLANTS
SAMPLED
SECTIONS
PREPARED
ISOLATES
OBTAINED
UNIQUE
ISOLATES1
A. fimbriata Leaf 5 20 6 6
Root 3 7 4 4
A. excelsa Leaf 3 36 4 3
S. australis Leaf 3 36 2 2
X. johnsonii Leaf 3 38 9 7
Trunk 1 10 9 9
L. camara Root 4 12 17 16
Leaf 3 32 4 4
A. ruscifolia Leaf 3 36 3 3
A. philippinensis Leaf 3 37 1 1
A. bidwillii Leaf 3 26 4 4
B. leichardtii Leaf 3 28 13 12
D. rex Root 9 118 29 22
Leaf 2 24 0 0
E. xylocarpa Leaf 3 36 3 3
H. australis Leaf 3 28 18 13
M. claoxylloides Leaf 3 36 3 3
S. brunonianus Leaf 3 36 3 3
W. nobilis
Leaf 1 24 0 0
Stem 1 9 1 1
Sap 1 N/A 0 0
SITE PLANTSSAMPLED
SECTIONS
PREPARED
ISOLATES
OBTAINED
Preston 25 191 55
Redwood Park 35 405 77
TOTAL (not includ-
ing Wollemi Pine) 60 596 132
TOTAL (including
Pine) 61 629 133
1 Unique isolates per plant host
The first part of the upper section of the table lists samples obtained from Preston,
while the second part lists those collected from Redwood Park. The Wollemi Pine
was a cultivated specimen.
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tion, though there may have been times where it resulted in over- or under-sterilisation
of the plant tissue surface. This can be dependent on the texture and size of the mate-
rial, and is a risk in common with any surface sterilisation method. However, it was
noted that in previous studies many researchers surface sterilised the material after it
was sectioned, rather than before, as was done in this project. It is not known what im-
pact this would have on the isolation of endophytic fungi, but may possibly decrease
the number of taxa obtained.
The procedures followed here, proved to be successful in the isolation of endophytic
fungi. Fifteen plant species from two main sites were selected for sampling, and ma-
terial was harvested from 61 individual plants. Following surface sterilisation and
sampling, 629 tissue segments were placed onto solid media for culturing. 133 isolates
were grown, and were predominantly moulds. Cursory morphological comparison
suggested over 100 fungal species were represented.
On average, 0.21 isolates were obtained per tissue segment. This figure is quite low
when compared with other studies – an average of 0.6 isolates per tissue sample was
obtained by Taylor et al. (1999), whilst Fro¨hlich et al. (2000) obtained an average of
1.44. Many factors would influence the rate of isolates obtained per tissue segment
including plant host species, growth conditions and location, treatment of plant tissue,
and culturing conditions. Of particular note in the latter, the use of additional sup-
plements in the media may have been of benefit, especially those used to restrict the
growth of fast growing fungi.
At least one endophyte was cultured from each plant species, a similar finding to that
of Pela´ez et al. (1998), where all but one plant species yielded an endophytic isolate.
Their study examined fewer plant species (9), and fewer individual hosts (45) than this
project. 2880 tissue samples were cultured, and produced 152 fungal species, a rate of
approximately 0.05 species per sample. This was almost half the rate obtained for this
project (0.16 species per sample), but is the closest to this research.
In their study of the endophytic assemblages of two tropical forests, Suryanarayanan
et al. (2003) examined 24 plant species. The culture of 3600 tissue segments resulted
in the production of 81 species of fungi, a rate of 0.02 species per sample.
A similar rate was obtained by Taylor et al. (1999) and Guo et al. (2000) in their bids to
identify all endophytic fungi associated with a single palm-host species. Taylor et al.
(1999) obtained 75 fungal species from 3256 leaf samples of Trachycarpus fortunei;
Guo et al. (2000) cultured 750 tissue samples from Livistona chinensis, which yielded
16 fungal species. This work resulted in an average species to sample rate of 0.23 and
0.2 respectively.
Due to the higher level of diversity encountered in this project, multiple isolations of
an individual fungal species were quite low. 7.5% of isolate species were found more
than once, and were predominantly isolated from the same individual host. Therefore,
92.5% of the fungal species isolated were unique. The study conducted by Fro¨hlich
et al. (2000) found 49.8% of isolates were found once, while only 30.9% of isolates
obtained by Suryanarayanan et al. (2003) were unique.
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Many aspects in the collection of endophytic fungi could have an impact on the results.
These include selection of hosts, host sampling conditions and methods, sample size,
tissue segment size, and tissue segment treatment.
Therefore, it is difficult to compare results with other studies due to the differing meth-
ods followed. In addition, the ultimate purpose of the individual research will have an
impact on the process, from the selection of plant hosts and sites, to the processing of
the material, to the subculturing and levels of identification of the resulting isolates.
The aim of this stage of this project was not to determine every endophytic species of
a plant host or site, but to obtain a diverse range of fungal species for further study in
the search for novel antibiotics. While the number of individual isolates obtained was
smaller than other studies, the diversity obtained was larger. Therefore, the procedures
followed as described under Materials and Methods, were sufficient for the fulfilment
of the original goal.
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Screening for Antimicrobial Activity
3.1 Introduction
Acquisition of endophytic fungi from the 15 plant species sampled yielded a total of
122 isolates for the next phase of the project. This involved the preliminary screening
of each fungal isolate for antimicrobial activity against a panel of selected nosocomial
pathogens.
Antibiotic activity comes from the production of secondary metabolites by the fun-
gal isolate. To determine the most suitable medium and method to encourage and
detect production of secondary metabolites, a trial was conducted. Two screening
methods were initially examined, testing the response of Staphylococcus aureus and
Escherichia coli to substances produced in culture by the fungus Penicillium chryso-
genum. As it was known the substances produced would potentially include penicillin,
the two test microbes offered a sensitive and resistant response respectively to the an-
tibiotic.
Using information garnered from the trial, two methods were developed for the screen-
ing of the isolates. These involved the culturing of each isolate on a suitable medium
and exposing the test bacteria to the secondary metabolites produced in the medium.
After incubation, the bacterial cultures were examined for the presence of inhibition.
Fungal isolates which demonstrated some activity against any of the test organisms
were further examined in the next two stages of this project.
3.1.1 Secondary Metabolites
Secondary metabolites are a by-product of an organism’s growth, yet do not appear to
be required for its normal growth (Demain 1986, Strobel & Daisy 2003, Deacon 2006).
However, while production of secondary metabolites does not appear to be a necessary
function (Deacon 2006), particularly when the fungus is grown in pure culture (De-
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main 1986, Strobel & Daisy 2003) it is thought that in a natural environment these
metabolites may play a specific role (Calvo et al. 2002, Strobel & Daisy 2003). Sec-
ondary metabolites would certainly enhance the survival of the fungus (Demain 1986),
for example by providing protection from pathogens (Strobel & Daisy 2003). They
have also been associated with fungal sporulation, but do not always appear to be an
essential component of the process (Calvo et al. 2002). It has also been suggested that
during periods of restricted growth, in order to avoid the accumulation of metabolic
intermediates and their potentially toxic affects, the fungus converts them via the sec-
ondary metabolite pathways into alternative products which may be less toxic, or can
be eliminated completely (Deacon 2006). Nonetheless, the purpose of endophytic sec-
ondary metabolites remains uncertain (Strobel & Daisy 2003). Examples of secondary
metabolites include mycotoxins and pigments (Demain 1986, Calvo et al. 2002).
Secondary metabolites with antimicrobial properties are not produced by all fungi (De-
main 1986, Pela´ez et al. 1998, Rosa et al. 2003, Strobel & Daisy 2003), and those
produced may vary depending on the environment to which the fungi have adapted
(Schulz et al. 2002, Strobel & Daisy 2003). Great variation has been observed be-
tween species (Demain 1986, Schulz et al. 1995) and between strains or isolates of the
same species (Pela´ez et al. 1998, Schulz et al. 1995, 2002, Rosa et al. 2003, Strobel &
Daisy 2003). Strobel & Daisy (2003) reported a case where a biologically active com-
pound was produced from a single endophytic fungal isolate out of many of the same
species isolated from the same plant. Therefore, in the search for antimicrobially active
secondary metabolites, all isolates should be screened regardless of species similarity
(Pela´ez et al. 1998, Rosa et al. 2003).
A number of factors influence the production of secondary metabolites in culture.
Growth rate is possibly the most important, as it has been found that secondary metabo-
lites are not produced during rapid growth (Demain 1986, Deacon 2006), and often do
not occur until the organism has reached its stationary phase (Demain 1986, Calvo et al.
2002, Deacon 2006). Growth rate can be influenced particularly by medium composi-
tion. For example, a rapidly utilised carbon source, such as glucose, encourages rapid
growth, and therefore can interfere with the production of secondary metabolites. Pro-
duction of penicillin and cephalosporin are inhibited where glucose is the sole carbon
source. Slowly metabolised sugars, including sucrose and galactose are preferable to
the rapidly metabolised sugars such as glucose and maltose (Demain 1986). Early
nutritional experiments conducted by Fleming (1929) found penicillin production by
Penicillium chrysogenum was delayed or inhibited when glucose or saccharose were
added to the culture medium.
The limiting factor for fungal growth is usually the nitrogen component of the medium
(Trilli et al. 1978, Calvo et al. 2002, Deacon 2006). While secondary metabolite pro-
duction may not commence until the nitrogen source has been depleted, the choice
of nitrogen source can also have a major impact on its production. Ammonia, for
instance, can suppress it completely while amino acids offer a better alternative. How-
ever, where specific amino acids share elements of the same metabolic pathway as the
secondary metabolite of interest, they may inhibit its production by being a part of the
feedback control (Demain 1986).
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Growth conditions may also be used to encourage the production of secondary metabo-
lites. Incubation of the culture at a temperature that is lower than that for optimal
growth, slows the growth rate down, and may also be required for the production of
some secondary metabolites (Demain 1986). Levels of aeration also have an impact
on secondary metabolism production (Jennison et al. 1956, Demain 1986, Schulz et al.
1995).
Secondary metabolites extracted from endophytes have found uses as antibiotics (De-
main 1986, Strobel & Daisy 2003), antivirals, anticancer, antioxidant, insecticidal,
anti-diabetic and immunosuppressive agents (Strobel & Daisy 2003).
3.1.2 Screening techniques
Methods for the screening of fungal secondary metabolites for antimicrobial activity
appear to be divided into three general approaches:
Approach 1 The fungal isolate was cultured on an agar plate capable of supporting
bacterial and fungal growth. When sufficient growth was obtained, the test bacteria
was applied to the plate. Plates were incubated, and then observed for evidence of
inhibition.
This was the primary screening method used by Emerson et al. (1946) to screen 210
moulds against a panel of 5 bacteria. Two types of media were utilised, and the fungi
grown until the colony size was between 20 to 25mm in diameter. Test organisms
were grown in broth, and streaked from the edge of the colony to the edge of the
plate. Following incubation overnight at 37oC, the streaks were examined for areas of
inhibition.
To screen for the presence of antimicrobial activity in 85 strains of Pezicula species,
Schulz et al. (1995) cultured the fungi on a medium similar in composition to Nutrient
agar with glucose. Once the fungal colonies reached 3.5cm in diameter, the plates were
sprayed with a suspension of the test organism in water. After overnight incubation at
37oC, the plates were examined for zones of inhibition. The same laboratory subse-
quently utilised this procedure in the screening for antimicrobial activity in over 6000
endophytic isolates (Schulz et al. 2002).
Approach 2 The fungal isolate was cultured in/on media suitable for the cultivation
of fungi. When suitable growth was obtained, the medium, or a portion of it, was
transfered to media suitable for cultivation of bacteria. The test bacteria were applied,
the plates incubated, and observed for inhibition.
Fleming combined broth in which P. chrysogenum had grown with agar, and poured
the mixture into a furrow previously cut into an agar plate. Once set, test bacteria were
streaked from the furrow edge to the edge of the plate, and incubated (Fleming 1929).
Trilli et al. (1978) poured media into plates to a depth of 3mm. Once set, 4mm disks
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were cut from the agar with a sterile cork borer, and the disks point inoculated with
the fungi. After incubation of up to 5 days, the disks were transferred to Nunc plates
containing bacterial medium incorporating the test organism, and the plates incubated
overnight. Uninoculated disks were kept in sterile conditions in a humid chamber at
28oC and used within 3 days.
In researching the production of penicillin by various species and strains of Penicil-
lium, Laich et al. (2002) grew the fungi on plates of Malt Extract Agar (MEA). After
7 to 10 days of growth at 25oC, 9mm plugs of the colonised agar were transferred onto
the surface of Tryptic Soy Agar (TSA) plates. After 48 hours of incubation at 25oC, the
plates were overlayed with a mixture of 1% TSA and the penicillin-sensitive test or-
ganism, Micrococcus luteus. The plates were held at 5oC for 2 hours, and subsequently
incubated overnight at 30 oC.
Approach 3 The fungal isolate was cultured in liquid media suitable for the cultivation
of fungi. Any secondary metabolites produced were chemically extracted, and the
finished preparation applied to plates inoculated with the test organism. Plates were
incubated and observed for inhibition.
Pela´ez et al. (1998) cultured 187 endophytic fungal isolates in a suitable broth for 3
weeks at 25oC with shaking at 220 rpm. Two millilitres of each culture were mixed
with 2ml of 100% methanol, and shaken for 15 minutes. After centrifugation for 15
minutes at 3000 rpm, 2ml of the supernatant was removed and evaporated to 1ml by
nitrogen flow, to remove some of the methanol and concentrate any secondary metabo-
lites present. Bacterial test plates were prepared by adding 3.3ml of a bacterial sus-
pension adjusted to an optical density of between 0.22 to 0.35 at 660nm, to 100ml of
medium and poured into 24x24cm Nunc plates. Once set, the fungal extracts were
applied to the plate surface, and the plates incubated overnight.
In screening basidiomycetes for antimicrobial activity, Rosa et al. (2003) cultured the
fungi in 100ml of liquid medium for 9 days at 28oC with shaking at 150 rpm. The
cultures were subsequently frozen until the extraction process could proceed. After
thawing, the cultures were homogenised and extracted 5 times with 30ml volumes of
ethyl acetate. The organic fraction was dried over anhydrous sodium sulphate, and
rotary evaporation used to remove the solvent. 10mg/ml stock solutions of the product
were prepared in di-methyl sulfoxide (DMSO) and stored at -40oC. Test plates were
prepared by spreading test bacteria over the surface of Brain Heart Infusion (BHI) agar
plates, and applying 10µl spots of diluted extract (1mg/ml in 5% aqueous DMSO) to
the surface. After 24 to 48 hours of incubation, the plates were observed for zones of
inhibition.
A similar culture and extraction process was followed by Rodrigues et al. (2000) with
selected endophytic isolates harvested from Spondias mombin, a Brazilian plant asso-
ciated with traditional medicine. Extracts were dissolved in methanol, and 10µl added
to wells in a 96-well cell culture plate, to which a system of growth media and test
organisms was added. The plates were analysed by a pharmaceuticals company as part
of a high throughput screening program.
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The screening programmes undertaken by the above researchers examined the re-
sponses of a range of organisms, including Bacillus subtilis, S. aureus and Pseu-
domonas aeruginosa (Emerson et al. 1946, Pela´ez et al. 1998, Rosa et al. 2003),
E. coli (Emerson et al. 1946, Schulz et al. 1995, Rodrigues et al. 2000, Rosa et al.
2003), B. cereus, S. epidermidis, Salmonella typhimurium (Rosa et al. 2003), Serratia
marcescens (Pela´ez et al. 1998), and a number of fastidious bacteria and yeasts (Pela´ez
et al. 1998, Rodrigues et al. 2000, Rosa et al. 2003). These have comprised laboratory
and ATCC typed strains.
3.2 Materials and Methods
3.2.1 Trial with known antibiotic producer
Two trials were utilised to determine the best procedure for screening the isolates
for production of antimicrobially-active secondary metabolites. A known antibiotic
producer, Penicillium chrysogenum, was used as the test fungal species against the
penicillin-sensitive bacterium Staphylococcus aureus (ATCC 25923). Escherichia coli
(ATCC 25922) was included as a negative (resistant) control. The first trial was based
on an ethanol extraction method and examined three areas – the growth medium;
growth conditions; and pre-extraction treatment. The second trial focused on the use
of direct screening on solid bacterial culture medium.
P. chrysogenum was grown on a PDA plate for seven days at 25oC. PBS (Phosphate
Buffered Saline) was prepared by diluting the appropriate volume of GIBCO’s 10XPBS
to make 200ml, and PBS-Tween prepared by adding 0.02ml of Tween 20 to the PBS.
After mixing, a portion of the solution was sterilised by filtration through a 0.2µm
filter. A spore suspension was prepared from the Penicillium culture by washing the
plate surface with 1ml of the sterile PBS-Tween solution. The spore-laden liquid was
then transferred to a 2.5ml volume bottle containing another 1ml of the PBS-Tween,
and stored at 4oC until required.
Four 100ml volumes of Nutrient broth, two 100ml volumes of Czapek Dox broth and
one 100ml full-strength Malt Extract broth were prepared from commercially available
stocks, and prepared as per the manufacturer’s instructions. A trace metals solution
was prepared by dissolving 0.05g zinc sulphate and 0.025g copper sulphate in 5ml of
water. Czapek Dox Yeast broth was prepared by adding 0.1ml of the trace metals and
0.5ml of yeast extract to one of the 100ml Czapek Dox broths. A 50% strength Malt
Extract broth was also prepared by preparing a 50ml volume as per the manufacturer’s
instructions, and diluting to 100ml with RO water. All broths were placed into 250ml
Erlenmeyer flasks, stoppered with rolled cotton wool, and the tops covered with a
square of alfoil.
Saline was prepared by dissolving 1.74g sodium chloride in 200ml reverse osmosis
(RO) water. This was divided into two volumes of 20ml and two of 80ml.
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Four hundred millilitres of Nutrient, Sensitest, Tryptic Soy, MacConkey and Mannitol
Salt Agars were prepared as per the manufacturer’s instructions. All media and the
saline were autoclaved at 121oC for 15 minutes, and once cooled to 50oC, the agar was
poured into 90mm Petri dishes. Formulations of all media can be found in Appendix
B.
A dozen Whatman 7cm No. 2 filter papers were placed into a glass Petri dish, and fifty
Whatman 13.0mm Antibiotic Assay disks were numbered with pencil and placed into
a small glass jar. These hard goods were autoclaved at 121oC for 15 minutes together
with eight 250ml Schott bottles and two alfoil-topped 25ml measuring cylinders.
Trial 1
One volume of prepared Nutrient broth was left uninoculated as a negative control; the
remaining seven flasks of broth were each inoculated with 50µl of the freshly prepared
Penicillium spore suspension. All cultures, except for one of the Nutrient broths, were
incubated at 25oC with shaking at 100rpm for six days. The remaining flask was
incubated as a stationary culture at 25oC for the same period of time. Therefore, a total
of eight flasks containing 100ml of a particular broth were incubated for this trial.
At the end of incubation, the contents of one shaken Nutrient broth culture were trans-
ferred entirely to a sterile 250ml Schott bottle. The contents from the negative control
(broth with no fungal growth) were transferred to a second sterile Schott bottle. The
mycelia were filtered out of the six remaining cultures, by vacuum filtration through a
sterile No. 2 Whatman filter – a fresh filter being used for each culture. Each filtrate
was transferred to a sterile 250ml Schott bottle, and all bottles stored at -20oC.
Culture solutions were progressively thawed overnight at 4oC. The first Nutrient broth
culture, which had been frozen without the prior removal of the mycelium, had the
mycelium filtered out as described for the other cultures. This mycelial mass was
stored at -20oC and freeze dried later as a separate sample. Two millilitres were trans-
ferred from each thawed broth solution to a sterile 2ml tube and refrozen. The remain-
ing liquid was transferred to a sterile vacuum flask and refrozen at an approximately
45o angle and gradually rotated to obtain as small a frozen profile as possible. Once
solidified, each flask was transferred to the -70oC freezer overnight to ensure the sam-
ple was sufficiently cold for freeze drying. Each sample required approximately 30
hours to freeze dry completely.
Each freeze dried product was transferred to a sterile 10ml McCartney bottle, and 10ml
of ethanol added to the freeze dried broths. Three millilitres of ethanol were added to
the freeze dried mycelial sample. After thorough mixing, the samples were held at
-20oC until testing.
The test bacteria were revived from -70oC storage, and cultured onto TSA plates. Af-
ter overnight incubation at 37oC, the E. coli (ATCC strain 25922) was streaked onto a
MacConkey agar plate, and the S. aureus (ATCC strain 25923) streaked onto a Man-
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nitol Salt Agar plate. Swabs were also used to apply each species to one half of a
Sensitest agar plate, and a commercial (Oxoid P10) Penicillin antibiotic disk placed
in the middle of each swabbed area. After incubation overnight at 37oC, these plates
were used to confirm identity, and resistance and sensitivity to penicillin.
Bacterial suspensions were prepared by swabbing each organism over the surface of a
fresh TSA plate and incubated as previously described. Approximately 3ml of sterile
saline was applied to the surface of each plate, and the growth dislodged and suspended
with a swab. Each bacterial wash was collected into separate sterile bottles, and with
additional sterile saline was used to prepare a 50ml bacterial suspension. In order to
standardise the inoculum, the final suspension was prepared with an optical density of
approximately 0.4 at 660nm against a saline blank.
Bacterial test plates were prepared by adding 8ml of the bacterial suspension to 250ml
molten Nutrient Agar (NA) which had been cooled to 50oC. After swirling to mix,
20ml volumes were measured with a sterile 25ml graduated measuring cylinder, and
poured into 90mm sterile plastic Petri dishes. Ten plates were prepared for each test
bacterium.
Test solutions were removed from storage, and the 2ml broth samples allowed to thaw.
Sterile paper disks were spread onto a sterile surface in the BSC. Two disks were
prepared for each sample by adding 100µl of test solution to each disk, and leaving to
dry. An additional two disks were similarly prepared as a control by adding 100µl of
ethanol only.
Flame sterilised forceps were used to place four test disks onto half of the prepared
bacterial test plates. A 3mm agar punch was used to create four wells in the remaining
plates, and 10µl of test solution added in the same pattern as the disks – two sets of
filtrate and ethanol extracted pairs per plate. A P10 penicillin disk was added to one set
of plates for comparison. After allowing thirty minutes for absorption of liquid in the
wells, the plates were bagged and incubated overnight at 37oC, before being examined
for the presence or absence of zones of inhibition. The radius of zones present were
measured from the edge of the well or disk to the edge of clear inhibition.
Trial 2
The centre of one Nutrient agar plate was inoculated with a 50µl spot of the Penicillium
spore suspension, and spread to cover an area of approximately 2.5cm in diameter.
After incubation at 25oC for four days, the plate surface was flooded by the S. aureus
suspension prepared for Trial 1, and incubated overnight at 37oC. The plate was then
examined for the presence of inhibition as per the plates from Trial 1.
A second Nutrient agar plate was prepared by inoculating with Penicillium spores col-
lected on a swab which was then rolled in the centre of the plate surface to cover an
area of approximately 1.5cm in diameter. The plate was incubated for five days at
25oC.
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Nutrient broths were used to grow a selection of additional bacteria for screening:
methicillin-resistant Staphylococcus aureus (MRSA), S. epidermidis, Pseudomonas
aeruginosa, Bacillus cereus and Serratia marcescens. Inoculated broths were incu-
bated overnight at 37oC. These additional bacteria were all laboratory strains except
for S. epidermidis ATCC 14990. All bacteria were readily available, and can cause
disease in humans.
After incubation of the fungus, a loopful of each bacterial broth was streaked across the
plate from the edge of the fungal growth to the edge of the plate. The plate was then
incubated overnight at 37oC, and examined for areas of non-growth of the bacterial
streaks.
3.2.2 Fungal Isolate Screening
Using information garnered from the trial, two methods were developed for the screen-
ing of the isolates. The first method resulted in the production of an ethanol extract for
testing, while the second method utilised direct screening.
Bacterial cultures that were screened included S. aureus, MRSA, S. epidermidis, E.
coli, P. aeruginosa, S. marcescens and B. cereus.
PDA was prepared and autoclaved as per the manufacturer’s instructions, and 10ml
poured into 5cm diameter Petri dishes. Fungal isolates were revived by inoculating the
centre of the small PDA plate with a small amount of culture removed from the PDA
slant storage. Plates were incubated at 25oC until sufficient growth was produced.
Nutrient Broth was prepared as per the manufacturer’s instructions, and 100ml volumes
prepared as described in the trial. Sensitest and TSA plates and saline were prepared
as previously described.
A flame sterilised scalpel was used to cut small cubes of mycelium from the revived
cultures. One square was used to inoculate a flask containing 100ml Nutrient Broth,
and incubated with shaking at 100rpm. Another square was placed in the centre of a
Sensitest Agar plate. Both cultures were incubated at 25oC for up to one month.
Method 1
The mycelium was removed from the broth culture as described in the trial, and the
broth transferred to a 100ml sterile McCartney bottle. Samples were stored at -20oC
until they could be freeze dried, as previously described. After freeze drying, 10ml
of ethanol was added to the freeze dried product. After swirling to ensure adequate
contact with the product, the alcohol was removed to a sterile 15ml McCartney bottle,
and 10 ml of sterile water added to the remaining product. Once dissolved, the solution
was transferred to another sterile 15ml McCartney bottle. Both solutions were stored
at -20oC until tested.
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Confluent growth plates of S. aureus, MRSA, S. epidermidis, E. coli, P. aeruginosa and
S. marcescens were prepared on Tryptic Soy Agar (TSA). After incubation overnight
at 37oC, a suspension with an optical density of 0.5 at 660nm was prepared by washing
the plate and diluting in sterile saline. Ten millilitres of sterile glycerol were added to
30ml of each suspension, and the mixture aliquoted into 5ml volumes for storage at -
70oC. As bacterial testing progressed, an aliquot of each bacterium was removed from
the freezer and allowed to thaw for incorporation into test plates.
Sensitest Agar was prepared by combining 16g of medium powder with 500ml of RO
water and boiling to dissolve. Eighty millilitres were dispensed into 100ml McCartney
bottles, and autoclaved at 121oC for 15 minutes. After being cooled to 50oC, 4ml of a
thawed bacterial suspension was added and mixed before pouring 20ml volumes into
sterile Petri dishes. Five plates were prepared per bacterium at a time.
Test disks for filtrate and ethanol extracts were prepared as previously described, al-
lowing sufficient disks to test against all six bacteria. Five dried disks were applied
per bacterial plate, and plates incubated overnight at 37oC. Each plate was examined
for the absence of bacterial growth surrounding a disk. A positive result was recorded
where a clear zone was found. Where growth occurred to the edge of the disk, a nega-
tive result was recorded.
A total of five isolates were tested in this manner.
Method 2
Cultures of S. aureus, MRSA, S. epidermidis, E. coli, P. aeruginosa, S. marcescens and
B. cereus were grown on TSA plates overnight at 37oC. Once the fungal cultures on
Sensitest Agar had sufficient growth, a flame sterilised bacteriological loop was used
to streak a small amount of each bacterial species across the plate from the edge of the
fungal growth to the edge of the plate. After incubation overnight at 37oC, the growth
of each bacterial streak was examined. Where growth did not occur to the fungal edge,
the result was recorded as a positive. If the bacterium was able to grow the entire length
of the streak, it was recorded as a negative result.
3.3 Results
3.3.1 Trial with known antibiotic producer
Trial 1
As can be seen in the results for Trial 1 in Table 3.1, Nutrient Broth proved to be the
most useful medium for encouraging the production of secondary metabolites from P.
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chrysogenum.
While the Czapek Dox Yeast broth filtrate resulted in the largest zone of inhibition, it
was believed that this was due to the trace metals in the medium rather than production
of a secondary metabolite. As these were not completely dissolved in the ethanol, their
absence from the ethanol extract would allow the bacteria to grow without inhibition,
thus explaining the reduction in zone size.
There appeared to be little difference between the stationary and shaken cultures, or
whether filtration occurred with or without the mycelium filtered out.
Apart from the unusual result for the Czapek Dox Yeast filtrate, no filtrate produced
a zone of inhibition. Concentrating the filtrate by freeze drying and reconstitution in
1/10 the volume improved the result. The use of ethanol as the reconstitution liquid
also had the potential to semi purify the solution, as non-alcohol soluble elements
were not dissolved in to the solution. However, this would be a problem if any useful
secondary metabolites produced by an isolate were not alcohol soluble.
The use of disks further increased the likelihood of positive inhibition detection, as ten
times the volume of extract was used when compared with the wells.
Trial 2
The initial plate prepared for Trial 2 proved to perform better than anticipated as the
zone of inhibition extended to the extreme edge of the plate. As the bacterial sus-
pension had successfully grown in Trial 1, it was decided the lack of growth by the
Staphylococcus could only be explained as inhibition by products produced by the
fungus. Ultimately, a small number of individual colonies were located at the edge of
the agar, confirming that interpretation.
The second plate prepared was much easier to read than the first and it was therefore
easier to interpret a result. Two bacterial species clearly did not grow the entire length
of the streak, whereas the remaining bacteria did so. The full results can be seen in
Table 3.2.
3.3.2 Fungal Isolate Screening
Initially, two screening methods were used to screen the isolates. However, it became
apparent that the direct Sensitest plate method would be the better screening choice, as
it was quicker and as seen in Table 3.3, appeared to be more sensitive than the ethanol
extraction.
Of the 122 isolates in storage, 13 weren’t tested as they were macroscopically identified
as yeasts. Of the 109 isolates remaining for screening, 27 (24.7%) did not recover from
PDA slant storage; 3 (2.8%) did not grow directly on the Sensitest agar and 2 (1.8%)
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Table 3.1: Results from Screening Trial 1
BROTH
MEDIUM TREATMENT/ROLE
TEST
LIQUID
E. coli S. aureus
DISK WELL DISK WELL
Nutrient Negative Control (No
inoculant)
Filtrate - - - -
Extract - - - -
Nutrient Shaken. Filtered before
freezing
Filtrate - - - -
Extract - - 5mm 3mm
Nutrient
Shaken. Filtered after
freezing
Filtrate - - - -
Extract - - 3mm -
Mycelium
extract
- - 1mm 1mm
Nutrient Stationary. Filtered
before freezing
Filtrate - - - -
Extract - - 5mm 4mm
100% Malt
Extract Shaken. Filtered beforefreezing
Filtrate - - - -
Extract - - 3mm -
50% Malt
Extract Shaken. Filtered beforefreezing
Filtrate - - - -
Extract - - - -
Czapek
Dox Shaken. Filtered beforefreezing
Filtrate - - - -
Extract - - - -
Czapek
Dox Yeast Shaken. Filtered beforefreezing
Filtrate - - 6mm 3.5mm
Extract - - 1mm -
N/A Solvent Control(Ethanol only) N/A - - - -
N/A Positive Control (P10Disk) N/A - - 9mm 10mm
Measurements were taken from the edge of the disk/well to the edge of inhibition.
Where no inhibition was detected, the result was recorded as a negative (-). From
these results it was determined the use of Nutrient Broth followed by freeze dry-
ing, ethanol extraction and antibiotic disk assay was the preferred method for the
screening of antimicrobial activity.
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Table 3.2: Results from Screening Trial 2
ORGANISM RESULT
S. aureus +
MRSA -
S. epidermidis +
E. coli -
P. aeruginosa -
S. marcescens -
B. cereus -
Following 5 days of growth, streaks of bacteria were made from the Penicillium
chrysogenum colony to the plate edge. After incubation the streaks were scored
for presence of a section of non-growth near the fungus (+ve) or total streak
growth (-ve).
grew so quickly and heavily that the bacteria could not be applied to the plate surface.
Seventy-seven (70.6%) isolates were successfully screened using the direct Sensitest
screening procedure.
Seven isolates demonstrated some level of activity against the selected micro-organisms.
However, in the case of four of the isolates, the results were not repeatable. Therefore,
the screening process yielded three isolates whose antimicrobial activity would be fur-
ther investigated. Based on the plant sample of origin, and the number of isolates
obtained from that sample, these isolates were designated as numbers 6.5, 12.1 and
129.1. Their activity profile can be seen in Table 3.4
3.4 Discussion
As a rapid screening method, the direct Sensitest plate method was preferred over the
ethanol extraction method for two reasons – it was quicker and appeared to be more
sensitive. It also required substantially fewer materials, and if it was to be utilised in a
small laboratory, less specialised equipment. A summary of the requirements for both
methods can be seen in Table 3.5.
However, the direct Sensitest plate method also has its limitations – as seen in the
results, not all fungi are capable of growing on the Sensitest medium or alternatively,
too much fungal growth prohibits the application of the test bacteria. Results could
also be altered by the addition of supplements required for the growth of fastidious
organisms; finally, the test is limited to screening against bacteria – the medium is not
suitable for fungal pathogens. In the majority of these cases, the ethanol extraction
method, or similar, would be required.
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Table 3.3: Comparison of results obtained from each screening method.
ISOLATE SCREEN S.
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6.4 Sensitest - - - - - -
Extract - - - - - -
6.5 Sensitest + + + + - -
Extract + + + + - -
7.2 Sensitest - - + - - -
Extract - - - - - -
12.1 Sensitest + + + - - -
Extract - - - - - -
19.2 Sensitest - - - - - -
Extract - - - - - -
While the majority of the results were identical, the Sensitest results obtained for
isolates 7.2 and 12.1 would suggest that it was potentially a more sensitive screen-
ing method than the ethanol extraction method. A “+ve” indicates inhibition of
bacterial growth was detected, while no inhibition is indicated with a “-ve”.
Table 3.4: Antimicrobial activity profile of selected isolates
ISOLATE S.
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B.
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us
6.5 + + + + - - +
12.1 + + + - - - +
129.1 + + + - - - -
Following sufficient growth of the isolate, streaks of bacteria were made from the
edge of the fungal colony to the edge of the plate. After incubation overnight
at 37oC, the streaks were scored for presence of a section of non-growth near
the isolate (“+ve”) or total streak growth (“-ve”). The isolates listed above were
selected for further investigation.
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Table 3.5: Summary of the main requirements of two screening procedures
Sensitest plate method Ethanol extraction method
Time after fungal incu-
bation
Approximately 20
hours Minimum of 70 hours
Consumables per fun-
gal isolate Sensitest Agar plate 100ml Nutrient broth
Filter paper
10ml ethanol
Paper disks (1 per test bac-
terium)
Sensitest Agar plate
Equipment required Standard incubators Standard incubators
Shaking incubator
Filtration equipment
Vacuum flasks
-40oC freezer
Freeze drier
However, neither method guarantees the production of antimicrobially active secondary
metabolites.
Sensitest agar and Nutrient broth are media normally reserved for the culturing of
bacteria, so it is not surprising that not all the fungal isolates grew successfully on them.
However, it is possible the use of this media encourages the production of secondary
metabolites in some of the fungi that can be successfully grown. Specifically, as the
media is not ideal for standard fungal growth, the growth rate may be reduced – one
aspect of secondary metabolite production is that high growth rates can reduce and
even halt its occurrence (Demain 1986).
Four percent of the fungal isolates which were successfully screened demonstrated
consistent antimicrobial activity against at least one of the seven test organisms. When
compared with results obtained from other studies, this appears to be quite low.
Emerson et al. (1946) cultured 210 moulds on two media formulations, and tested for
antimicrobial activity against a panel of five bacteria. 56% (117) of the fungi demon-
strated some antimicrobial activity against at least one of the test bacteria.
Of the 103 extracts obtained by Rosa et al. (2003), 10% showed activity against at least
one of the 12 bacteria tested. However, their research was confined to Basidiomycetes,
a single phylum of the Fungal kingdom.
Approximately 22% of the 85 Pezicula species isolates tested by Schulz et al. (1995)
demonstrated some activity against one of the two bacteria tested. The same screening
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procedure was followed by the researchers later when examining over 6000 endophytic
fungal isolates. Antibacterial, fungicidal, algicidal or herbicidal activity was detected
in 80% of the isolates (Schulz et al. 2002).
Pela´ez et al. (1998) found that of 187 fungal endophytes tested, 24% demonstrated
activity against at least one of the test organisms, which included six bacteria and three
yeasts. One third of the active isolates showed activity against both classes of test
microorganism.
However, results are difficult to compare due to the differences in screening method.
In addition, different results would be expected if the number of test organisms were
expanded, different test species or strains were used, if alternative or multiple fun-
gal culture media were employed or if fungi were cultured in alternative conditions.
Schulz et al. (1995) found every Pezicula strain tested produced the same metabolite
when grown on one medium, but growth on a different medium failed to produce the
compound at all. In addition, it was found that the secondary metabolites produced by
one strain of Pezicula when grown in a fermenter culture were different when grown
in the same medium but in shaken culture. The difference appeared to be that levels
of oxygen saturation and pH were constant in the former culture, whereas they were
variable in the latter.
Aspects of this screening process could be improved. As previously mentioned, the
Sensitest plate method appeared to be more sensitive than the ethanol extraction method.
However, this may actually be as a result of enhanced production of secondary metabo-
lites by the fungus due to the presence of the bacteria. This potential feature of sec-
ondary metabolite production is routinely utilised by Kingsland & Barrow (2009), who
incorporate an autoclaved suspension of S. aureus cells into their fermentaion medium
to encourage said production. This possibility was not considered prior to the conduc-
tion of this project, and therefore, not included. It would be of interest to compare
differences in fungal secondary metabolite production with and without the presence
of bacteria, and include this as part of future screening programmes.
While the Sensitest plate method was intended as a rapid screening process, it must
be confirmed that it is also an effective screening process. Due to time constraints and
initial result comparisons, the Sensitest plate method was utilised for the majority of
the isolate screening, rather than the ethanol extraction method. However, this deci-
sion was based on the comparison of results involving just five fungal isolates. Since
expenses are incured in any type of screening programme, from the initial gathering of
the fungal isolates, to their maintenance and screening, there needs to be a maximum
chance of success. Therefore, a larger comparison of the two screening methods, and
others, needs to be undertaken to determine the optimal procedure.
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Identification of Selected Isolates
4.1 Introduction
Following screening for antimicrobially active isolates, three unique mould species
were selected for further analysis. This firstly required the determination of their
scientific classification, so as not to re-evaluate a fungus which had been previously
described and assessed. Morphological and molecular identification techniques were
utilised for this process.
The isolates were grown on PDA until some colony colour developed. A description
of the colony’s physical appearance was recorded, and the plate photographed. The
culture was subsequently used to prepare slides for microscopic examination, where a
sample of the fungus was placed onto a slide and stained with lacto-fuchsin stain. Slide
preparations were examined under x400 magnification, and microscopic structures de-
scribed.
Morphological examination was sufficient to determine the identification of one of the
isolates to genus level. Molecular analysis was required for the identification of the
two remaining isolates.
DNA was extracted from the mycelium of each isolate, and the internal transcribed
spacer (ITS) region of their DNA amplified. Following purification and cloning, the
DNA was sequenced, and the results compared with other sequences held in the Gen-
Bank database in order to determine a likely identification. Phylogenetic relationships
were also analysed for these two isolates.
4.1.1 Morphological identification
Macroscopic examination of fungal cultures can provide a description of the colony
colour (Guo et al. 2000), margin shape (Bills 1996), texture and growth rate (Bills
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1996, Guo et al. 2000), as well as the production of pigmented compound into the
culture medium (Bills 1996).
Slides for microscopic examination have been prepared in water (Arenal et al. 2005),
lactophenol cotton blue (Guo et al. 2000, Arenal et al. 2005) or in 90% lactic acid,
which also renders the slides semi-permanent (Paulus et al. 2003). Prepared slides can
also be sealed with nail varnish to improve storage (Guo et al. 2000).
Microscopic examination can be used for the description of hyphae (hyphal pigments
(Bills 1996), size, colour, presence/absence of septa), and when present, description
of the sporulation structures (Bills 1996, Guo et al. 2000, Yanna & Hyde 2002, Paulus
et al. 2003, Arenal et al. 2005), and description of spores (size, shape, texture, produc-
tion) (Guo et al. 2000, Yanna & Hyde 2002, Paulus et al. 2003, Arenal et al. 2005).
Gross colony characteristics can be used to place isolates into morphologically-similar
groups (Bills 1996, Johnston 1998, Pela´ez et al. 1998), and is especially useful where
fungi fail to sporulate (Taylor et al. 1999, Fro¨hlich et al. 2000, Guo et al. 2000, Arnold
& Lutzoni 2007). However, morphological characterisation of fungi has been used to
divide isolates into phyla (Arnold & Lutzoni 2007), families (Johnston 1998), genera
(Fro¨hlich et al. 2000) and species (Taylor et al. 1999, Yanna & Hyde 2002, Paulus et al.
2003).
For morphological examination to be used to its full potential, fungi are required to
sporulate. However, many fungi do not produce spores in artificial culture, or the
time required for them to sporulate may be prohibitive (Bills 1996). Therefore, if
identification is required, other methods must be employed (Guo et al. 2000, Healy
et al. 2004, Arnold & Lutzoni 2007).
4.1.2 Molecular identification
In the study of the endophytic fungi from the palm host Livistona chinensis, Guo et al.
(2000) were determined to identify or describe the phylogenetic relationship of ev-
ery isolate obtained. By manipulating the culture media and growth conditions to
encourage sporulation, 83.5% of isolates obtained could be identified by morpholog-
ical examination. This was comparable with results obtained by Taylor et al. (1999),
who were able to identify 87% of the isolates obtained from the palm Trachycarpus
fortunei; whilst Fro¨hlich et al. (2000) were only able to identify 56% of the isolates
obtained in their study of palms.
In the case of Guo et al. (2000), the remaining 16.5% of isolates were identified using
molecular techniques.
Located within each tandem repeat of ribosomal DNA, and flanked by the small sub-
unit 18S and large subunits 5.8S and 28S, lie two non-coding sections – the internal
transcribed spacer (ITS) region (Gardes & Bruns 1993). While the subunit genes are
highly conserved, ITS rDNA is variable between species, making it useful in molecu-
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lar identification (Gardes & Bruns 1993, Guo et al. 2000). In fungi, the combined ITS
regions comprise approximately 600 to 800 base pairs (Gardes & Bruns 1993, Arnold
& Lutzoni 2007).
Several primers have been designed for amplification of various sections of the ITS-
DNA, and several combinations of these primers have been useful in the identification
of fungi. ITS1-F is a primer specifically designed for amplification of fungal DNA
(Gardes & Bruns 1993), and in combination with a universal primer, ITS4, is highly
selective for basidiomycetes and ascomycetes (Gardes & Bruns 1993, Arenal et al.
2005). Guo et al. (2000) combined ITS4 with the primer ITS5, which amplifies the
same ITS1-5.8S-ITS2 region as the former combination, but with less fungal speci-
ficity.
Following the sequencing of the amplified DNA, the National Centre for Biotechnol-
ogy Information (NCBI) database on GenBank is searched to locate similar sequences
of known fungi to obtain an identification (Guo et al. 2000, Healy et al. 2004, Are-
nal et al. 2005, Arnold & Lutzoni 2007). The Basic Local Alignment Search Tool
(BLAST) on GenBank is generally used to compare and obtain the sequences, which
can be further analysed so as to infer phylogenetic relationships (Bills 1996, National
Centre for Biotechnology Information 2009).
4.2 Materials and Methods
4.2.1 Morphology
The isolates to be identified were grown on PDA plates until some colony colour de-
veloped. At this point, macroscopic examination was recorded. This included general
colony size, shape, colour, surface texture, margin shape and growth rate. The plates
were photographed, and the culture subsequently used for the preparation of slides for
microscopic examination.
Lacto-fuchsin Stain was prepared by adding 0.1 g of Acid fuchsin to 100 ml of con-
centrated lactic acid, and mixed well to dissolve. The solution was placed in to dropper
bottles for easy application to slides.
Three methods were used to prepare slides. The simplest method involved pressing a
small amount of sticky tape to the surface of the culture, and then transferring the tape
to a microscope slide onto which a drop of stain had been placed.
Slides were also prepared by removing a small amount of the culture with an agar
cutter, and emulsifying it in the drop of stain on the slide. A coverslip was placed over
the stain and, if necessary, pressed gently onto the slide surface with the handle-end of
the cutter.
The third method involved the preparation of slide cultures. The isolates were cultured
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on squares of PDA, measuring approximately 1cm by 1cm, which had been cut from
the plate and flipped onto the remaining agar surface. There were two such squares
prepared on each plate. The upper edge of each square was inoculated with material
from the isolate, and an alcohol flamed coverslip was placed on the top. The plates
were incubated at 25oC until colour developed in the culture. Slides were finally pre-
pared by placing a drop of the stain on to the middle of a microscope slide, and one of
the cultured coverslips placed over it.
All preparations were placed briefly onto a warm heat plate to remove air bubbles and
aid stain penetration.
Slides were examined under a compound microscope as they were prepared using x400
magnification. Slides which clearly showed hyphae and any other identifiable struc-
tures were sealed with clear nail polish and stored flat in the dark for further observation
and photography.
4.2.2 Molecular Identification
LB Broth was prepared as per the manufacturer’s instructions, and dispensed into 10ml
volumes before autoclaving, along with 100ml volumes of Milli-Q water. Both were
stored at room temperature.
Ampicillin solution was prepared by dissolving 250mg ampicillin in 5ml Milli-Q wa-
ter. After filter sterilisation through a 0.22µl syringe filter, it was dispensed into 1.25ml
aliquots. 0.1M IPTG was prepared by dissolving 120mg of IPTG in 5ml Milli-Q water.
It was filter sterilised as for the ampicillin, but dispensed into 1ml volumes for stor-
age. A 50mg/ml X-Gal solution was prepared by dissolving 250mg X-Gal in 5ml of
molecular grade DMSO, and dispensed into 1 ml volumes. All solutions were stored
at -20oC until required.
Four hundred millilitres of LB Agar was prepared as per the manufacturers instruc-
tions. After being allowed to cool to 50oC, 400µl of 50mg/ml ampicillin, 1000µl 0.1M
IPTG and 500µl 50mg/ml X-Gal solutions (thawed) were aseptically added and mixed
before pouring into 90mm Petri dishes. Once set, plates were labelled, bagged and
stored upside down in the refrigerator, and used within one month.
All preparations and manipulations were performed in a lamina flow cabinet, until the
cloning procedure, where the presence of bacteria necessitated the use of the BSC.
DNA Extraction was performed using a DNeasy Plant Mini Kit (Qiagen, Doncaster,
VIC, Australia), which was designed to extract total DNA from up to 100mg of plant
or fungal tissues. Ethanol was previously added to the extraction and wash buffer
concentrates as per the manufacturer’s instructions.
Fungal material was available either on a PDA plate or in Yeast Extract-Sucrose (YES)
broth culture. A sterile scalpel blade was used to scrape the fungal growth off each
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plate and into a sterile microcentrifuge tube. The amount of agar removed with the
growth was limited as much as possible. Due to its small growth area, two plates of
isolate 6.5 were used, whereas only one plate was required of isolates 12.1 and 129.1.
Alternatively, flamed forceps were used to remove a sufficient amount of growth from
the broth culture and placed into sterile 1.5ml microcentrifuge tubes. Each tube was
topped up with sterile water, and mixed. This was removed from the fungal mass after
centrifugation at 1000rpm for 5 minutes.
A small amount of previously autoclaved fine sand was added to each tube, and the
mixture ground with a plastic pestle. To minimise cross-contamination, gloves were
changed between samples.
400µl of lysis buffer was added to each tube, followed by 4µl RNase A. Each tube
was well vortexed to ensure a lump free mixture was obtained. After incubation, with
occasional shaking, at 65oC for 10 minutes, 130µl of precipitation buffer was added,
and the mixture incubated on ice for 5 minutes.
After centrifugation at 13,200rpm for 5 minutes, the supernatant was transferred to
a shredder spin column held in a collection tube, and centrifuged for 2 minutes at
11,000rpm. The flow through (approximately 450µl) was transferred to a new set of
microcentrifuge tubes, and 675µl of extraction buffer added and mixed. 650µl of this
mixture was transferred to a DNeasy spin column in a collection tube and centrifuged
for 1 minute at 8000rpm. The flow through was discarded, and the centrifugation
repeated with the remaining sample. The final flow through and the collection tube
were discarded, and the column placed into a fresh 2ml collection tube.
500µl of wash buffer was added to the column, followed by centrifugation for 1 minute
at 8000rpm. The flow through was discarded, and 500µl of buffer added to the col-
umn again before centrifugation for 2 minutes at 13,200rpm. The column was then
transferred to a fresh microcentrifuge tube, ensuring no contact was made between the
column and the final flow through liquid.
Elution buffer was heated to 65oC, and 100µl added to the column. After five minutes
of incubation at room temperature, the DNA was eluted by centrifugation at 8000rpm
for 1 minute. This step was repeated with the column transferred to a fresh microcen-
trifuge tube before the pre-warmed buffer was added. The final products were then
combined for use in PCR.
A PCR master mix was freshly prepared by combining the following proportions of in-
gredients in sufficient quantity for each duplicate test, a PCR control and small amount
for pipette error:
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Milli-Q Water 38µl 14µl
10x Buffer1 5µl 10xBuffer
incorporating MgCl22
2µl
50mM MgCl21 2.5µl
10mM dNTP1 1µl 2µl
ITS1F Primer3 1µl 0.5µl
ITS4 Primer4 1µl 0.5µl
Taq DNA polymerase1 0.5µl Taq DNA polymerase2 0.5µl
Total Volume 49µl 19.5µl
DNA Volume required 1µl 0.5µl
1 Supplied by Invitrogen Australia, Mt Waverley, VIC, Australia
2 Supplied by Scientifix, Cheltenham, VIC, Australia
3 Gardes & Bruns (1993)
4 White et al., (1990), as cited by Gardes & Bruns (1993).
After mixing, the solution was dispensed into sterile thin walled PCR tubes in either
49µl or 19.5µl aliquots, depending on the PCR preparation used. The volume of ex-
tracted DNA required was then added to each tube; the control tube received the same
volume in sterile distilled water. Amplification was performed over 35 cycles consist-
ing of 95oC for 1 minute; 50oC for 1 minute and 72oC for 1 minute. Final incubation
was at 72oC for 10 minutes.
A 2% (w/v) agarose gel was prepared by dissolving the appropriate amount of agarose
in TAE Buffer. When cooled to approximately 50oC, a 0.625mg/ml ethidium bromide
solution was added at a rate of one drop (25µg ethidium bromide) per 50ml gel. After
mixing, the mixture was poured into the selected casting tray, and the comb added.
Once set, the comb was removed and the gel placed into the electrophoresis tank. The
compartment/s were filled as required with TAE Buffer and/or RO water.
Following PCR, 2µl from each tube was mixed with 0.5µl of running dye, and elec-
trophoresed for 30 minutes at 100V on the freshly prepared gel. After visualisation
under UV light, if it was determined there was sufficient PCR product available, it was
ready for DNA purification. Where insufficient product was produced, as occurred
with isolate 6.5 and 12.1, the PCR was repeated with the initial PCR product.
A DNA Purification Kit (Machery Nagel, Cheltenham, VIC, Australia) was utilised to
purify the PCR products for use in cloning. Replicate products were combined, and
the volume made up to 100µl with sterile distilled water. 200 µl of binding buffer
was added to each tube and well mixed, before transferring the tube contents to a
spin column held in a collection tube. After centrifugation for 1 minute at 13,200rpm,
the flow through was discarded, and the column returned to the collection tube. Six
hundred µl of wash buffer was added to the column, and the centrifugation repeated.
After discarding the flow through, remaining traces of wash buffer were removed by
centrifugation for 2 minutes at 13,200rpm.
The column was placed into a new microcentrifuge tube, and 30µl of elution buffer
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added. After incubation at room temperature for 1 minute, the column and tube were
centrifuged for 1 minute at 4000rpm. This produced approximately 12.5 µl of eluate,
containing the purified DNA.
The concentration of the purified product was checked by running 2µl volumes of
eluate on a 2% (w/v) agarose gel as previously described, and the DNA made available
for cloning.
The pGEM R©-T Easy Vector System (Promega, Annandale, NSW, Australia) was used
for preparation of ligation tubes as follows:
Samples Positive Negative
2x Buffer1 5µl 5µl 5µl
Easy vector2 1µl 1µl 1µl
PCR Product 3µl − −
Control insert DNA2 − 2µl −
T4 DNA ligase 1µl 1µl 1µl
Milli-Q water − 1µl 3µl
Final Volume 10µl 10µl 10µl
1 Vortexed before use
2 Centrifuged briefly before use
The ligation was allowed to progress overnight at 4oC.
The following day, 2µl of each ligation mixture was placed into fresh sterile micro-
centrifuge tubes, and 50µl of E. coli competent cells (JM109) added. The mixture was
placed on ice for 20 minutes, followed by heat shocking for 90 seconds at 42oC. The
tubes were then returned to the ice for a further 2 minutes. 950µl of LB broth was
added to each tube, and the tubes transferred to a platform shaker for incubation at
37oC and 150rpm for 1.5 hours. A sufficient number of LB Agar plates containing
ampicillin, IPTG and X-Gal were allowed to come to room temperature. Two plates
were allowed for each sample transformation, and one plate for each of the controls.
100µl volumes from each tube was spread onto its respective plate, and the surface
allowed to dry. Plates were incubated at 37oC until sufficient growth was apparent.
After incubation, the negative control plate was checked for the presence of blue
coloured colonies, and the positive for a mixture of blue and white. A white colony
from the positive control, and each sample (if present) was streaked on to a fresh plate
and incubated overnight at 37oC, to ensure transformation was truly successful.
For bulking of plasmid DNA, ten microlitres of 50mg/ml ampicillin was added to sev-
eral tubes containing 10ml LB broth. A single colony from each of the latter plates was
added to the broth, and the tubes incubated overnight in a 37oC waterbath and shaken
at 150rpm.
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Mini-prepping of the plasmid DNA was undertaken by Dr John Dearnaley, with an
Eppendorf FastPlasmid Mini kit used as per the manufacturer’s instructions: 1.5ml of
each fresh broth culture was pelleted at 13,000rpm for one minute and the supernatant
discarded. 400µl of ice cold lysis solution was added, and the mixture thoroughly vor-
texed to produce a homogenous solution. Following a three minute incubation at room
temperature, the lysate was transferred to a spin column assembly and centrifuged at
maximum speed for 30-60 seconds. Centrifugation was repeated after the addition of
400µl of wash buffer, and the waste contents discarded from the collection tube. After
another minute of centrifugation at maximum speed, the spin column was transferred
to a fresh collection tube. 50µl of elution buffer was added directly to the surface of the
spin column membrane, and the DNA eluted by centrifugation at maximum speed for
30-60 seconds. The spin column was discarded, and the DNA stored in the collection
tube at -20oC until required for sequencing.
Two microlitres of T7 promoter primer were placed into a number of sterile microcen-
trifuge tubes, and 8µl of purified plasmid DNA or PCR product added. The tubes were
sent to the Australian Genome Research Facility (AGRF) for sequencing. A BLAST
search (Altschul et al. 1997) using the National Centre for Biotechnology Information
(NCBI) database on GenBank was used to analyse the ITS sequence to locate possible
matches. In addition, phylogenetic analysis of isolates 6.5 and 129.1 were performed
by comparing their sequences with selected, related sequences, copied from GenBank
in FASTA format. Phylogenetic analyses were conducted in MEGA4 (Tamura et al.
2007). Sequences aligned using Clustal W were used to create a neighbour-joining
tree (Saitou & Nei 1987), using the Maximum Composite Likelihood method in order
to draw the tree to scale. 1000 replicates were utilised in the bootstrap test (Felsenstein
1985).
4.3 Results
4.3.1 Morphology
Following sufficient incubation on PDA, results of macroscopic examination of the
three isolates was described and recorded.
Isolate 6.5 was slow growing, and would grow to a certain point and not become any
larger. It produced a relatively small, heaped and folded colony, which was light tan in
colour on both sides. Figure 4.1(a) shows a photograph of the isolate taken after about
30 days incubation.
Figure 4.1(b) shows the colony morphology of isolate 12.1. This was the fastest grow-
ing of the three isolates, producing a large flat colony with a blue-green, powdery
surface edged with white within seven days. The reverse was dark-orange to a yellow
edge and smooth.
Isolate 129.1 was moderately fast growing, and produced a colony which almost cov-
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ered the full surface of the 90mm plate after approximately 2 weeks incubation. It was
off-white to tan in colour, and velvety to fluffy in appearance. As can be seen in Figure
4.1(c), a yellow pigment diffused into the agar.
(a) Isolate 6.5 (34mm across) (b) Isolate 12.1 (55mm across)
(c) Isolate 129.1 (75mm across)
Figure 4.1: Photographs of PDA cultures of each isolate, taken after colour had devel-
oped in the colony. Note yellow pigment produced by isolate 129.1, diffused into the
medium.
Microscopic morphology of two of the isolates was not definitive in the identification
process. In an attempt to obtain sufficient information from microscopic examination
to aid in the identification of isolates 6.5 and 129.1, all three methods of slide prepara-
tion were used. Figures 4.2(a) and (c) reveal hyphae, but little else. Regardless of the
preparation, microscopic examination was inconclusive for both of these isolates.
Several microscopic features were readily identified in isolate 12.1 with both the sticky
tape slide preparation, and direct culture emulsion techniques. Therefore, a slide cul-
ture was not required. As can be seen in Figure 4.2(b), identifiable features include
septate hyphae, phialides atop a conidiophore and masses of smooth walled, round
conidiospores. These features were consistent with a Penicillium sp.
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(a) Isolate 6.5
(b) Isolate 12.1
(c) Isolate 129.1
Figure 4.2: Photographs of microscopic preparations of each isolate taken at x400
magnification. Note the septate hyphae and phialides present in the view of isolate
12.1. Bar measurement in all photographs is 5µm
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Table 4.1: Closest species results from BLAST sequencing search
ACCESSION
CODE
CLOSEST SPECIES MATCH
MAX.
IDENTITY
(%)
E-VALUE
Isolate 6.5
EF155505.1 Schizophyllum commune 99 0.0
AY605705.1 Basidiomycete sp 98 0.0
AB505421.1 Schizophyllum sp 98 0.0
FJ478109.1 Schizophyllum commune 97 0.0
AB369910.1 Schizophyllum commune 97 0.0
Isolate 129.1
EU490094.1 Uncultured ascomycete 99 0.0
AY943053.1 Sporormiella isomera 89 0.0
EU551184.1 Sporormiella isomera 88 0.0
AY510420.1 Preussia africana 81 0.0
AY510418.1 Preussia africana 81 0.0
Data obtained following BLAST searches of the ITS sequences amplified from
isolates 6.5 and 129.1.
4.3.2 Molecular Identification
Difficulties were experienced in obtaining transformants from isolates 6.5 and 12.1.
However, as isolate 12.1 was identified microscopically as a Penicillium sp., it was
decided not to further pursue its identification; the purified PCR product obtained from
isolate 6.5 was used for sequencing rather than the preferred, but difficult to obtain,
plasmid DNA.
After sequencing, a nucleotide BLAST search (Altschul et al. 1997) was performed.
Isolate 6.5 was identified as Schizophyllum commune and isolate 129.1 was identified
as Sporormiella isomera. GenBank accession codes, maximum identity and E-values
for the closest species matches as at June 2009 for each isolate are shown in Table 4.1.
These and fourteen additional sequences were obtained from each isolate’s BLAST
search result for phylogenetic analysis and generation of phylogenetic trees. Figure
4.3 shows the phylogenetic tree obtained for isolate 6.5. Figure 4.4 displays the tree
generated for isolate 129.1. Captions for each figure were primarily generated by the
“Caption” option available in the MEGA4 software.
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Figure 4.3: Phylogenetic tree of isolate 6.5, showing evolutionary relationships of 20
taxa. The evolutionary history was inferred using the Neighbor-Joining method. The
optimal tree with the sum of branch length = 0.03921422 is shown. The percentage
of replicate trees in which the associated taxa clustered together in the bootstrap test
(1000 replicates) are shown next to the branches. The tree is drawn to scale, with
branch lengths in the same units as those of the evolutionary distances used to infer
the phylogenetic tree. The evolutionary distances were computed using the Maximum
Composite Likelihood method and are in the units of the number of base substitutions
per site. All positions containing gaps and missing data were eliminated from the
dataset (Complete deletion option). There were a total of 538 positions in the final
dataset. Phylogenetic analyses were conducted in MEGA4. Isolate 6.5 clusters with a
group predominantly populated with S. commune strains
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Figure 4.4: Phylogenetic tree of isolate 129.1 showing evolutionary relationships of
20 taxa. The evolutionary history was inferred using the Neighbor-Joining method.
The optimal tree with the sum of branch length = 0.15633813 is shown. The percent-
age of replicate trees in which the associated taxa clustered together in the bootstrap
test (1000 replicates) are shown next to the branches. The tree is drawn to scale, with
branch lengths in the same units as those of the evolutionary distances used to infer
the phylogenetic tree. The evolutionary distances were computed using the Maximum
Composite Likelihood method and are in the units of the number of base substitu-
tions per site. All positions containing gaps and missing data were eliminated from
the dataset (Complete deletion option). There were a total of 406 positions in the final
dataset. Phylogenetic analyses were conducted in MEGA4. While isolate 129.1 clus-
ters predominantly with Preussia africana and not Sporormiella, it is suggested that
the two genera names can actually be used synonymously (Arenal et al. 2005).
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4.4 Discussion
The three isolates demonstrating repeatable antimicrobial activity were identified as
follows:
ISOLATE IDENTIFICATION PHYLUM
6.5 Schizophyllum commune Basidiomycota
12.1 Penicillium sp Ascomycota
129.1 Sporormiella isomera Ascomycota
Schizophyllum commune, also known as Split Gill fungus, is generally a saprobe, and
usually found on rotting wood. However, it is also known to cause disease in humans,
causing sinusitis and bronchopulmonary mycosis particularly in the immunocompro-
mised patient (Ellis et al. 2007).
Saprobes have been classed as epiphytes as well as endophytes (Bills 1996, Guo et al.
2000), and are frequently isolated from the inner tissues of leaves (Bills 1996). While
it is possible isolate 6.5 was an epiphytic contaminant of the root material from which
it was obtained, it is also feasible that at the time of isolation, it was present within the
tissue as part of its normal life cycle. Thus, it potentially fulfils the original definition
of endophytic fungi as previously described. In addition, it should be considered that
hyphal growth from within surface sterilised tissues is sufficient proof of their endo-
phytic status (Bills 1996).
Penicillium species are frequently isolated as endophytes. Species from this genus
were the third most frequently isolated endophyte from the bark of the neem tree
(Azadirachta indica) by Mahesh et al. (2005), making up 11.6% of the total number
of isolates. Vega et al. (2006) isolated 13 different species of Penicillium from coffee
plants (Coffea spp.).
Sporormiella and Preussia are two genera with a high degree of similarity. Differ-
entiation has previously been based primarily on substrate and the presence/absence
of ostiolate ascomata. Sporormiella has been associated with a coprophilous habitat,
whereas Preussia was associated with plants, soil and wood; the former genus pro-
duces ostiolate ascomata, whereas the latter does not. However, it has been found that
Sporormiella is not confined to dung, and has been isolated from other habitats, and
production of the ostiolate ascomata is variable, often dependent on the culture condi-
tions. Therefore it has been suggested the two genera names be used synonymously
(Arenal et al. 2005). Three species of Sporormiella have been previously isolated as
endophytes from nine plants studied by Pela´ez et al. (1998)
Microscopic examination can be used to identify the genus. However, the culture
conditions used in this project did not induce sporulation in this isolate. As well as
PDA, (Arenal et al. 2005) cultured Preussia species on oat meal agar, and utilised a
12 hour near-UV light/daylight cycle for a minimum of 14 days. While the lighting
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regime is currently beyond the capability of our laboratory, alternative media may have
been sufficient to encourage the sporulation of the isolate.
This project utilised morphological and molecular procedures to identify the three iso-
lates previously determined to demonstrate reliable antimicrobial activity. Difficulties
can be associated with each process. To reach its maximum potential, morphologi-
cal identification relies on the production of sporulating structures. Molecular analysis
requires the use of critical procedures, and identification relies on the availability of se-
quences in the GenBank database from known and correctly identified fungi. However,
the methods utilised in this project were sufficient for determining the identification of
the three isolates in question.
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Evaluation of Activity
5.1 Introduction
Screening of the endophytic isolates collected in the first stage of this project yielded
three isolates possessing antimicrobial activity. The antimicrobial activities of these
isolates, identified as a Penicillium species (isolate 12.1), Schizophyllum commune
(isolate 6.5) and Sporormiella isomera (isolate 129.1), were further evaluated in the
final stage of this project.
Crude preparations of each isolate and the control fungus Penicillium chrysogenum
were prepared from cultures grown in two different media formulations. After suf-
ficient growth had been obtained, the cultures were filtered, freeze-dried and con-
centrated by resuspending the freeze-dried product in water with a volume of ap-
proximately one tenth of that of the original. A dilution series was generated from
each crude preparation, and used in the determination of the Minimum Inhibitory
Concentration (MIC) and Minimum Bactericidal Concentration (MBC) against three
strains of bacteria.
A second set of dilutions were prepared for use in the determination of the toxicity of
the crude product against murine fibroblast cells. Evaluation of toxicity was performed
using the MTT Cell Viability and Crystal Violet Dye Exclusion (CVDE) assays.
5.1.1 Sample Preparation
Both Fleming (1929) and Emerson et al. (1946) conducted further antimicrobial anal-
ysis directly on fungal culture broths; the former in his standard nutrient medium, and
the latter in four different formulations of liquid media. Antimicrobial evaluation was
progressively examined by removal of a small portion of the broths after various days
of incubation.
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Predominant sample preparations undertaken by others in the evaluation of biological
activity of fungal secondary metabolites appears to involve the chemical extraction and
some level of purification of the products from the culture medium (Wei et al. 1973,
Schulz et al. 1995, Pongcharoen et al. 2007, Aly et al. 2008). Following incubation,
liquid cultures were filtered and the filtrate chemically extracted, usually with ethyl
acetate (Schulz et al. 1995, Healy et al. 2004, Davis 2005, Davis et al. 2005, Aly et al.
2008, Davis et al. 2008), n-butanol (Aly et al. 2008) or ethanol/dichloromethane mix-
ture (Kingsland & Barrow 2009). Mycelial masses have been extracted with ethanol
(Michael et al. 2003, Kingsland & Barrow 2009) or methanol (Schulz et al. 1995, Aly
et al. 2008). Cultures grown on solid media were blended before being extracted with
ethyl acetate (Schulz et al. 1995, Aly et al. 2008). Further purification of compounds
included processes such as partitioning, fractionation, evaporation, chromatographic
separation and/or dissolution in additional solvents. Thus, multiple compounds could
be obtained from each culture, and biological activity determined for each.
Prior to compound extraction, Schulz et al. (1995) were able to increase the initial
production of secondary metabolites produced by the Pezicula isolates being examined
by optimising the culture medium and culture conditions for each strain.
5.1.2 Antimicrobial Activity
Minimum Inhibitory Concentration (MIC)
Fleming (1929) and Emerson et al. (1946) performed quantitative analysis of the an-
timicrobial activity each had detected in fungi grown in broth culture. Both prepared
serial dilutions of the broth in which the fungi had been grown in fresh liquid media,
and inoculated each dilution with a set volume of broth containing the test organism.
After incubation, the opacity of the broths was examined to determine the highest dilu-
tion of fungal broth culture required to prevent growth of the test bacteria. This demon-
strates the underlying principle behind the Minimum Inhibitory Concentration (MIC)
assay (CLSI 2006).
According to the Clinical and Laboratory Standards Institute (CLSI) standard M7-
A7: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow
Aerobically; Approved Standard - Seventh Edition, two methods utilising broth and
one method utilising a solid medium can be used in the determination of an agent’s
MIC (CLSI 2006).
The two broth methods differ mainly in the volume of broth and containment vessels
used – 2ml per test tube are required for the macrodilution method, whereas 0.1ml
per well in 96 well microdilution plates are required for the microdilution method. A
dilution series of the test agent is prepared in the broth, and each dilution inoculated
with a volume of standardised bacterial suspension. After incubation, the broths are
examined for inhibition of growth as detected by the unaided eye.
The agar dilution method involves adding the test agent directly into the medium, each
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plate prepared containing a different concentration of the agent. The plate surface
is then point inoculated with multiple test organisms, preferably using an inoculum-
replicating device. Up to 36 inocula can be tested on a single plate. After incubation,
plates are examined for inhibition of growth.
The MIC is defined as the lowest concentration of an antimicrobial agent required
to prevent visible growth of the test organism in a susceptibility test. The true MIC
actually lies between the reported MIC value and the next lower agent concentration.
The MIC assay provides a quantitative measure of an antimicrobial agent’s in vitro
activity against a particular bacterial isolate. However, different end points can be
obtained each time the test is performed, despite following carefully controlled con-
ditions. Acceptable reproducability of the test is considered to be within one twofold
dilution of the actual end point.
Minimum Bactericidal Concentration (MBC)
Fleming further evaluated his crude penicillin broth, by examining its bactericidal
properties. A volume of a staphylococcal broth culture was added to tubes contain-
ing a series of dilutions of the penicillin broth. At various timed intervals, a measured
quantity of the mixture was removed from each tube and spread onto solid medium.
Following incubation of the agar plates, Fleming was able to estimate the rate of death
in the bacteria, as well as the minimum concentration required to be effective. This re-
mains the basic premise behind the assessment of the killing effect of an antimicrobial
agent (CLSI 1999).
According to CSLI guideline M26-A: Methods for Determining Bactericidal Activ-
ity of Antimicrobial Agents, two methods can be generally followed in bactericidal
assessment: MBC and time-kill.
MBC can be determined via a macrodilution or microdilution method, the methods dif-
fering in the volume of broth and containment vessels used – 2ml per tube in borosil-
icate glass tubes for the former, and 0.1ml per well in 96 well microdilution plates in
the latter.
A series of broths containing dilutions of the test agent are inoculated with a volume
of a standardised bacterial suspension. After incubation for 24 hours, a sample from
each tube or well showing inhibition of bacterial growth is removed and plated so as
to perform a colony count after incubation of the plate.
Time-kill analysis is established in a manner similar to the MBC tests, but with a larger
volume (≥ 10ml). This allows for optimal growth of the test microorganism and kill
rate, as well as reducing the impact of sample removal. At timed intervals over a 24
hour period, a sample is removed, diluted and plated so as to perform a colony count
24 to 48 hours after incubation of the plate. Results obtained can be plotted and a
time-kill curve prepared and the MBC determined.
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The MBC is defined as the Minimum Bactericidal Concentration (MBC) required to
kill 99.9% (≥ 3 log10 drop in CFU/ml) of the final inoculum. Therefore, counts ob-
tained from each test must be compared with a count obtained from the final standard-
ised bacterial inoculum used to establish the test.
The advantage of the MBC over the time-kill analysis, is that it can directly follow
the MIC assay – once the MIC is obtained, the cultures showing inhibition can be
immediately sampled to obtain the MBC. Time-kill analysis is useful in determining
the rate at which killing occurs, and can determine whether it is dependent on agent
concentration or contact time.
Generally, bacteriostatic agents are sufficient for the treatment of bacterial diseases –
the organism is inhibited while the body’s natural defences neutralise the organism.
However, in the case of immunocompromised patients, and diseases such as endo-
carditis and meningitis, bactericidal agents are necessary. These tests can provide an
approximation of the effectiveness of an agent’s ability to eradicate bacteria, but the
results may differ in clinical use (CLSI 1999).
5.1.3 Cell Toxicity
Animals have been frequently utilised in the assessment of the toxicity of bioactive
products (Wei et al. 1973, Tominaga et al. 1999, Anon. 2001). Fleming (1929) used
a rabbit and a mouse to make initial observations that the filtered penicillin broth was
not toxic. This was followed by constant irrigation of large areas of skin and repeated
irrigation of the conjuctiva in two human subjects, again with no apparent signs of
toxicity. Wei et al. (1973) utilised weanling albino rats in determining the toxicity
levels of mycotoxins produced by Penicillium roqueforti. Lethality assays involving
brine shrimp (Artemia salina) have also been used to determine the toxicity of natural
products (Healy et al. 2004, Davis 2005). However, alternative methods in toxicity
assessment have been developed utilising tissue culture cell viability assays (Tominaga
et al. 1999, Anon. 2001).
While for the moment animals will continue to be used in cytotoxicity testing in vivo,
the use of in vitro methods can be used to lower the numbers of animals used by
predicting toxic endpoints. A wide variety of cell types are available though rodent- or
human-derived cell lines appear to be the most frequently used (Anon. 2001). These
include Balb/c 3T3 (mouse embryo) (Tominaga et al. 1999, Anon. 2001), L929 (mouse
fibroblast) (Tominaga et al. 1999), NHK (normal human keratinocytes) (Anon. 2001),
as well as a variety of tumour cell lines (Tominaga et al. 1999, Aly et al. 2008, Atalla
et al. 2008, Davis et al. 2008) such as HeLa (human cervical cancer) (Tominaga et al.
1999, Atalla et al. 2008) and L5178 mouse lymphoma cells (Aly et al. 2008).
A variety of assays are available, and can be used to detect cell proliferation as well
as cell viability. Unless a particular compound requires a specific cell type in which to
express it’s toxicity, no basal cytotoxicity assay can be recommended as the best assay
to follow (Anon. 2001). Two of the more frequently encountered tests are the SRB
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(sulforhodamine B) anticancer drug screening assay (Pongcharoen et al. 2007, Atalla
et al. 2008) and the MTT cell viability assay (Tominaga et al. 1999, Morrison et al.
2001, Aly et al. 2008).
For precise measurement of the end point, 96-well microplates which can be scanned
with suitably designed spectrophotometers are preferred (Anon. 2001).
In general, each well is seeded with actively growing cells usually at a rate of 5x103
(Tominaga et al. 1999) to 5x104 (Morrison et al. 2001, Atalla et al. 2008) cells per well.
After 24 hours incubation, allowing for cell attachment and growth, the old media is
replaced with fresh media incorporating the test agents and the plate reincubated for
24 (Morrison et al. 2001) to 48 hours (Tominaga et al. 1999, Atalla et al. 2008). After
the appropriate time of incubation, the specific assay is run.
Final results can be reported as IC50 values, which is the concentration of test agent
required to inhibit 50% of cell growth (Tominaga et al. 1999, Anon. 2001).
MTT Assay
The MTT assay is one method used to determine cell viability by measuring levels of
cellular metabolic activity (Anon. 2001).
When in the presence of metabolically active cells, the tetrazolium salt (3-(4,5-dimethylthiazole-
2-yl)-2,5-diphenyl-tetrazolium bromide) (MTT) is reduced by mitochondrial dehydro-
genase to produce formazan crystals (Tominaga et al. 1999, Morrison et al. 2001,
Anon. 2001).
Following sufficient exposure to the test agents, an MTT solution is added to the con-
tents of each well and the plates reincubated for three (Tominaga et al. 1999) to four
hours (Morrison et al. 2001). The well contents are subsequently removed, and the
adherent cells lysed to release the formazan crystals which then dissolve in the sol-
vent used. Suitable solvents include DMSO (Tominaga et al. 1999) and 10% sodium
dodecyl lauryl sulphate (SDS) in 0.01M HCl (Morrison et al. 2001).
Absorbance of each well is read at a wavelength determined by the solvent used.
CVDE Assay
The CVDE assay is routinely practiced in our laboratory for cytotoxicity assays, such
as in determining the impact of TNFα concentrations on L929 cells.
Generally, following exposure to the test agents for a predetermined period of time, the
media is removed from the wells and the plates gently washed. This allows dead cells
to be washed away while viable cells remain adhered to the well surface. A solution
containing crystal violet is added, and the stain allowed to penetrate the adherent cell
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layer at room temperature for up to 30 minutes – crystal violet is absorbed by the cells’
DNA. Excess stain is removed by gentle washing of the plate, and the plate allowed to
dry. One molar acetic acid or other suitable solvent is added to each well to dissolve
the crystal violet, and the absorbance read at a wavelength determined by the solvent
used (Grekova et al. 2002).
5.1.4 Collaboration
Slant cultures of each isolate were sent to a collaborating laboratory for secondary
metabolite analysis and extraction. Small amounts of penicillic acid were extracted
from isolate 12.1. Since this product was well known, it was not analysed further.
Small amounts of montagnetol were extracted from isolate 129.1, a compound first
extracted from a lichen-associated fungus, Roccella montagnei in 1942 (Rao & Se-
shadri 1942). Approximately 6mg of montagnetol were extracted from the isolate, and
provided for analysis of antimicrobial activity.
Difficulties were encountered with isolating active products from isolate 6.5. Insuf-
ficient growth of the fungus was obtained for analysis, when the culture protocol as
suggested was followed. However, alternative conditions which increased the culture
matter prevented formation of the relevant secondary metabolites.
Therefore, several cultures were grown in Yeast Extract Sucrose (YES) as described in
the materials and methods below. The mycelium was removed by filtration, and it and
the filtrate placed into separate vacuum flasks. After freeze-drying, both flasks were
sent to the collaborating laboratory. However, despite demonstrating substantial an-
timicrobial activity in a rapid test performed on the culture broth, the active substances
could not be extracted.
5.2 Materials and Methods
5.2.1 Sample preparation
Four 100ml volumes of Nutrient broth were prepared from commercially available
stocks, and prepared as per the manufacturer’s instructions. Twenty 100ml volumes of
YES (Yeast Extract Sucrose) broth were prepared by dissolving 40g yeast extract, 300g
sucrose and 1g magnesium sulphate in 1770ml of reverse osmosis (RO) water. Both
broths were dispensed into 100ml volumes into 250ml Erlenmeyer flasks, stoppered
with rolled cotton wool, and the tops covered with a square of alfoil. All flasks were
autoclaved at 121oC for 15 minutes.
Fresh subcultures of Penicillium chrysogenum and isolates 6.5, 12.1 and 129.1 were
prepared on fresh PDA plates. Small squares were cut into each culture, and a single
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square used to inoculate each Nutrient and YES broths. Due to a variable growth
pattern, 16 YES broths were inoculated with isolate 6.5, while one YES culture was
prepared for the remaining fungi. One Nutrient broth only was inoculated per fungus.
All broths were initially incubated at 25oC. After sufficient growth had been obtained,
the cultures were transferred to 18oC, to decrease the growth rate and hopefully main-
tain secondary metabolite production. After approximately two weeks they were held
at 4oC until the next stage of the process occurred.
The cultures were progressively filtered to remove the mycelium by vacuum filtration
through a sterile No. 2 Whatman filter – a fresh filter was used for each culture. The
filtrate was transferred to a sterile vacuum flask, which was held at -20oC at a 45o
angle. During the freezing process, the flask was gradually rotated to obtain as small
a frozen profile as possible. Once solidified, each flask was transferred to the -70oC
freezer overnight to ensure the sample was sufficiently cold for freeze drying. Each
sample required approximately 30 hours to freeze dry completely.
Ten millilitres of sterile RO water was added directly to the freeze dried product in
the vacuum flask, and the product allowed to redissolve. The crude preparations were
stored at -20oC until testing.
To ensure ingredients in the media were not responsible for any biological activity
detected, concentrated solutions of Nutrient and YES broth were prepared for use as
media controls. 1.3g of Nutrient broth powder was dissolved in 10ml of RO water, and
2g yeast extract, 15g sucrose and 0.05g magnesium sulphate combined with 8.85ml of
RO water. Both solutions were autoclaved at 121oC for 15 minutes, and stored at 4oC
until required. At 10 times stronger than the normal working concentration, these were
equivalent in strength to the culture preparations after freeze-drying. These prepara-
tions will be referred to as concentrated media controls, with the medium specified
where necessary.
The montagnetol provided by the collaborating laboratory, was resuspended in 0.5ml
sterile Milli Q water. This volume was split into two 250µl aliquots, which were made
up to two 3mg/ml stock solutions by the addition of 750µl of either bacterial or cell
culture medium.
5.2.2 Antimicrobial activity
Minimum Inhibitory Concentration
Where applicable, the Clinical and Laboratory Standards Institute standard M7-A7:
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aer-
obically; Approved Standard - Seventh Edition were followed in the execution of the
MIC assay, with additional reference to M100-S18: Performance Standards for An-
timicrobial Susceptibility Testing; Eighteenth Informational Supplement (CLSI 2006,
2008). The microdilution broth method was followed.
67
CHAPTER 5. EVALUATION OF ACTIVITY
Two 100ml volumes of Mueller Hinton Broth (MHB) were prepared as per the manu-
facturer’s instructions, and stored at 4oC. Cation adjustment stocks were prepared by
dissolving 0.836g magnesium chloride heptahydrate (MgCl.7H2O) in 10ml RO water,
and dissolving 0.368 calcium chloride dihydrate (CaCl.2H2O) in a second 10ml vol-
ume of RO water. Both solutions were filter sterilised through a 0.22µm filter into ster-
ile bottles and stored at 4oC. For use in standardised MIC testing, the broth required
adjustment of cations from 3.36mg/L Ca++ and 6.531mg/L Mg++ (levels as speci-
fied on the medium container) to a maximum level of 25mg/L Ca++ and 12.5mg/L
Mg++. Addition of 0.1ml of either cation adjustment stock increased that cation level
by 1mg/L. Thus 0.217ml of cold Ca++ adjustment stock and 0.06ml of cold Mg++
adjustment stock were added to each cold 100ml volume of MHB with stirring. The
cation adjusted Mueller Hinton Broth (CAMHB) was dispensed into 1ml volumes into
sterile bottles with a capacity of 2.5ml, and stored at 4oC until required.
Tryptic Soy Agar (TSA) plates were prepared as previously described, and stored at
4oC until required
100ml of saline was prepared by dissolving 0.87g sodium chloride (NaCl) in 100ml
RO water. This was dispensed into eight 10ml volumes and four 5ml volumes and
autoclaved with the media.
A stock solution of 0.2M monobasic phosphate was prepared by dissolving 15.6g of
sodium di-hydrogen orthophosphate (NaH2PO4.2H2O) in 500ml of RO water. A 0.2M
dibasic phosphate stock was prepared by dissolving 28.4g of anhydrous di-sodium
orthophosphate (Na2HPO4) in 1000ml of RO water. Six millilitres of 0.1M phosphate
buffer pH 8.0 was prepared by combining 0.16ml of the monobasic stock with 2.84ml
of the dibasic stock, and made up to the final volume with RO water. 0.1M phosphate
buffer pH 6.0 was prepared in the same manner, combining 2.63ml and 0.34ml of each
stock respectively.
Ampicillin stock (5120µg/ml) was prepared by dissolving 25.6mg of ampicillin pow-
der in 2.5ml of 0.1M phosphate buffer pH 8.0 and made up to final volume (5ml) with
0.1M phosphate buffer pH 6.0.
A stock solution of penicillin G, sodium salt was available at 10 000 Units/ml with
an activity listed by the manufacturer as 1500-1750 U/mg. This was calculated to be
equivalent to 900-1050µg/mg, with the value of 1000µg/mg being selected for ease
of calculations. Therefore the stock was determined to be equivalent to 6000µg/ml.
To prepare an intermediate stock of 512µg/ml, 0.427ml of the 10000U/ml stock was
added to 4.573ml of sterile RO water.
Both antibiotic stocks were stored at -20oC until required.
A series of 10 doubling dilutions were prepared for each of the freeze-dried Nutri-
ent and YES broth fungal cultures, using 1ml of inoculum and the 1ml volumes of
CAMHB. The ampicillin, penicillin and montagnetol stocks were diluted with CAMHB
to obtain 128µg/ml working stocks, and a set of 10 doubling dilutions prepared for each
as for the cultures.
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Nine sterile 96-well cell culture plates were used to establish the MIC assay. Wells
were round-based, and each plate was lidded. Columns 1-11 contained the test agents,
while column 12 was used for controls. Two adjacent rows were used for each sample
test, so four samples were run per plate. Therefore, three plates were required to
test all eight culture samples, a known antibiotic sample and the montagnetol. Two
staphylococcal strains and an E. coli were challenged, so three sets of each plate were
prepared. Every well in each plate received 100µl of the relevant sample dilution or
control broth, as summarised in Table 5.1.
Table 5.1: Design summary of each MIC plate prepared.
ROW COLUMNS 1-11 COLUMN 12
TEST PLATE 1
A, B Isolate 6.5 Nutrient broth culture. Dilutions 1:11 to 1:1024 CAMHB
C, D Isolate 6.5 YES broth culture. Dilutions 1:1 to 1:1024 50% NB2
E, F Isolate 12.1 Nutrient broth culture. Dilutions 1:1 to 1:1024 50% YES2
G, H Isolate 12.1 YES broth culture. Dilutions 1:1 to 1:1024 CAMHB
TEST PLATE 2
A, B Isolate 129.1 Nutrient broth culture. Dilutions 1:1 to 1:1024 CAMHB
C, D Isolate 129.1 YES broth culture. Dilutions 1:1 to 1:1024 100% NB3
E, F P. chrysogenum Nutrient broth culture. Dilutions 1:1 to 1:1024 100% YES3
G, H P. chrysogenum YES broth culture. Dilutions 1:1 to 1:1024 CAMHB
TEST PLATE 3
A, B Antibiotic4 Dilutions 128µg/ml to 0.125µg/ml CAMHB
C, D Montagnetol Dilutions 128µg/ml to 0.125µg/ml CAMHB
E, F Not used for this project N/A
G, H Not used for this project N/A
1 All 1:1 dilutions were the reconstituted freeze-dried product with no additional dilution
2 Concentrated Nutrient or YES medium control diluted to 50% with CAMHB
3 Concentrated Nutrient or YES medium control with no additional dilution
4 Penicillin used for the two staphylococci and ampicillin for the E. coli
Once prepared, the assay plates were placed into plastic bags and stored at -20oC until
required, when they were allowed to thaw and come up to room temperature.
Bacteria challenged were S. aureus ATCC 29213, methicillin-resistant S. aureus (MRSA)
ATCC 43300, and E. coli ATCC 25922. After revival from -70oC stock, each organism
was subcultured on TSA plates at least three times before use in the test.
The bacteria were cultured on TSA for 20 hours before preparation of test organism
suspensions. As each suspension had to be used within 15 minutes of preparation, each
bacterial strain was processed to completion before the next one commenced.
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Several colonies from the plate were added to 5ml sterile saline until the optical density
was within 0.08 to 0.13 when measured at 625nm. 225µl of this suspension was added
to 10ml sterile saline and transferred to a multichannel pipette reservoir. A multichan-
nel pipette was used to dispense 20µl of the final suspension into each well in columns
1-11 of each of the three plates. 20µl of the final suspension was added to alternate
wells in column 12, so that each medium control pair provided a positive (rows A, C,
E, G) and negative (rows B, D, F, H) growth control.
By following the procedure described for preparation of the bacterial suspension, each
well theoretically contained a final concentration of approximately 5x105 CFU/ml. In
order to confirm the final inoculum size, a bacterial count was conducted on well 12A
of test plate 1. A 10µl volume was removed from the well and added to 10ml sterile
saline. After mixing, 100µl was spread over the surface of a TSA plate and allowed to
soak in.
An inoculum purity check was performed by streaking a sample of the inoculum onto
a TSA plate.
All plates were placed into plastic bags and incubated at 35oC± 2oC for 20 hours. The
inoculum purity test plate was checked to ensure each test organism remained a pure
culture, and number of colonies on the inoculum size test plates counted. Finally, the
MIC assay plates were read by comparing the growth obtained in well 12A with the
growth obtained in the remaining wells of the plate. Results were recorded as either
positive for growth present or negative for no observable growth.
Minimum Bactericidal Concentration
Guidelines for determining the bactericidal activity of antimicrobial agents (CLSI 1999)
were referred to in the development of the procedure to be followed as described below.
The plates utilised for the MIC assay were subsequently used for the determination
of the MBC. Following the reading of the MIC plates, wells showing no growth (i.e.
demonstrating inhibition) were mixed, 10µl removed and the sample spread across half
the surface of a TSA plate. One plate was required per two well samples. Only one
set of wells per paired MIC assay were sampled (rows A, C, E and F from each MIC
plate). All plates were bagged and incubated at 35oC for 24 to 48 hours.
Following incubation, the numbers of colonies grown on each MBC assay plate were
counted. Counts of 11 colonies or greater were recorded as positive for growth, while
less than 11 were recorded as growth negative.
5.2.3 Cell Toxicity Assay
The murine fibroblast-like L929 cells were revived from liquid nitrogen storage and
cultured in Dulbeco’s Modified Eagle’s Medium (DMEM) supplemented with 10%
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foetal calf serum at 37oC in a humidified environment containing 5% carbon dioxide.
The cells were passaged every 3 days, using TrypLE Express (Gibco) a Trypsin re-
placement enzyme to dislodge the cells. Cells were passaged three times before being
used for the assay.
To prepare the test plates, the cells were resuspended in fresh medium, and a visual
count performed using a haemocytometer loaded with a sample comprising a known
dilution of cell suspension in 0.4% trypan blue. Following calculation of number of
viable cells available, a suspension containing a final concentration of 2x105 viable
cells/ml was prepared in 100ml of warmed DMEM.
Six, flat-based 96-well tissue culture plates were prepared for the assays. All wells
on the outer edge of each plate were filled with 200µl sterile water, and the remaining
wells seeded with 100µl of the prepared cell suspension. All plates were incubated
overnight at 37oC in a humidified environment containing 5% carbon dioxide.
Based on observations made during the antimicrobial assays, it was decided to only
perform the cell toxicity assay on the crude YES broth preparations. In addition, the
penicillin used in the antimicrobial assays was included, as well as a set of higher
concentrations aimed at eliciting a toxic response from the antibiotic. Therefore, six
agents were tested. Where necessary, dilutions tested were adjusted so as to cover the
MIC and MBC levels obtained previously for each test agent.
Test agent dilutions were prepared in six V-based 96-well plates – two agents per plate;
3 rows each (B-D and E-G). Two sets of each plate were prepared – one for each assay.
100µl of fresh DMEM was added to all wells in rows B to G. 100µl of the highest
test agent concentration was added to the wells containing media in column 3, and
additional doubling dilutions prepared in the plate, so that the lowest test dilution was
located in column 10. Therefore, only the inner 8 columns were used for test agent
dilutions. A smaller dilution series was also prepared of the concentrated YES medium
control. This proceeded by adding 100µl of the concentrated preparation to the media
in wells 2E-G of the first plate of each assay set. Doubling dilutions were subsequently
continued in wells 11B-D of the first plate, followed by wells 2E-G and 11B-D of the
second plate, then wells 2E-G and 11B-D of the third plate. No additional agents were
added to the remaining wells containing media. A diagram of the overall plate design
can be seen in Figure 5.1.
Following the incubation of the cell culture plates, they were progressively processed,
to reduce risk of damage to the cell layer. Water from wells 1B-G and 12B-G was
removed, and old media carefully removed from the wells containing cells. A multi-
channel pipette was then used to transfer the contents of one V-based plate, containing
the diluted test agents, directly into the equivalent wells of the cell culture plate, and
the plates re-incubated for up to 48 hours.
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Figure 5.1: General layout of the 96-well plates prepared for the cell toxicity assay.
Rows A and H contained water only. Wells for Blanks initially contained water, which
was replaced with culture medium during test plate setup. Wells for the +ve growth
control contained cells and medium only, while the remaining wells contained cells
and medium containing dilutions of either one of the test agents or concentrated YES
medium control (YES dilution series)
MTT Assay
Fresh MTT solution was prepared by dissolving 50mg of MTT in 10ml phosphate
buffered saline (PBS), filtering through a 0.22µm filter into a sterile bottle, and stored
at 4oC until required. Acid propanol was prepared by adding 2ml of 1M hydrochloric
acid to 48ml of propan-2-ol.
After incubation for approximately 44 hours, one set of three assay plates was removed
from the incubator, and 20µl of MTT solution added to all wells containing media. The
plates were placed on an orbital shaker and gently shaken for 5 minutes, before being
returned to the incubator for a further 3.5 hours. The contents of each test well were
removed, and any formazan crystals formed dissolved with the addition of 100µl acid
propanol. After mixing for ten minutes on an orbital shaker, the absorbance of each
well was read at 570nm with reference to 630nm.
CVDE Assay
0.2% crystal violet in 20% methanol was prepared by dissolving 0.08g of crystal violet
in 8ml of 100% methanol, and diluting to 40ml with MilliQ water. One molar acetic
acid was prepared by diluting 3ml of glacial acetic acid in 50ml MilliQ water.
After approximately 48 hours of incubation, the second set of three assay plates were
removed from the incubator. The contents of all wells containing media were removed
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and replaced with 100µl of 0.2% crystal violet in 20% methanol. The plates were
placed on an orbital shaker and allowed to incubate at room temperature with gentle
shaking. After 30 minutes, the stain was removed, the plates thoroughly washed with
MilliQ water, and then set aside to dry. Any crystal violet which had been absorbed by
the living cells was redissolved with 1M acetic acid. After 10 minutes of addition of
the acid, the absorbance of each well was read at 540nm with reference to 690nm
Both assay plates were read on an anthos Zenyth 200rt microplate spectrophotometer
controlled via a computer with ADAP Basic PC software. This program automatically
calculated the difference between the two absorbance measurements obtained for each
well. The raw data was exported and analysed with OpenOffice 3.1 calc (spreadsheet).
5.3 Results
The freeze dried products were to be initially dissolved with 10ml ethanol in order to
obtain a solution containing antimicrobially active product and reduced levels of media
components. However, subsequent to freeze drying it was discovered the products,
particularly from the YES broths, formed into a high volume, highly absorbent matrix.
An excessive volume of ethanol would have been required to obtain a sufficient volume
of test solution. It was therefore decided to dissolve the freeze-dried product from both
media formulations in 10ml of water.
Chemical extraction, as previously described, would have been the preferred method
for sample preparation. Unfortunately, this level of compound preparation was beyond
the time and scope of this project.
5.3.1 Antimicrobial activity
Minimum Inhibitory Concentration
Purity checks performed on the bacterial inocula confirmed the absence of any contam-
ination. Bacterial counts conducted on well 12A of test plate 1 for each organism con-
firmed the presence of approximately 5x105 CFU/ml in the final mixture. Counts ob-
tained ranged from 4.5x105 CFU/ml for the E. coli to 5.5x105 CFU/ml for the MRSA.
Growth obtained in the MIC assay plates appeared as either turbidity of the cell con-
tents, or as a button on the base of the well. Firstly, the concentrated media growth
controls were checked to ensure growth had occurred in the wells containing concen-
trated medium but no test agent. Results were recorded as “+ve” for the presence of
growth or “-ve” for its absence, and can be seen in Table 5.2.
These results would suggest the increased concentration of components in the Nutrient
broth did not interfere with the MIC assay, whereas the 10 times concentration of
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Table 5.2: Results of media and growth controls in MIC determination.
Growth Control S. aureus MRSA E. coli
CAMHB +ve +ve +ve
100% NB +ve +ve +ve
50% NB +ve +ve +ve
100% YES -ve -ve -ve
50% YES +ve +ve +ve
Results were recorded as “+ve” for the presence of growth or “-ve” for its absence,
and are listed for each microorganism tested. Note, when present at a 100% con-
centration the concentrated YES medium inhibited growth of all bacteria.
components in the YES broth did. Therefore, absence of growth in the 1:1 dilution of
the freeze-dried YES broths could not be solely attributed to action by the test agent,
and had to be taken into account when reading the assay.
To finally read the MIC plates the growth obtained in well 12A was compared with
the growth obtained in the remaining wells of the plate. Results were recorded as
either positive or negative for observable growth, and can be seen in Appendix C. The
Minimum Inhibitory Concentration for each sample was obtained by recording the
lowest dilution factor of the stock concentrate at which no bacterial growth occurred.
Where growth was detected in every dilution tested, a negative result for inhibition was
recorded. The MIC for each sample against each test organism can be seen in Tables
5.3(a) and (b).
Results obtained for the known antibiotics against the test organisms were compared
with expected MIC ranges as listed in the supplement to the standard (CLSI 2008), to
ensure the organisms responded appropriately. As can be seen in Table 5.4 results for
ampicillin against E. coli were within the expected range, while those obtained for the
staphylococci were not.
Due to its known resistance to penicillin, this result was expected for the MRSA. How-
ever, the other S. aureus should have been sensitive to penicillin. This suggested either
a problem with the bacterial isolate, or a problem with the dilution of the penicillin.
As a penicillin sensitivity test plate had been prepared elsewhere and demonstrated the
organism was sensitive to the antibiotic, it was suspected the latter problem was more
likely. A fresh penicillin sensitivity plate was prepared, and sensitivity in the bacterium
demonstrated. Therefore, the suggestion of a problem with the penicillin dilutions was
confirmed.
Unfortunately the montagnetol was not inhibitory at the concentrations tested. Growth
occurred in all wells of the Nutrient broth preparation of isolate 129.1, while the single
well showing inhibition for each organism against the YES broth culture of isolate
129.1 contained the undiluted crude preparation. As previously discussed under media
growth controls, concentrated components of this medium were sufficient to inhibit
the growth of the bacteria. Therefore, it was concluded that preparations from isolate
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Table 5.3: Results of MIC Assay on known antibiotic, and Isolate Stock Concentrate
dilutions against S. aureus, MRSA and E. coli.
Control Drug S. aureus MRSA E. coli
Penicillin 0.5µg/ml 32µg/ml NA
Ampicillin NA NA 4µg/ml
(a) Antibiotic controls
Isolate Medium S. aureus MRSA E. coli
6.5 NB 1:256 1:256 1:64
YES 1:256 1:256 1:64
12.1 NB -ve -ve -ve
YES 1:2 1:2 -ve
129.1 NB -ve -ve -ve
YES -ve -ve -ve
P. chrysogenum NB 1:32 1:8 1:1
YES 1:16 1:32 1:4
Montagnetol -ve -ve -ve
(b) Test agents
96-well plates were prepared with doubling dilutions of the test agents, and
the wells inoculated with the test organism. Following incubation, results were
recorded as positive or negative for growth, and the minimum inhibitory concen-
trations for each sample determined. All bacteria were inhibited to some extent
by products produced by isolate 6.5 and P. chrysogenum, while the YES medium
preparation of isolate 12.1 inhibited the staphylococci. Note the differences in
MIC outcomes between the two media formulations used to grow the fungi, an
indication that medium choice plays an important role in the evaluation of sec-
ondary metabolites produced by fungi. No inhibition was detected with isolate
129.1 or montagnetol, and is recorded as “-ve”: this indicates that bacterial growth
occurred at every dilution tested. “NA” indicated the test solution was not appli-
cable to that test organism.
Table 5.4: Comparison of MIC results obtained for known antibiotic standards against
expected ranges provided in CLSI (2008).
ORGANISM SENSITIVE RESISTANT MIC STATUS
Penicillin
S. aureus
≤ 0.12µg/ml ≥ 0.25µg/ml 0.5µg/ml Resistant
MRSA 32µg/ml Resistant
Ampicillin
E. coli ≤ 8µg/ml ≥ 32µg/ml 4µg/ml Sensitive
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129.1 weren’t inhibitory.
Low activity was measured against the staphylococci in the YES broth preparation of
isolate 12.1, but not in the Nutrient broth preparation. This may mean that low ac-
tivity of any secondary metabolites produced, augmented the inhibition properties of
the concentrated medium to give rise to a “false” positive inhibition. Alternatively,
the YES broth may have provided a better medium for encouraging the production of
secondary metabolites in this isolate. The latter would also account for differences ob-
tained between the Nutrient broth and YES broth preparations of the P. chrysogenum.
Isolate 6.5 demonstrated the highest activity of all the isolates, and was active against
all three test organisms. However, unlike the others, there appeared to be no difference
in activity between the two preparations.
Minimum Bactericidal Concentration
As the MBC assay was not conducted in duplicate, and the final well inoculum in the
pre-incubated MIC plates was approximately 5x105 CFU/ml, the figure of 11 colonies
was documented in the guidelines (CLSI 1999) as the rejection value for the deter-
mination of the MBC. Therefore, MBC plate counts of 11 colonies or greater were
recorded as positive, while less than 11 were recorded as negative for growth. These
full results can be seen in Appendix C. The MBC for each sample was obtained by
recording the lowest dilution factor of the stock concentrate which was negative for
growth (equivalent to positive for bactericidal activity), and are shown in Tables 5.5(a)
and (b).
Suitable MBC result ranges for ampicillin against E. coli ATCC 25922 were the only
results supplied in the guidelines, and the result obtained in this assay (8µg/ml) fell
within the range provided (4-16µg/ml).
When reading the results obtained for the MIC assay, isolate 129.1 showed inhibition
only in the lowest dilution factor of the YES broth preparation. As the concentrated
broth also inhibited growth at that dilution, it was determined inhibition displayed in
these wells was due to the medium rather than products of the isolate. Despite this
decision, one of these wells was sampled as part of the MBC assay. Once spread onto
the TSA MBC test plate, it was expected that growth would occur, as the concentrated
media components would effectively be diluted. This proved to be the case.
The only preparations to provide bactericidal activity were the control fungus P. chryso-
genum and isolate 6.5 against E. coli only. The P. chrysogenum Nutrient broth prepa-
ration against S. aureus and both preparations against E. coli aligned with the MIC
result – i.e. the minimum inhibitory concentration also proved to be bactericidal. All
remaining bactericidal results were achieved at higher concentrations than their respec-
tive MIC results.
By examining the MIC and MBC results for each isolate preparation and organism, it
appeared that when grown under the conditions and in the media previously described,
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Table 5.5: Results of MBC Assay on known antibiotic or Isolate Stock Concentrate
dilutions against S. aureus, MRSA and E. coli.
Control Drug S. aureus MRSA E. coli
Penicillin 1µg/ml 32µg/ml NT
Ampicillin NT NT 8µg/ml
(a) Antibiotic controls
Isolate Medium S. aureus MRSA E. coli
6.5 NB 1:1 -ve 1:32
YES -ve -ve 1:32
12.1 NB -ve NT NT
YES -ve -ve NT
129.1 NB NT NT NT
YES -ve -ve -ve
P. chrysogenum NB 1:32 -ve 1:1
YES 1:8 1:8 1:4
(b) Test agents
10µl was removed from the negative growth MIC test wells, and spread onto agar
plates. After incubation, colony numbers were counted and the minimum bac-
tericidal concentration determined for each sample. Of the isolates, only isolate
6.5 demonstrated any bactericidal activity, especially against E. coli. Results for
the remaining isolates demonstrated no bactericidal activity, and are recorded as
“-ve”; this indicates that 11 colonies or more grew with every MIC well tested.
“NT” indicated no dilutions were tested, as growth occured in all the MIC test
wells.
isolate 129.1 showed no antimicrobial activity; isolate 12.1 had a minor inhibitory
effect on the two staphylococcal species; and isolate 6.5 had an inhibitory effect on all
three organisms but no bactericidal effect on the staphylococci. This would suggest
the latter’s effect on staphylococci was bacteriostatic, but bactericidal against E. coli.
What is not known is whether these results are due to the presence of one or more
secondary metabolites, or in the case of the latter, due to different metabolites.
5.3.2 Cell Toxicity Assay
Despite its inhibitory effect on bacterial cells, it was decided to perform the cell toxicity
assays on the crude YES broth preparations only, as they had generally provided a
slightly better result in the antimicrobial assays than the Nutrient broth preparations.
As fewer agent concentrations were able to be tested in the toxicity assay than the
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antimicrobial assay, dilutions tested for isolate 6.5 were adjusted so as to cover the
MIC and MBC levels obtained previously. Therefore, dilutions covered the range of
1:8 to 1:1024 for isolate 6.5, and 1:2 to 1:256 for the remaining fungal preparations.
Mean values and standard deviation were calculated from the raw data obtained from
the readings of each plate. Each test agent’s results and those for the positive growth
control were adjusted for the blank, and the percent viability calculated by the formula
ODtestagent
ODgrowthcontrol
x 100. This process was repeated for the YES medium control dilutions.
Raw data and calculations can be seen in Appendix D.
Toxicity was determined as the test agent concentration at which 50% of the cells were
no longer viable, expressed as the IC50 value.
As a reference chemical, penicillin was listed as having an IC50 of 5.73mmol/L (Anon.
2001) which is equivalent to 2.04mg/ml. Unfortunately, using the stock penicillin of
6mg/ml did not allow for a large range of high dilutions, and a clear result was not
obtained in either assay. However, there was a decrease in the percentage of viable
cells at the first dilution tested (3mg/ml) (MTT: 58% viable; CVDE: 70% viable) and
the second dilution in the MTT assay (1.5mg/ml: 76% viable). These results may
confirm a problem with the penicillin stock.
Results for the YES medium control were analysed first, to determine the presence of
any effect caused by the fungal culture medium. As can be seen in Table 5.6, pres-
ence of 25% (CVDE) to 12.5% (MTT) of the medium control was sufficient to have a
deleterious effect on the cells.
Therefore, results for determination of toxicity in the isolate tests were restricted to
those containing less than 12.5% of the medium. These results can be seen in Table
5.7 for isolates 12.1 and 129.1, and Table 5.8 for isolate 6.5.
From these results it was determined that at least one secondary metabolite produced
by isolates 6.5 and 12.1 were toxic to L929 cells. In the case of the former, this toxi-
city covered the entire range of dilutions tested, whilst toxic levels were detected at a
dilution factor of 1:16 for isolate 12.1
Results which indicate a viability of greater than 100% can indicate an agent con-
tributes to cell proliferation. However, in this case it is considered that these results
highlight the variability inherent in living culture assays.
5.4 Discussion
Because they have already proven to be a successful base for production of antimi-
crobially active secondary metabolites by the relevant isolates, the media utilised for
this part of the project should have been identical to those used in the initial screening,
namely Nutrient Broth and Sensitest Agar. While the former was used, at the time it
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Table 5.6: Determination of toxic effect on L929 cells as caused by the concentrated
YES medium control.
Component Percent 50.00 25.00 12.50 6.25 3.13 1.57
CVDE
Mean 1.4020 0.5703 1.8700 2.8457 3.1913 3.2590
SD 0.1057 0.0248 1.0830 0.5092 0.0863 0.0229
% Viability 40.76 13.65 54.59 85.61 96.70 99.46
MTT
Mean 0.0853 0.0727 0.0987 0.6463 0.6493 0.9130
SD 0.0189 0.0065 0.0287 0.0295 0.1607 0.0806
% Viability 10.35 7.71 10.90 88.62 96.89 118.61
Results show the mean optical density, measured at 570nm with reference at
630nm for MTT results, and 540nm with reference at 690nm for the CVDE assay,
standard deviation (SD) and the calculated value for percent viability. Toxicity
was determined as the agent concentration at which 50% of the cells were no
longer viable. These figures are highlighted in the results in bold. As can be seen
in the MTT results, when the L929 cells were exposed to the concentrated YES
medium at a concentration of 12.5 percent, almost 90 % were destroyed. This had
to be taken into consideration when determining the results of the test agents.
was considered to be too difficult to obtain sufficient extracted test material from the
agar. This would have involved the culturing of many plates of each isolate, followed
by chemical extraction, filtration and evaporation of excess solvent. As time was lim-
ited, it was decided to use an alternative liquid medium. Yeast Extract Sucrose Broth
was selected for this purpose. Unfortunately, this meant the suitability of Sensitest
Agar as a medium useful in the production of secondary metabolites by fungi could
not be verified.
As noted earlier, the freeze dried products were to be initially dissolved with 10ml
ethanol in order to obtain a solution containing antimicrobially active product and re-
duced levels of media components. This proved difficult, as the products, particularly
from the YES broths, formed into a high volume, highly absorbent matrix, requiring
significantly greater volumes of ethanol to ensure complete dissolution of the product.
With sufficient time, this would not have been an issue, as the excess ethanol could
have been evaporated to produce the required volume of test sample. The benefits of
this process would have been two-fold – the elimination of the toxic components of
the YES medium; and the production of an optimal volume/maximum concentration
of the test sample for testing. However, sufficient time was not available, hence the
decision to dissolve the freeze-dried product from both media formulations in 10ml of
water.
The results obtained in the evaluation of bioactivity in the water-based test samples are
summarised in Table 5.9.
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Table 5.7: Determination of toxic effect caused by the test agents on L929 cells.
Dilution factor 1:16 1:32 1:64 1:128 1:256
ISOLATE 12.1 MTT
Mean 0.2567 0.3573 0.6120 0.7070 0.6753
SD 0.0199 0.0565 0.1161 0.1260 0.1029
% Viability 36.16 51.33 89.70 104.02 99.25
CVDE
Mean 1.2727 2.1263 3.1417 3.1810 3.2403
SD 0.0280 0.0903 0.0775 0.0135 0.0384
% Viability 36.65 63.78 96.04 97.29 99.17
ISOLATE 129.1 MTT
Mean 0.6120 0.8097 0.7037 0.7333 0.7757
SD 0.0234 0.0231 0.0506 0.0696 0.0492
% Viability 83.83 111.38 96.61 100.74 106.64
CVDE
Mean 2.9700 3.1947 3.2467 3.2880 3.2903
SD 0.0308 0.0344 0.0663 0.0139 0.0150
% Viability 89.64 96.92 98.61 99.95 100.02
P. chrysogenum MTT
Mean 0.4833 0.6823 0.7023 0.6423 0.8153
SD 0.0664 0.0561 0.0992 0.0281 0.0306
% Viability 61.03 86.97 89.57 81.75 104.30
CVDE
Mean 2.8647 3.1250 3.2527 3.2603 3.2700
SD 0.0912 0.0331 0.0180 0.0468 0.0241
% Viability 86.24 94.52 98.58 98.82 99.13
Results show the mean optical density measured at 570nm with reference at
630nm for MTT results, and 540nm with reference at 690nm for the CVDE assay,
standard deviation (SD) and percent viability calculated on the blank-adjusted op-
tical densities by the formula ODtestagent
ODgrowthcontrol
x 100. Toxicity was determined as the
agent concentration at which 50% of the cells were no longer viable, and is high-
lighted in bold in the results. This can be seen in the results obtained for isolate
12.1, which demonstrated toxicity to the cells at a dilution of 1:16. No toxicity
was detected at these dilutions for the remaining test agents. Results for the first
three dilutions tested were not included here, due to the toxic effect caused by the
culture medium at those levels.
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Table 5.8: Determination of toxic effect of secondary metabolites produced by isolate
6.5 on L929 cells.
Component percent 1:16 1:32 1:64 1:128 1:256 1:512 1:1024
ISOLATE 6.5 MTT
Mean 0.0177 0.0153 0.0630 0.2887 0.3810 0.2980 0.2547
SD 0.0012 0.0015 0.0139 0.0227 0.0095 0.0092 0.0236
% Viability 0.27 -0.05 6.40 36.91 49.39 38.17 32.31
CVDE
Mean 0.4050 0.4533 0.3677 1.1593 1.9530 1.2587 1.0293
SD 0.0243 0.0374 0.0215 0.2176 0.1326 0.0295 0.0627
% Viability 8.46 9.98 7.29 32.13 57.03 35.25 28.05
Results show the mean optical density measured at 570nm with reference at
630nm for MTT results, and 540nm with reference at 690nm for the CVDE assay,
standard deviation (SD) and percent viability calculated on the blank-adjusted op-
tical densities by the formula ODtestagent
ODgrowthcontrol
x 100. Toxicity was determined as the
agent concentration at which 50% of the cells were no longer viable. Note that
this is the case in every dilution tested for this isolate
Table 5.9: Summary of results obtained in the evaluation of biological activity of the
three main isolates
ISOLATE 6.5 12.1 129.1
IDENTIFICATION S. commune Penicillium sp. S. isomera
MIC - Staphylococci 1:256 1:2 No activity
MIC - E. coli 1:64 -ve No activity
MBC - Staphylococci 1:1 -ve No activity
MBC - E. coli 1:32 -ve No activity
IC50 <1:1024 1:16 (to 1:32) Little activity
TOXICITY STATUS Toxic Some toxicity No activity
No inhibition against E. coli and no bactericidal activities against any test bac-
terium were displayed by isolate 12.1, and are indicated by a “-ve” in the re-
sults. No biological activity was demonstrated by isolate 129.1, while isolate 6.5
demonstrated the highest levels of activity of all agents tested. Toxicity status is
an arbitrary assignment given to each isolate in order to give meaning to the IC50
result.
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Isolate 129.1, Sporormiella isomera, appeared to lose its ability to produce antimicro-
bially active secondary metabolites. This may be a result of repeated subculturing,
despite attempts to minimise the number of sequential subcultures, or may be a spon-
taneous occurance. It is not an unusual phenomenon – others have found the same
effect in strains of Penicillium chrysogenum (Wainwright & Swan 1986).
Sporormiella species have some history of producing bioactive natural products. Two
compounds have been isolated from a strain of S. minima by Hatori et al. (2004). These
particular compounds demonstrated promise as inhibitors of cholesterol synthesis, and
were antifungal against Candida albicans and Aspergillus fumigatus.
The Penicillium species, isolate 12.1, showed some bioactivity, but not as much as the
control fungus, P. chrysogenum, used in the experiments.
Isolate 6.5, Schizophyllum commune demonstrated promising antimicrobial activity,
particularly against MRSA, with a dilution of 1:256 inhibiting growth of the organism.
Research conducted by Rosa et al. (2003), concentrated on the screening of basid-
iomycetes for antimicrobial activity. This included three strains of S. commune located
in Brazil. A range of bacteria were screened including several common to this project.
However, no antimicrobial activity was detected in any of these strains. This could
indicate a difference between their S. commune strains and the one isolated in this
project, or culture medium and growth conditions utilised by the researchers were not
effective. Emerson et al. (1946) found great differences in the antibiotic activities ob-
tained from soil-borne fungal isolates when grown in four different formulations of
liquid media.
However, the toxicity assay for isolate 6.5 revealed its toxic nature, with the highest
dilution tested being capable of killing over 50% of L929 cells. Therefore, while it
demonstrated useful antimicrobial activity, its toxicity would prevent its immediate
use as such.
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Summary of Results
A total of three fungal isolates were determined to produce secondary metabolites
posessing antimicrobial activity, and were therefore subjects of the full range of proce-
dures encountered in this project. A summary of the information and results obtained
for each of these isolates is provided on the following pages.
83
CHAPTER 6. SUMMARY OF RESULTS
6.1 Isolate 6.5
Identified by molecular techniques as Schizophyllum commune
Phylum: Basidiomycota
Isolated from Lantana camara root obtained from Preston.
Antimicrobial screening profile:
“+” indicates inhibition observed; “-” indicates no inhibition observed
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MIC and MBC:
“-ve” indicates no bactericidal activity observed
MEDIUM S. aureus MRSA E. coli
MIC NB 1:256 1:256 1:64
YES 1:256 1:256 1:64
MBC NB 1:1 -ve 1:32
YES -ve -ve 1:32
Antimicrobial status: Bacteriostatic against staphylococci
Bactericidal against E. coli
Cytotoxicity:
Assay MTT CVDE
IC50 <1:1024 <1:1024
Toxicity status Toxic
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6.2 Isolate 12.1
Identified by morphological techniques as Penicillium sp.
Phylum: Ascomycota
Isolated from Acacia fimbriata root obtained from Preston
Antimicrobial screening profile:
“+” indicates inhibition observed; “-” indicates no inhibition observed
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MIC and MBC:
“-ve” indicates none of the relevantl activity was observed;
“NT” indicates procedure not tested
Medium S. aureus MRSA E. coli
MIC NB -ve -ve -ve
YES 1:2 1:2 -ve
MBC NB -ve NT NT
YES -ve -ve NT
Antimicrobial status: Bacteriostatic against staphylococci
No activity against E. coli
Cytotoxicity:
Assay MTT CVDE
IC50 1:16 1:16
Toxicity status Some toxicity
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6.3 Isolate 129.1
Identified by molecular techniques as Sporormiella isomera
Phylum: Ascomycota
Isolated from Xanthorrhoeae johnsonii leaf obtained from Preston
Antimicrobial screening profile:
“+” indicates inhibition observed; “-” indicates no inhibition observed
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MIC and MBC:
“-ve” indicates none of the relevant activity was observed;
“NT” indicates procedure not tested
Medium S. aureus MRSA E. coli
MIC NB -ve -ve -ve
YES -ve -ve -ve
MBC NB NT NT NT
YES -ve -ve -ve
Antimicrobial status: No activity detected
Cytotoxicity:
“-” indicates no toxicity detected
Assay MTT CVDE
IC50 - -
Toxicity status No activity
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Conclusion
The purpose of this project was the discovery and evaluation of novel antimicrobial
agents affective against nosocomial pathogens, and was divided into four distinct areas
of investigation:
Acquisition of Fungal Isolates The goal of the first phase of the project was the ac-
quisition of a sufficient number and variety of fungal isolates. While fungi are
ubiquitous, it was decided to concentrate efforts on the collection of endophytic
fungi from a variety of mostly native plant hosts. Harvested plant tissues were
washed, surface sterilised and portions transferred to suitable growth media. As
isolates grew, they were subcultured until pure cultures were obtained, cultured
onto slants for short term use, and longer term storage preparations made.
A total of 133 fungal cultures were isolated, with over 90% being moulds.
Macroscopic examination suggested that over 100 fungal species were repre-
sented, including species of Fusarium, Epicoccum, Aspergillus and Penicillium.
Almost 92% of these isolates grew sufficiently enough to be incorporated into
the isolate collection.
Screening for Antimicrobial Activity The second stage of the project involved the
screening of the fungal isolates collected during the first phase against a panel
of selected nosocomial pathogens. After a suitable screening method was deter-
mined, the fungal isolates were progressively subcultured from the slants, and if
successfully grown, screened for antimicrobial activity.
Of the 122 isolates in storage, 13 were not tested as they were macroscopically
identified as yeasts. Of the 109 isolates remaining for screening, 27 (24.7%) did
not recover from PDA slant storage; 3 (2.8%) did not grow directly on the test
medium and 2 (1.8%) grew so quickly and heavily that the bacteria could not be
applied to the plate surface. Seventy-seven (70.6%) isolates were successfully
screened using the direct Sensitest screening procedure.
Seven isolates demonstrated some level of activity against the selected micro-
organisms. However, in the case of four of the isolates, the results were not
repeatable. Therefore, the screening process yielded three isolates whose an-
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timicrobial activity was investigated further. Based on the plant sample of ori-
gin, and the number of isolates obtained from that sample, these isolates were
designated as numbers 6.5, 12.1 and 129.1.
Identification of Selected isolates The three isolates which demonstrated antimicro-
bial activity against one or more of the test bacteria required the determination
of their scientific classification, so as not to re-evaluate a fungus which had been
previously described and assessed. Morphological characteristics, both macro-
scopic and microscopic, were initially studied, and were sufficient to determine
the genus of isolate 12.1 as that of Penicillium. Molecular techniques were re-
quired to obtain identification of the remaining isolates, which were ultimately
identified as Schizophyllum commune (isolate 6.5) and Sporormiella isomera
(isolate 129.1).
Evaluation of Activity The final part of the project involved the evaluation of the an-
timicrobial activity and the assessment of potential toxicity of crude preparations
from the three selected isolates. The MIC and MBC were determined for the
fungal preparations against three strains of bacteria. Toxic effects of the crude
preparations were tested on murine fibroblasts and evaluated using the MTT Cell
Viability and Crystal Violet Dye Exclusion (CVDE) assays. Cytotoxicity results
were expressed as the IC50, the concentration at which 50% of the cells were no
longer viable.
Following the final part of the project, it was determined that isolates 6.5 and 12.1 could
produce secondary metabolites that were capable of demonstrating bacteriostatic ac-
tivity against staphylococcal species. In addition, products manufactured by isolate 6.5
proved to be bactericidal against E. coli. The antimicrobial screening process also in-
dicated both isolates possessed activity against B. cereus, but this was not investigated
further at this stage.
Initial screening of isolate 129.1 demonstrated antimicrobial activity against staphylo-
cocci. However, this activity was not repeated during MIC or MBC evaluation. Nu-
merous reasons may be used to explain this occurance, including spontaneous halt in
the production of the relevant secondary metabolite by the fungus; subtle differences
in culture conditions; or a requirement for bacterial inducement. Continued evaluation
would be required to determine the actual cause.
Any secondary metabolites produced by isolate 129.1, under the culturing methods
utilised for bioactivity evaluation, did not display any cytotoxicity against the fibroblast-
like L929 cells. Some cytotoxicity was detected with isolate 12.1, while products of
isolate 6.5 proved to be highly toxic. The highest dilution tested was able to kill greater
than 50% of test cells.
Attempts were made by a collaborating laboratory to analyse and extract the secondary
metabolites produced by isolates 6.5, 12.1 and 129.1. Small amounts of penicillic
acid were extracted from isolate 12.1. Since the product was well known, it was not
analysed further.
88
CHAPTER 7. CONCLUSION
Approximately 6mg of monagnetol was extracted from isolate 129.1. This was evalu-
ated for antimicrobial activity, but none was detected at this concentration.
To date, no secondary products have been extracted from isolate 6.5. Continued at-
tempts will be made, as further analysis of the isolate’s secondary metabolites may
reveal multiple products, with varying levels of activity and toxicity, novel modes of
action, or novel structures. Separation of the active products could allow for further
investigations, and if combinatorial chemistry is utilised, their structures may be ma-
nipulated in order to reduce the levels of toxicity.
All isolates collected over the course of the project remain stored in glycerol at -70oC.
Therefore, screening can be repeated with additional bacterial species and alternative
screening methods can be employed so as to screen other microorganisms, including
pathogenic yeasts and fungi. Not only does this work potentially contribute to the
discovery of novel antimicrobial products, but as so few fungi have been described,
the identification of the fungi so far isolated could reveal new species, and provide
additional information about fungal diversity.
The increasing rate in the development of antibiotic resistance by pathogenic organ-
isms means new antibiotics need to be sourced quickly, so that current standards in
health care and disease treatment can be maintained. It has been shown by this study
and numerous others, that endophytic fungi can be a valuable source in the search for
these new antimicrobials. Their variable hosts, habitats, and history, coupled with the
sheer number of undiscovered species, suggests that numerous discoveries are yet to
be made.
As long as bacteria continue to develop resistance to the antibiotics we use to treat their
infections, we will need to source new antibiotics. The continued isolation, screening
and evaluation of endophytic fungi and their secondary metabolites can only be of
benefit to all higher life forms on Earth.
89
References
Alovero, F., Nieto, M., Mazzieri, M. R., Then, R. & Manzo, R. H. (1998), ‘Mode
of action of sulfanilyl fluoroquinolones’, Antimicrobial Agents and Chemotherapy
42(6), 1495–1498. Retrieved on May 17, 2009 from aac.asm.org.
Altschul, S. F., Madden, T. L., Scha¨ffer, A. A., Zhang, J., Zhang, Z., Miller, W. & Lip-
man, D. J. (1997), ‘Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs’, Nucleic Acids Res 25, 3389–3402.
Aly, A. H., Edrada-Ebel, R., Wray, V., Mu¨ller, W. E. G., Kozytska, S., Hentschel,
U., Proksch, P. & Ebel, R. (2008), ‘Bioactive metabolites from the endophytic
fungus Ampelomyces sp. isolated from the medicinal plant Urospermum pi-
croides’, Phytochemistry 69, 1716–1725. Retrieved on June 15, 2009 via www.
sciencedirect.com.
Anon. (2001), Guidance document on using In Vitro data to estimate In Vivo start-
ing doses for acute toxicity, Technical report, The NTP Interagency Center for the
Evaluation of Alternative Toxicological Methods (NICEATM) and the Interagency
Coordinating Committee on the Validation of Alternative Methods (ICCVAM).
Retrieved June 12, 2008 from iccvam.niehs.nih.gov/docs/acutetox_
docs/guidance0801/iv_guide.pdf.
Anon. (2002a), Fact sheet No 194: Antimicrobial resistance, World Health Organi-
zation (WHO). Retrieved April 29, 2009 from www.who.int/mediacentre/
factsheets/.
Anon. (2002b), ‘Naturally sourced pharmaceuticals making a comeback’, Bioshares
(11), 18–20.
Anon. (2003), National strategy to address health care associated infections,
Technical report, Australian Infection Control Association; The Australian
Commission for Safety and Quality in Health Care. Retrieved on March 13,
2009 from www.health.gov.au/internet/safety/publishing.
nsf/Content/F22384CCE74A9F01CA257483000D845E/$File/
NationalStrategy_web.pdfxxxx.
Anon. (2005a), Introduction to national guidelines for surveillance, Techni-
cal report, Australian Infection Control Association;The Australian Com-
mission for Safety and Quality in Health Care. Retrieved on March 13,
2009 from www.health.gov.au/internet/safety/publishing.
nsf/Content/2716397CDDE8A410CA257483000D8462/$File/
introgdesurvlnc05.pdf.
90
REFERENCES
Anon. (2005b), Multi-resistant organism (MRO) surveillance indicator definitions,
Technical report, Australian Infection Control Association; The Australian
Commission for Safety and Quality in Health Care. Retrieved on March 13,
2009 from www.health.gov.au/internet/safety/publishing.
nsf/Content/F22384CCE74A9F01CA257483000D845E/$File/
mrosurvlncdefine05.pdf.
Anon. (2005c), Multi-resistant organism screening and clearance recommenda-
tions, Technical report, Australian Infection Control Association; The Australian
Commission for Safety and Quality in Health Care. Retrieved on March 13,
2009 from www.health.gov.au/internet/safety/publishing.
nsf/Content/F22384CCE74A9F01CA257483000D845E/$File/
mroscreenjun05.pdf.
Anon. (2007), “‘Super bug” closes hospital wards’, The Age . Retrieved December 3,
2007 from www.theage.com.au/.
Arenal, F., Platus, G. & Pela´ez, F. (2005), ‘Two new Preussia species defined based on
morphological and molecular evidence’, Fungal Diversity 20, 1–15. Retrieved on
June 17, 2009 from www.fungaldiversity.org/fdp/sfdp/20-1.
Arnold, A. E. & Lutzoni, F. (2007), ‘Diversity and host range of foliar fungal endo-
phytes: are tropical leaves biodiversity hotspots?’, Ecology 88(3), 54–549.
Arnold, A. E., Maynard, Z. & Gilbert, G. S. (2001), ‘Fungal endophytes in di-
cotyledonous neotropical trees: patterns of abundance and diversity’, Mycol. Res.
105(12), 1502–1507.
Atalla, M. M., Zeinab, H. K., Eman, R. H., Amani, A. Y. & Abeer, A. A. E. A. (2008),
‘Production of some biologically active secondary metabolites from marine-derived
fungus Varicosporina ramulosa’, Malaysian Journal of Microbiology 4(1), 14–
24. Retrieved on June 16, 2009 from www.usm.my/mjm/issues/vol4no1/
research3.pdf.
Bayman, P., Angulo-Sandoval, P., Ba¨ez-Ortiz, Z. & Lodge, D. J. (1998), ‘Distribution
and dispersal of Xylaria endophytes in two tree species in Puerto Rico’, Mycol. Res.
102(8), 944–948.
Bills, G. F. (1996), Isolation and analysis of endophytic fungal communities from
woody plants, in S. C. Redlin & L. M. Carris, eds, ‘Endophytic Fungi in Grasses
and Woody Plants’, The American Phytopathological Society, chapter 2.
Calvo, A. M., Wilson, R. A., Bok, J. W. & Keller, N. P. (2002), ‘Relationship between
secondary metabolism and fungal development’, Microbiology and Molecular Bi-
ology Reviews 66(3), 447–459. Retrieved April 23, 2009 from mmbr.asm.org/
cgi/content/abstract/66/3/447.
Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing,
J. & Sanders, A. G. (1940), Penicillin as a chemotherapeutic agent, in W. K. Joklik,
L. G. Ljungdahl, A. D. OBrien, A. von Graevenitz & C. Yanofsky, eds, ‘Microbiol-
ogy: A Centenary Perspective’, American Society for Microbiology, pp. 112–114.
91
REFERENCES
CLSI (1999), Methods for Determining Bactericidal Activity of Antimicrobial Agents;
Approved Guideline. CLSI document M26-A, Vol. 19, 18 edn, Clinical and Labora-
tory Standards Institute, Wayne, Pennsylvania.
CLSI (2006), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That
Grow Aerobically; Approved Standard - Seventh Edition. CLSI document M7-A7,
Vol. 26, 7 edn, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
CLSI (2008), Performance Standards for Antimicrobial Susceptibility Testing; Eigh-
teenth Informational Supplement. CLSI document M100-S18, Vol. 28, 1 edn, Clini-
cal and Laboratory Standards Institute, Wayne, Pennsylvania.
Cosgrove, S. E., Carroll, K. C. & Perl, T. M. (2004), ‘Staphylococcus aureus with
reduced susceptibility to vancomycin’, Clinical Infectious Diseases 39, 539–545.
Cragg, G. M., Newman, D. J. & Snader, K. M. (1997), ‘Natural products in drug
discovery and development’, Journal of Natural Products 60, 52–60. Retrieved
November 1, 2009 from http://pubs.acs.org.
Cruickshank, M. & Ferguson, J., eds (2008), Reducing harm to patients
from health care associated infection: the role of surveillance, Australian
Commission on Safety and Quality in Health Care. Retrieved May
02, 2009 from www.health.gov.au/internet/safety/publishing.
nsf/Content/prog-HAI_Surveillance.
Davis, B. D. (1987), ‘Mechanism of bactericidal action of aminoglycosides’, Mi-
crobiological Reviews 51(3), 341–350. Retrieved on May 05, 2009 from www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=373115.
Davis, R. A. (2005), ‘Isolation and structure elucidation of the new fungal metabolite
(–)-xylariamide A’, Journal of Natural Products 68(5), 769–772. Retrieved Novem-
ber 1, 2009 from ScienceDirect.
Davis, R. A., Andjic, V., Kotiw, M. & Shivas, R. G. (2005), ‘Phomoxins B and C:
Polyketides from an endophytic fungus of the genus Eupenicillium’, Phytochemistry
66, 2771–2775. Retrieved November 1, 2009 from ScienceDirect.
Davis, R. A., Longden, J., Avery, V. M. & Healy, P. C. (2008), ‘The isolation, structure
determination and cytotoxicity of the new fungal metabolite, trichodermamide C’,
Bioorganic & Medicinal Letters 18, 2836–2839. Retrieved November 1, 2009 from
ScienceDirect.
Deacon, J. (2006), Fungal Biology, 4 edn, Blackwell Publishing. Additional pic-
tures available at http://www.biology.ed.ac.uk/research/groups/
jdeacon/FungalBiology/.
Demain, A. L. (1986), ‘Regulation of secondary metabolism in fungi’, Pure & Applied
Chemistry 58(2), 219–226. Retrieved February 26, 2007 from www.iupac.org/
publications/pac/1986/pdf/5802x0219.pdf.
Dingle, J. & McGee, P. A. (2003), ‘Some endophytic fungi reduce the density of pus-
tules of Puccinia recondita f. sp. tritici in wheat’, Mycol. Res 107(3), 310–316.
92
REFERENCES
Ellis, D., Davis, S., Alexiou, H., Handke, R. & Bartley, R. (2007), Descriptions of
Medical Fungi, 2 edn, The authors, Adelaide, South Australia, Australia.
Emerson, R. L., Whiffen, A. J., Bohonos, N. & DeBoer, C. (1946), ‘Studies on
the production of antibiotics by actinomycetes and molds’, Journal of Bacteri-
ology 52(3), 357–366. Retrieved February 26, 2007 from jb.asm.org/cgi/
reprint/52/3/357.pdf.
Felsenstein, J. (1985), ‘Confidence limits on phylogenies: An approach using the boot-
strap.’, Evolution 39, 783–791.
Fleming, A. (1929), ‘On the antibacterial action of cultures of a penicillium, with
special reference to their use in the isolation of B. influenzae’, British Journal of
Experimental Pathology 10, 226–236.
Fro¨hlich, J., Hyde, K. D. & Petrini, O. (2000), ‘Endophytic fungi associated with
palms’, Mycol. Res. 104(10), 1202–1212.
Gardes, M. & Bruns, T. D. (1993), ‘ITS primers with enhanced specificity for basid-
iomycetes - application to the identification of mycorrhizae and rusts’, Molecular
Ecology 2, 113–118. Retrieved April 19, 2008 via Blackwell Synergy at www.
blackwell-synergy.com.ezproxy.usq.edu.au/toc/mec/2/2.
Gloer, J. B. (1997), Applications of fungal ecology in the search for new bioactive
natural products, in D. T. Wicklow & B. So¨derstro¨m, eds, ‘The Mycota’, Vol. 4 of
Environmental and Microbial Relationships, Springer-Verlag.
Grekova, S. P., Vodyanik, M. A. & Chernyshov, V. P. (2002), ‘Effect of progesterone
and 17β-estradiol on the cytotoxicity mediated by tumor necrosis factor’, Experi-
mental Oncology 24, 228–230.
Grossman, C. M. (2008), ‘The first use of penicillin in the United States’, Annals
of Internal Medicine 149(2), 135–136. Retrieved on May 13, 2009 from www.
annals.org/cgi/content/abstract/149/2/135.
Guo, L. D., Hyde, K. D. & Liew, E. C. Y. (2000), ‘Identification of endophytic fungi
from Livistona chinensis based on morphology and rDNA sequences’, New Phytol.
147, 617–630.
Hatori, H., Shibata, T., Tsurumi, Y., Nakanishi, T., Katsuoka, M., Ohtsu, Y., Sakamoto,
K., Takase, S., Ueda, H., Hino, M. & Fuji, T. (2004), ‘FR171456, a novel choles-
terol synthesis inhibitor produced by Sporormiella minima no. 15604: I. Taxon-
omy, fermentation, isolation, physico-chemical properties’, The Journal Of Antibi-
otics 57(4), 253–259. Retrieved June 4, 2009 from www.antibiotics.or.jp/
journal/contents/vol-57/full_text/57-4/ja57_0260.pdf.
Hawksworth, D. L. (2001), ‘The magnitude of fungal diversity: the 1.5 million species
estimate revisited’, Mycol. Res 105(12), 1422–1432.
Healy, P. C., Hocking, A., Tran-Dinh, N., Pitt, J. I., Shivas, R. G., Mitchell, J. K.,
Kotiw, M. & Davis, R. A. (2004), ‘Xanthones from a micofungus of the genus
Xylaria’, Phytochemistry 65, 2373–2378. Retrieved November 1, 2009 from Sci-
enceDirect.
93
REFERENCES
Henry, C. (2005), ‘The top pharmaceuticals that changed the world - penicillin’, Chem-
ical and Engineering News 83(25). Retrieved May 25, 2009 from pubs.acs.
org/cen/coverstory/83/8325/8325penicillin.html.
Henry, R. J. (1944), ‘The mode of action of sulfonamides’, Microbiology and Molec-
ular Biology Reviews pp. 175 – 262. Retrieved May 22, 2009 from mmbr.asm.
org/cgi/content/citation/7/4/175.
Hyde, K. D. (1996), ‘Biodiversity of microfungi in North Queensland’, Australian
Systematic Botany 9, 261–271.
Jennison, M. W., Richberg, C. G. & Krikszens, A. E. (1956), ‘Physiology of
wood-rotting basidiomycetes – ii. Nutritive composition of mycelium grown in
submerged culture’, Applied and Environmental Microbiology 5, 87–95. Re-
trieved May 15, 2006 from www.pubmedcentral.gov/picrender.fcgi?
artid=1057264&blobtype=pdf.
John, J. F. & Harvin, A. M. (2007), ‘History and evolution of antibiotic resistance in
coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal
agents’, Therapeutics and Clinical Risk Management 3(6), 1143–1152.
Johnston, P. R. (1998), ‘Leaf endophytes of manuka (Leptospermum scoparium)’, My-
col. Res 102(8), 1009–1016.
Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR)
(2003), ‘Strategy for antimicrobial resistance surveillance in Australia’, Commu-
nicable Diseases Intelligence 27(4), 435–448. Retrieved on March 13, 2009 from
www.health.gov.au/internet/main/publishing.nsf/Content/
cda-2003-cdi2704-pdf-cnt.htm/$FILE/cdi2704c.pdf.
Katz, S. (2002), ‘Beneficial uses of plant pathogens: anticancer and drug agents de-
rived from plant pathogens’, Can. J. Plant Pathol 24, 10–13. Symposium contribu-
tion.
Kingsland, S. R. & Barrow, R. A. (2009), ‘Identification of chaetoviridin E from a
cultured microfungus, Chaetomium sp. and structural reassignment of chaetoviridins
B and D’, Australian Journal of Chemistry 62, 269–274. Retrieved November 1,
2009 from CSIRO Publishing.
Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., Har-
rison, L. H., Lynfield, R., Dumyati, G., Townes, J. M., Craig, A. S., Zell, E. R.,
Fosheim, G. E., McDougal, L. K., Carey, R. B. & Fridkin, S. K. (2007), ‘Invasive
methicillin-resistant Staphylococcus aureus infections in the United States’, JAMA
298(15), 1763–1771. Retrieved October 18, 2008 from www.jama.com.
Koehn, F. E. & Carter, G. T. (2005), ‘The evolving role of natural products in drug
discovery’, Nature Reviews Drug Discovery 4, 206–220. Retrieved November 1,
2009 from http://www.nature.com.
Laich, F., Fierro, F. & Martin, J. F. (2002), ‘Production of penicillin by fungi growing
on food products: Identification of a complete penicillin gene cluster in Penicil-
lium griseofulvum and a truncated cluster in Penicillium verrucosum’, Applied and
94
REFERENCES
Environmental Microbiology 68(3), 1211–1219. Retrieved October 19, 2006 from
aem.asm.org/cgi/reprint/68/3/1211.
Lee, S. W., Foley, E. J. & Epstein, J. A. (1944), ‘Mode of action of penicillin’,
Journal of Bacteriology pp. 393–399. Retrieved May 20, 2009 from www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=373984.
Lowy, F. D. (2003), ‘Antimicrobial resistance: the example of Staphylococcus aureus’,
The Journal of Clinical Investigation 111(9), 1265–1273. Retrieved April 27, 2009
from www.jci.org/articles/view/18535/version/1.
Mahesh, B., Tejesvi, M. V., Nalini, M. S., Prakash, H. S., Kini, K. R., Subbiah, V. &
Shetty, H. S. (2005), ‘Endophytic mycoflora of inner bark of Azadirachta indica A.
Juss’, Current Science 88(2), 218–219. Retrieved June 22, 2009 from www.ias.
ac.in/currsci/jan252005/218.pdf.
McGinnis, M. R., Padhye, A. A. & Ajello, L. (1974), ‘Storage of stock cultures of
filamentous fungi, yeasts and some aerobic actinomycetes in sterile distilled water’,
Applied Microbiology 28(2), 218–222. Retrieved April 19, 2009 from aem.asm.
org/cgi/reprint/28/2/218.pdf.
McKenzie, E. H. C. (2001), ‘Fungi anamorphici in Australasia’, Australian Systematic
Botany 14, 485–500.
Michael, A. P., Grace, E. J., Kotiw, M. & Barrow, R. A. (2003), ‘Isochromophilone IX,
a novel GABA-containing metabolite isolated from a cultured fungus, Penicillium
sp.’, Australian Journal of Chemistry 56, 13–15. Retrieved November 1, 2009 from
CSIRO Publishing.
Morrison, E., Rundberget, T., Kosiak, B., Aastveit, A. H. & Bernhoft, A. (2001), ‘Cy-
totoxicity of trichothecenes and fusarochromanone produced by Fusarium equiseti
strains isolated from Norwegian cereals’, Mycopathologia 153, 49–56. Retrieved
April 2, 2009 from springerlink.metapress.com.
National Centre for Biotechnology Information (2009). NCBI, U.S. National Library
of Medicine, 8600 Rockville Pike, Bethesda, MD 20894. Viewed 20th June 2009 at
www.ncbi.nlm.nih.gov/.
Newman, D. J. & Cragg, G. M. (2007), ‘Natural products as sources of new drugs over
the last 25 years’, Journal of Natural Products 70, 461–477. Retrieved November
1, 2009 from http://pubs.acs.org.
Newman, D. J., Cragg, G. M. & Snader, K. M. (2003), ‘Natural products as sources
of new drugs over the period 1981 – 2002’, Journal of Natural Products 66, 1022–
1037. Retrieved November 1, 2009 from http://pubs.acs.org.
Nimmo, G. R., Coombs, G. W., Pearson, J. C., O’Brien, F. G., Christiansen,
K. J., Turnidge, J. D., Gosbell, I. B., Collignon, P. & McLaws, M.-L. (2006),
‘Methicillin-resistant Staphylococcus aureus in the Australian community: an
evolving epidemic’, Medical Journal of Australia 184(8), 384–388. Retrieved April
19, 2009 from www.mja.com.au/public/issues/184-08-170406/
nim10691_fm.pdf.
95
REFERENCES
Nimmo, G. R., Pearson, J. C., Collignon, P. J., Christiansen, K. J., Coombs, G. W.,
Bell, J. M. & McLaws, M.-L. (2007), ‘Prevalence of MRSA among Staphylococcus
aureus isolated from hospital inpatients, 2005: Report from the Australian Group
for Antimicrobial Resistance’, Communicable Diseases Intelligence 31(3), 288–
296. Retrieved April 25, 2009 from www.health.gov.au/internet/main/
publishing.nsf/Content/cda-cdi3103d.htm.
Paulus, B. C., Gadek, P. A. & Hyde, K. D. (2003), ‘Cylindrosympodium cryptocaryae
sp. nov. (anamorphic fungi), with keys to the described species and to similar gen-
era’, Australian Systematic Botany 16, 577–580.
Paulus, B. C., Kanowski, J., Gadek, P. A. & Hyde, K. D. (2006), ‘Diversity and dis-
tribution of saprobic microfungi in leaf litter of an Australian tropical rainforest’,
Mycological Research 110, 1441–1454.
Pela´ez, F., Collado, J., Arenal, F., Basilio, A., Cabello, A., Dı´ez Matas, M. T., Garcı´a,
J. B., Gonza´lez Del Val, A., Gonza´lez, V., Gorrochategui, J., Herna´ndez, P., Martı´n,
I., Platas, G. & Vicente, F. (1998), ‘Endophytic fungi from plants living on gypsum
soils as a source of secondary metabolites with antimicrobial activity’, Mycol. Res
102(6), 755–761.
Petrini, O. (1996), Ecological and physiological aspects of host-specificity in endo-
phytic fungi, in S. C. Redlin & L. M. Carris, eds, ‘Endophytic Fungi in Grasses and
Woody Plants’, The American Phytopathological Society, chapter 4.
Pongcharoen, W., Rukachaisirikul, V., Isaka, M. & Sriklung, K. (2007), ‘Cytotoxic
metabolites from the wood-decayed fungus Xylaria sp. BCC 9653’, Chem. Pharm.
Bull. 55(11), 1647–1648. Retrieved June 15, 2009 from www.jstage.jst.go.
jp/article/cpb/55/11/1647/_pdf.
Rantz, L. A. (1954), ‘Consequences of the widespread use of antibiotics’, California
Medicine 81(1). Retrieved May 21, 2009 from www.pubmedcentral.nih.
gov/picrender.fcgi?artid=1532084&blobtype=pdf.
Rao, V. S. & Seshadri, T. R. (1942), ‘Chemical examination of Indian Lichens: Part
v. Occurrence of active montagnetol in Roccella montagnei’, Proceddings of the
Indian Academy of Sciences, Section A 15, 429–431. Viewed June 15 2009 at www.
ias.ac.in/i_archive/proca/15/6/429-431/viewpage.html.
Rodrigues, K. F., Hesse, M. & Werner, C. (2000), ‘Antimicrobial activ-
ities of secondary metabolites produced by endophytic fungi from Spon-
dias mombin’, J. Basic Microbiol. 40(4), 261–267. Retrieved February
12, 2009 from www3.interscience.wiley.com/journal/72515920/
abstract?CRETRY=1&SRETRY=0.
Rosa, L. H., Machado, K. M. G., Jacob, C. C., Capelari, M., Rosa, C. A. & Zani, C. L.
(2003), ‘Screening of Brazilian basidiomycetes for antimicrobial activity’, Mem Inst
Oswaldo Cruz 98(7), 967–974.
Saitou, N. & Nei, M. (1987), ‘The neighbor-joining method: A new method for recon-
structing phylogenetic trees.’, Molecular Biology and Evolution 4, 406–425.
96
REFERENCES
Schlu¨nzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A.
& Franceschi, F. (2001), ‘Structural basis for the interaction of antibiotics with the
peptidyl transferase centre in eubacteria’, Nature 413, 814–821. Retrieved May 13,
2009 from www.nature.com.
Schulz, B., Boyle, C., Draeger, S., Ro¨mmert, A.-K. & Krohn, K. (2002), ‘Endophytic
fungi: a source of novel biologically active secondary metabolites’, Mycol. Res
106(9), 996–1004.
Schulz, B., Sucker, J., Aust, H. J., Krohn, K., Ludewig, K., Jones, P. G. &
Do¨ring, D. (1995), ‘Biologically active secondary metabolites of endophytic Pez-
icula species’, Mycol. Res 99(8), 1007–1015. Retrieved June 10, 2009 via www.
sciencedirect.com/.
Smith, D. (1988), Culture and preservation, in D. L. Hawksworth & B. E. Kirsop, eds,
‘Living Resources for Biotechnology’, Filamentous Fungi, Cambridge University
Press, chapter 4.
Stork, W. (2005), ‘The top pharmaceuticals that changed the world - prontosil’, Chem-
ical and Engineering News 83(25). Retrieved May 25, 2009 from pubs.acs.
org/cen/coverstory/83/8325/8325prontosil.html.
Strobel, G. & Daisy, B. (2003), ‘Bioprospecting for microbial endophytes and their
natural products’, Microbiology and Molecular Biology Reviews 67(4), 491–502.
Suffredini, I., Sader, H., Gonc¸alves, A., Reis, A., Gales, A., Varella, A. & Younes, R.
(2004), ‘Screening of antibacterial extracts from plants native to the Brazilian Ama-
zon Rain Forest and Atlantic Forest’, Brazillian Journal of Medical and Biological
Research 37, 379–384.
Suryanarayanan, T. S., Venkatesan, G. & Murali, T. S. (2003), ‘Endophytic fungal
communities in leaves of tropical forest trees: Diversity and distribution patterns’,
Current Science 85(4), 489–493.
Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007), ‘ MEGA4: Molecular Evolu-
tionary Genetics Analysis (MEGA) software version 4.0.’, Molecular Biology and
Evolution 24, 1596–1599.
Taylor, J. E., Hyde, K. D. & Jones, E. B. G. (1999), ‘Endophytic fungi associated with
the temperate palm, Trachycarpus fortunei, within and outside its natural geographic
range’, New Phytol. 142, 335–346.
Tominaga, H., Ishiyama, M., Ohseto, F., Sasamoto, K., Hamamoto, T., Suzuki, K.
& Watanabe, M. (1999), ‘A water-soluble tetrazolium salt useful for colorimetric
cell viability assay’, Anal. Commun. 36, 47–50. Retrieved March 10, 2009 from
www.rsc.org/ej/AC/1999/a809656b.pdf.
Trilli, A., Michelini, V., Mantovani, V. & Pirt, S. J. (1978), ‘Development of the
agar disk method for the rapid selection of cephalosporin producers with improved
yields’, Antimicrobial Agents and Chemotherapy 13(1), 7–13.
97
REFERENCES
Vega, F. E., Posada, F., Peterson, S. W., Gianfagna, T. J. & Chaves, F. (2006), ‘Peni-
cillium species endophytic in coffee plants and ochratoxin A production’, Mycolo-
gia 98(1), 31–42. Retrieved June 22, 2009 from www.mycologia.org/cgi/
reprint/98/1/31.
Wainwright, M. & Swan, H. T. (1986), ‘C.G. Paine and the earliest surviving clin-
ical records of penicillin therapy’, Medical History 30, 42–56. Retrieved May
22, 2009 from www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1139580.
Wei, R.-D., Still, P. E., Smalley, E. B., Schnoes, H. K. & Strong, F. M.
(1973), ‘Isolation and partial characterisation of a mycotoxin from Penicil-
lium roqueforti’, Applied Microbiology 25(1), 111–114. Retrieved January
27, 2009 from www.pubmedcentral.nih.gov/articlerender.fcgi?
tool=pubmed&pubmedid=4687064.
Yanna & Hyde, K. D. (2002), ‘New saprobic fungi on fronds of palms from northern
Queensland, Australia’, Australian Systematic Botany 15, 755–764.
Yocum, R. R., Rasmussen, J. R. & Strominger, J. L. (1980), ‘The mechanism of action
of penicillin’, The Journal of Biological Chemistry 255(9), 3977–3986. Retrieved
May 17, 2009 from www.jbc.org.
Yotsuji, A., Mitsuyama, J., Hori, R., Yasuda, T., Saikawa, I., Inoue, M. & Mitsuhashi,
S. (1988), ‘Mechanism of action of cephalosporins and resistance caused by de-
creased affinity for penicillin-binding proteins in Bacteroides fragilis’, Antimicro-
bial Agents and Chemotherapy 32(12), 1848–1853. Retrieved May 17, 2009 from
aac.asm.org.
98
Appendix A
Acronyms
BSC Biological Safety Cabinet
CAMHB Cation adjusted Mueller Hinton Broth
CVDE Crystal Violet Dye Exclusion
DMSO di-methyl sulfoxide
IPTG Isopropyl-β-D-1-thiogalactopyranoside
ITS internal transcribed spacer
LB Luria-Bertoni
MEA Malt Extract Agar
MBC Minimum Bactericidal Concentration
MHB Mueller Hinton Broth
MIC Minimum Inhibitory Concentration
MRSA methicillin-resistant Staphylococcus aureus
MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl-tetrazolium bromide)
NA Nutrient Agar
NB Nutrient Broth
PDA Potato Dextrose Agar
RO reverse osmosis
SDA Sabouraud Dextrose Agar
TSA Tryptic Soy Agar
VRE vancomycin-resistant Enterococci
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X-Gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
YES Yeast Extract-Sucrose
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Media Formulations
Note: All media autoclaved at 121oC for 15 minutes unless specified All ingredients
listed as per litre unless specified
Czapek Dox
Czapek Dox Broth
Supplier: Difco
Bacto Laboratories, Mt Pritchard, NSW, Australia
Saccharose 30g
Sodium nitrate (NaNO3) 3g
di-Potassium hydrogen orthophosphate (K2HPO4) 1g
Magnesium sulphate (MgSO4.7H2O) 0.5g
Potassium chloride (KCl) 0.5g
Ferric sulphate (FeSO4.7H2O) 0.01g
35g per 1000ml
Czapek Yeast Broth
Supplier: Difco (Base Broth as above)
Yeast Extract 5g
Trace Metals 1ml
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Trace Metals Solution:
Zinc sulphate (ZnSO4.7H2O) 1% w/v
Copper sulfate (CuSO4.5H2O) 0.5% w/v
Luria-Bertoni
LB Agar
Supplier: Amyl Media
Amyl Media, Dandenong, VIC, Australia
Casein Peptone Pancreatic Digest 10g
Sodium chloride 5g
Yeast Extract 5g
Agar, bacteriological 15g
35g per 1000ml
LB Broth
Supplier: Difco
Bacto Laboratories, Mt Pritchard, NSW, Australia
Pancreatic Digest of Casein 10g
Yeast Extract 5g
Sodium chloride 10g
25g per 1000ml
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Malt Extract
Malt Extract Agar
Supplier: Oxoid
Oxoid Australia, Adelaide, SA, Australia
Malt Extract 30g
Mycological Peptone 5g
Agar 15g
50g per 1000ml
Malt Extract Broth
Supplier: Oxoid
Oxoid Australia, Adelaide, SA, Australia
Malt Extract 17g
Mycological Peptone 3g
20g per 1000ml
Mueller-Hinton Broth
Supplier: Oxoid
Oxoid Australia, Adelaide, SA, Australia
Beef, dehydrated infusion from 300g
Casein hydrolysate 17.5g
Starch 1.5g
21g per 1000ml
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Nutrient
Nutrient Agar
Supplier: Amyl Media
Amyl Media, Dandenong, VIC, Australia
Bacteriological Peptone 5g
Sodium chloride 5g
Yeast Extract 2g
Beef Extract 1g
Agar, bacteriological 13g
26g per 1000ml
Nutrient Broth
Supplier: Amyl Media
Amyl Media, Dandenong, VIC, Australia
Bacteriological Peptone 5g
Sodium chloride 5g
Yeast Extract 2g
Beef Extract 1g
13g per 1000ml
Potato Dextrose Agar
Supplier: BD Difco
Bacto Laboratories, Mt Pritchard, NSW, Australia
Potato Infusion from 200g potato 4g
Dextrose 20g
Agar 15g
39g per 1000ml
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Sabouraud Dextrose Agar
Supplier: Amyl Media
Amyl Media, Dandenong, VIC, Australia
Mycological Peptone 10g
Glucose 40g
Agar 14g
64g per 1000ml
Sensitest Agar
Supplier: Oxoid
Oxoid Australia, Adelaide, SA, Australia
Hydrolysed casein 11.0g
Peptone 3.0g
Sodium chloride 3.0g
Glucose 2.0g
Starch 1.0g
Buffer salts 3.3g
Nucleoside bases 0.02g
Thiamine 0.00002g
Agar 8.0g
32g per 1000ml
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Tryptic Soy
Tryptic Soy Agar
Supplier: Amyl Media
Amyl Media, Dandenong, VIC, Australia
Casein Peptone Pancreatic Digest 15g
Soy Peptone 5g
Sodium chloride 5g
Agar 13g
38g per 1000ml
Tryptic Soy Broth
Supplier: Amyl Media
Amyl Media, Dandenong, VIC, Australia
Casein Peptone Pancreatic Digest 17g
Soy Peptone 3g
di-potassium hydrogen orthophosphate 2.5g
Sodium chloride 5g
Glucose 2.5g
30g per 1000ml
Yeast Extract-Malt Agar
Supplier: Prepared In-house
Yeast Extract 4g
Malt Extract 10g
Glucose 4g
Agar 20g
per 1000ml
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Yeast Extract-Sucrose Broth
Supplier: Prepared In-house
Yeast Extract 20g
Sucrose 150g
Magnesium Sulfate 0.5g
R.O. Water 885ml
Dissolve and dispense before autoclaving
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Appendix C
MIC and MBC Data
The tables on the following pages show the data obtained for evaluation of the MIC and
MBC of each test agent against the three test bacteria, as described in Chapter 5. The
general layout of each table follows that of the 96 well plates used for the MIC assay.
Each well in columns 1 to 11 contained a dilution of a test agent, and a standard volume
of test organism. Column 12 contained media with no test agents. “Medium +” were
inoculated with the test organism; “Medium -” were not inoculated at all. Following
incubation, the plates were scored for presence or absence of bacterial growth. Test
wells which had been inoculated with bacteria and showed no growth were plated to
determine if the bacteria were inhibited or eliminated.
Eash test agent was tested twice, in adjacent rows. Therefore, in able to refer which
MIC wells were sampled to determine the MBC, the MBC results are displayed under
each test agent’s paired rows. Wells which were not sampled as part of the MBC assay
are indicated with a “/”.
The MIC is defined as the lowest concentration of an antimicrobial agent required to
prevent visible growth of the test organism. The true MIC actually lies between the
reported MIC value and the next lower agent concentration. The MBC is defined as
the Minimum Bactericidal Concentration (MBC) required to kill 99.9% (≥ 3 log10
drop in CFU/ml) of the final inoculum.
Tables C.1(a-c) show data related to E. coli; Tables C.2(a-c)show data related to S.
aureus, and Tables C.3(a-c) show data related to MRSA.
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Table C.1: MIC and MBC data for each test preparation against E. coli. For the MIC data,“+” indicates growth of the bacterium; “-” indicates no
growth observed. For the MBC data, “+” indicates 11 colonies or greater were counted on the test plates; “-” indicates less than 11 colonies were
observed; “/” indicates well contents were not tested as growth had occured in the wells in the MIC test.
Column 1 2 3 4 5 6 7 8 9 10 11 12
Row Dilution Factor 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Controls
A Isolate 6.5 - - - - - - - + + + + CAMHB + +
B NB - - - - - - - + + + + CAMHB - -
MBC - - - - - - + / / / /
C Isolate 6.5 - - - - - - - + + + + 1:2 NB + +
D YES - - - - - - - + + + + 1:2 NB - -
MBC + - - - - - + / / / /
E Isolate 12.1 + + + + + + + + + + + 1:2 YES + +
F NB + + + + + + + + + + + 1:2 YES - -
MBC / / / / / / / / / / /
G Isolate 12.1 - + + + + + + + + + + CAMHB + +
H YES - + + + + + + + + + + CAMHB - -
MBC + / / / / / / / / / /
(a) E. coli, plate 1
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Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Dilution Factor 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Controls
A Isolate 129.1 + + + + + + + + + + + CAMHB + +
B NB + + + + + + + + + + + CAMHB - -
MBC / / / / / / / / / / /
C Isolate 129.1 - + + + + + + + + + + 1:1 NB + +
D YES - + + + + + + + + + + 1:1 NB - -
MBC + / / / / / / / / / /
E P. chrysogenum - + + + + + + + + + + 1:1 YES + -
F NB - + + + + + + + + + + 1:1 YES - -
MBC - / / / / / / / / / /
G P. chrysogenum - - - + + + + + + + + CAMHB + +
H YES - - - + + + + + + + + CAMHB - -
MBC - - - / / / / / / / /
(b) E. coli, plate 2
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Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Conc. µg/ml 128 64 32 16 8 4 2 1 0.5 0.25 0.13 Controls
A Ampicillin - - - - - - + + + + + CAMHB + +
B - - - - - - + + + + + CAMHB - -
MBC - - - - - + / / / / /
C Montagnetol + + + + + + + + + + + CAMHB + +
D + + + + + + + + + + + CAMHB - -
MBC / / / / / / / / / / /
(c) E. coli, plate 3
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Table C.2: MIC and MBC data for each test preparation against E. coli. For the MIC data,“+” indicates growth of the bacterium; “-” indicates no
growth observed. For the MBC data, “+” indicates 11 colonies or greater were counted on the test plates; “-” indicates less than 11 colonies were
observed; “/” indicates well contents were not tested as growth had occured in the wells in the MIC test.
Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Dilution Factor 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Controls
A Isolate 6.5 - - - - - - - - - + + CAMHB + +
B NB - - - - - - - - - + + CAMHB - -
MBC + + + + + + + + + / /
C Isolate 6.5 - - - - - - - - - + + 1:2 NB + +
D YES - - - - - - - - - + + 1:2 NB - -
MBC + + + + + + - - + / /
E Isolate 12.1 + + + + + + + + + + + 1:2 YES + +
F NB - + + + + + + + + + + 1:2 YES - -
MBC + / / / / / / / / / /
G Isolate 12.1 - - + + + + + + + + + CAMHB + +
H YES - - + + + + + + + + + CAMHB - -
MBC + + / / / / / / / / /
(a) S. aureus, plate 1
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Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Dilution Factor 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Controls
A Isolate 129.1 + + + + + + + + + + + CAMHB + +
B NB + + + + + + + + + + + CAMHB - -
MBC / / / / / / / / / / /
C Isolate 129.1 - + + + + + + + + + + 1:1 NB + +
D YES - + + + + + + + + + + 1:1 NB - -
MBC + / / / / / / / / / /
E P. chrysogenum - - - - - - + + + + + 1:1 YES + -
F NB - - - - - - + + + + + 1:1 YES - -
MBC + + + + - - / / / / /
G P. chrysogenum - - - - - + + + + + + CAMHB + +
H YES - - - - - + + + + + + CAMHB - -
MBC - - - - - / / / / / /
(b) S. aureus, plate 2
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Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Conc. µg/ml 128 64 32 16 8 4 2 1 0.5 0.25 0.13 Controls
A Penicillin - - - - - - - - + + + CAMHB + +
B - - - - - - - - - + + CAMHB - -
MBC - - - - - - - - + / /
C Montagnetol + + + + + + + + + + + CAMHB + +
D + + + + + + + + + + + CAMHB - -
MBC / / / / / / / / / / /
(c) S. aureus, plate 3
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Table C.3: MIC and MBC data for each test preparation against E. coli. For the MIC data,“+” indicates growth of the bacterium; “-” indicates no
growth observed. For the MBC data, “+” indicates 11 colonies or greater were counted on the test plates; “-” indicates less than 11 colonies were
observed; “/” indicates well contents were not tested as growth had occured in the wells in the MIC test.
Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Dilution Factor 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Controls
A Isolate 6.5 - - - - - - - - - + + CAMHB + +
B NB - - - - - - - - - + + CAMHB - -
MBC + + + + + + + + + / /
C Isolate 6.5 - - - - - - - - - + + 1:2 NB + +
D YES - - - - - - - - - + + 1:2 NB - -
MBC + + + + + + - - + / /
E Isolate 12.1 + + + + + + + + + + + 1:2 YES + +
F NB + + + + + + + + + + + 1:2 YES - -
MBC / / / / / / / / / / /
G Isolate 12.1 - - + + + + + + + + + CAMHB + +
H YES - - + + + + + + + + + CAMHB - -
MBC + + / / / / / / / / /
(a) MRSA, plate 1
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Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Dilution Factor 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Controls
A Isolate 129.1 + + + + + + + + + + + CAMHB + +
B NB + + + + + + + + + + + CAMHB - -
MBC / / / / / / / / / / /
C Isolate 129.1 - + + + + + + + + + + 1:1 NB + +
D YES - + + + + + + + + + + 1:1 NB - -
MBC + / / / / / / / / / /
E P. chrysogenum - - - - + + + + + + + 1:1 YES + -
F NB - - - - + + + + + + + 1:1 YES - -
MBC + + - + / / / / / / /
G P. chrysogenum - - - - - + + + + + + CAMHB + +
H YES - - - - - - + + + + + CAMHB - -
MBC - - - - + + / / / / /
(b) MRSA, plate 2
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Row Column 1 2 3 4 5 6 7 8 9 10 11 12
Conc. µg/ml 128 64 32 16 8 4 2 1 0.5 0.25 0.13 Controls
A Penicillin - - - + + + + + + + + CAMHB + +
B - - - + + + + + + + + CAMHB - -
MBC - - - / / / / / / / /
C Montagnetol + + + + + + + + + + + CAMHB + +
D + + + + + + + + + + + CAMHB - -
MBC / / / / / / / / / / /
(c) MRSA, plate 3
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Appendix D
Cell Toxicity Data
The tables on the following pages show the data obtained for evaluation of the toxi-
city of each test agent as detected by two cytotoxicity assays – MTT and CVDE, as
described in Chapter 5.
The general layout of each table follows that of the 96 well plates used for the cytotoxi-
city assays. Reading for rows A and H are not shown, as they contained water only and
were not used to generate results. The remaining wells of columns 1 and 12 were for
blanks, which contained medium and no cells. Columns 2 and 11 were used for con-
trols, either for positive cell growth or concentrated YES medium dilutions. Growth
controls contained medium and cells, whereas the others contained various dilutions
of the concentrated YES medium in DMEM and cells. The remaining wells contained
cells exposed to test agent dilutions in DMEM. Following incubation and assay proce-
dure, the plates were read in a spectrophotometer at the wavelengths specified.
Eash test agent was tested three times, in adjacent rows. Results displayed in the
following tables are grouped as such.
Tables D.1(a-c) show data related to the MTT assay; Tables D.2(a-c)show data ob-
tained from the CVDE assay.
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Table D.1: Cell toxicity data obtained for each test preparation using the MTT assay. Figures listed for each row are the optical densities obtained
at 570nm with reference to 630nm. The mean and standard deviation were calculated for each group of three results, and the results adjusted for
the blank (“x” indicates blank used). The result obtained for the growth control was assumed to be 100%. Percent viability was calculated by the
formula ODtestagent
ODgrowthcontrol
x 100.
Column 1 2 3 4 5 6 7 8 9 10 11 12
Controls Test Dilutions isolate 6.5 Controls
Row Blank Growth 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 YES 25% Blank
B 0.0140 0.7670 0.0380 0.0190 0.0140 0.0710 0.3130 0.3820 0.2880 0.2630 0.0790 0.0160
C 0.0100 0.7390 0.0390 0.0170 0.0150 0.0710 0.2850 0.3900 0.3060 0.2730 0.0660 0.0150
D 0.0170 0.7600 0.0320 0.0170 0.0170 0.0470 0.2680 0.3710 0.3000 0.2280 0.0730 0.0160
Mean 0.0137 0.7553 0.0363 0.0177 0.0153 0.0630 0.2887 0.3810 0.2980 0.2547 0.0727 0.0157
SD 0.0035 0.0146 0.0038 0.0012 0.0015 0.0139 0.0227 0.0095 0.0092 0.0236 0.0065 0.0006
Adjusted 0.7397 0.0207 0.0020 -0.0003 0.0473 0.2730 0.3653 0.2823 0.2390 0.0570 x
%Viability 100.00 2.79 0.27 -0.05 6.40 36.91 49.39 38.17 32.31 7.71
Test Dilutions isolate 12.1
Row Blank YES 50% 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 Growth Blank
E 0.0160 0.1060 0.1460 0.0490 0.0480 0.2710 0.4150 0.7310 0.8230 0.7910 0.7850 0.0180
F 0.0090 0.0810 0.1490 0.0520 0.0520 0.2650 0.3550 0.6060 0.7250 0.6410 0.6830 0.0160
G 0.0160 0.0690 0.1140 0.0450 0.0560 0.2340 0.3020 0.4990 0.5730 0.5940 0.5730 0.0160
Mean 0.0137 0.0853 0.1363 0.0487 0.0520 0.2567 0.3573 0.6120 0.7070 0.6753 0.6803 0.0167
SD 0.0040 0.0189 0.0194 0.0035 0.0040 0.0199 0.0565 0.1161 0.1260 0.1029 0.1060 0.0012
Adjusted 0.0687 0.1197 0.0320 0.0353 0.2400 0.3407 0.5953 0.6903 0.6587 0.6637 x
%Viability 10.35 18.03 4.82 5.32 36.16 51.33 89.70 104.02 99.25 100.00
(a) MTT assay, plate 1
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Column 1 2 3 4 5 6 7 8 9 10 11 12
Controls Test Dilutions isolate 129.1 Controls
Row Blank Growth 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 YES 6.25% Blank
B 0.0080 0.7430 0.0520 0.0490 0.4280 0.6390 0.8360 0.6650 0.7160 0.8320 0.6750 0.0170
C 0.0120 0.6830 0.0490 0.0440 0.2430 0.5970 0.7930 0.6850 0.6740 0.7540 0.6160 0.0180
D 0.0120 0.7580 0.0490 0.0430 0.2660 0.6000 0.8000 0.7610 0.8100 0.7410 0.6480 0.0220
Mean 0.0107 0.7280 0.0500 0.0453 0.3123 0.6120 0.8097 0.7037 0.7333 0.7757 0.6463 0.0190
SD 0.0023 0.0397 0.0017 0.0032 0.1008 0.0234 0.0231 0.0506 0.0696 0.0492 0.0295 0.0026
Adjusted x 0.7173 0.0393 0.0347 0.3017 0.6013 0.7990 0.6930 0.7227 0.7650 0.6357
%Viability 100.00 5.48 4.83 42.05 83.83 111.38 96.61 100.74 106.64 88.62
Test Dilutions P. Chrysogenum
Row Blank YES 12.5% 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 Growth Blank
E 0.0180 0.0760 0.1310 0.1720 0.1210 0.5150 0.7020 0.7940 0.6390 0.8420 0.7790 0.0180
F 0.0240 0.0890 0.1120 0.1360 0.1230 0.5280 0.7260 0.7160 0.6720 0.8220 0.7530 0.0130
G 0.0140 0.1310 0.0850 0.1140 0.1280 0.4070 0.6190 0.5970 0.6160 0.7820 0.8150 0.0140
Mean 0.0187 0.0987 0.1093 0.1407 0.1240 0.4833 0.6823 0.7023 0.6423 0.8153 0.7823 0.0150
SD 0.0050 0.0287 0.0231 0.0293 0.0036 0.0664 0.0561 0.0992 0.0281 0.0306 0.0311 0.0026
Adjusted 0.0837 0.0943 0.1257 0.1090 0.4683 0.6673 0.6873 0.6273 0.8003 0.7673 x
%Viability 10.90 12.29 16.38 14.21 61.03 86.97 89.57 81.75 104.30 100.00
(b) MTT assay, plate 2
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Column 1 2 3 4 5 6 7 8 9 10 11 12
Controls Test Dilutions isolate Penicillin – MIC dilutions µg/ml Controls
Row Blank Growth 32 16 8 4 2 1 0.5 0.25 YES 1.57% Blank
B 0.0070 0.8510 0.8250 0.7110 0.8330 0.8900 0.9340 0.8940 0.9650 0.8170 0.9620 0.0050
C 0.0080 0.7860 0.7740 0.8030 0.8230 0.7500 0.8690 0.8780 0.8690 0.7970 0.9570 0.0050
D 0.0090 0.6760 0.8810 0.9050 0.7780 0.8350 0.8440 0.7880 0.8750 0.7110 0.8200 0.0080
Mean 0.0080 0.7710 0.8267 0.8063 0.8113 0.8250 0.8823 0.8533 0.9030 0.7750 0.9130 0.0060
SD 0.0010 0.0885 0.0535 0.0970 0.0293 0.0705 0.0465 0.0571 0.0538 0.0563 0.0806 0.0017
Adjusted x 0.7630 0.8187 0.7983 0.8033 0.8170 0.8743 0.8453 0.8950 0.7670 0.9050
%Viability 100.00 107.30 104.63 105.29 107.08 114.59 110.79 117.30 100.52 118.61
Test Dilutions isolate Penicillin – strong dilutions mg/ml
Row Blank YES 3.13% 3.00 1.50 0.75 0.38 0.19 0.09 0.05 0.02 Growth Blank
E 0.0110 0.6760 0.3880 0.6920 0.8370 0.8450 0.7950 0.8800 0.7740 0.7160 0.7460 0.0050
F 0.0370 0.7950 0.3510 0.4270 0.7880 0.8200 0.8750 0.8400 0.9860 0.7520 0.7010 0.0070
G 0.0200 0.4770 0.4370 0.4140 0.7850 0.7490 0.7910 0.8020 0.5830 0.6180 0.5630 0.0060
Mean 0.0227 0.6493 0.3920 0.5110 0.8033 0.8047 0.8203 0.8407 0.7810 0.6953 0.6700 0.0060
SD 0.0132 0.1607 0.0431 0.1569 0.0292 0.0498 0.0474 0.0390 0.2016 0.0693 0.0954 0.0010
Adjusted 0.6433 0.3860 0.5050 0.7973 0.7987 0.8143 0.8347 0.7750 0.6893 0.6640 x
%Viability 96.89 58.13 76.05 120.08 120.28 122.64 125.70 116.72 103.82 100.00
(c) MTT assay, plate 3
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Table D.2: Cell toxicity data obtained for each test preparation using the CVDE assay. Figures listed for each row are the optical densities obtained
at 540nm with reference to 690nm. The mean and standard deviation were calculated for each group of three results, and the results adjusted for
the blank (“x” indicates blank used). The result obtained for the growth control was assumed to be 100%. Percent viability was calculated by the
formula ODtestagent
ODgrowthcontrol
x 100.
Column 1 2 3 4 5 6 7 8 9 10 11 12
Controls Test Dilutions isolate 6.5 Controls
Row Blank Growth 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 YES 25% Blank
B 0.1440 3.2920 0.3450 0.4330 0.4870 0.3780 1.3800 2.0250 1.2250 1.0820 0.5990 0.1390
C 0.1340 3.3590 0.2950 0.3930 0.4600 0.3820 1.1530 1.8000 1.2710 1.0460 0.5560 0.1730
D 0.1280 3.3160 0.2280 0.3890 0.4130 0.3430 0.9450 2.0340 1.2800 0.9600 0.5560 0.1320
Mean 0.1353 3.3223 0.2893 0.4050 0.4533 0.3677 1.1593 1.9530 1.2587 1.0293 0.5703 0.1480
SD 0.0081 0.0339 0.0587 0.0243 0.0374 0.0215 0.2176 0.1326 0.0295 0.0627 0.0248 0.0219
Adjusted x 3.1870 0.1540 0.2697 0.3180 0.2323 1.0240 1.8177 1.1233 0.8940 0.4350
% Viability 100.00 4.83 8.46 9.98 7.29 32.13 57.03 35.25 28.05 13.65
Test Dilutions isolate 12.1
Row Blank YES 50% 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 Growth Blank
E 0.1190 1.2830 0.9720 0.7660 0.4350 1.2500 2.0320 3.0920 3.1680 3.2250 3.2550 0.1180
F 0.1230 1.4380 0.9980 0.7560 0.4920 1.2640 2.1350 3.1020 3.1950 3.2120 3.2740 0.1200
G 0.1160 1.4850 0.9100 0.5750 0.3780 1.3040 2.2120 3.2310 3.1800 3.2840 3.2700 0.1080
Mean 0.1193 1.4020 0.9600 0.6990 0.4350 1.2727 2.1263 3.1417 3.1810 3.2403 3.2663 0.1153
SD 0.0035 0.1057 0.0452 0.1075 0.0570 0.0280 0.0903 0.0775 0.0135 0.0384 0.0100 0.0064
Adjusted x 1.2827 0.8407 0.5797 0.3157 1.1533 2.0070 3.0223 3.0617 3.1210 3.1470
% Viability 40.76 26.71 18.42 10.03 36.65 63.78 96.04 97.29 99.17 100.00
(a) CVDE assay, plate 1
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Column 1 2 3 4 5 6 7 8 9 10 11 12
Controls Test Dilutions isolate 129.1 Controls
Row Blank Growth 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 YES 6.25% Blank
B 0.2040 3.2490 0.2800 0.2850 0.9810 2.9420 3.2150 3.2400 3.3040 3.2980 3.1730 0.2400
C 0.2020 3.3330 0.2600 0.2510 0.8540 2.9650 3.2140 3.3160 3.2810 3.3000 3.1050 0.3050
D 0.2080 3.2870 0.2480 0.2860 1.1900 3.0030 3.1550 3.1840 3.2790 3.2730 2.2590 0.1910
Mean 0.2047 3.2897 0.2627 0.2740 1.0083 2.9700 3.1947 3.2467 3.2880 3.2903 2.8457 0.2453
SD 0.0031 0.0421 0.0162 0.0199 0.1697 0.0308 0.0344 0.0663 0.0139 0.0150 0.5092 0.0572
Adjusted x 3.0850 0.0580 0.0693 0.8037 2.7653 2.9900 3.0420 3.0833 3.0857 2.6410
% Viability 100.00 1.88 2.25 26.05 89.64 96.92 98.61 99.95 100.02 85.61
Test Dilutions P. Chrysogenum
Row Blank YES 12.5% 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 Growth Blank
E 0.1420 2.7180 0.2450 0.5750 0.8530 2.8100 3.0960 3.2520 3.2170 3.2930 3.2730 0.2550
F 0.1550 2.2420 0.1180 0.5730 0.7670 2.8140 3.1180 3.2350 3.2540 3.2720 3.2530 0.1980
G 0.1650 0.6500 0.0940 0.6060 0.6940 2.9700 3.1610 3.2710 3.3100 3.2450 3.3660 0.2110
Mean 0.1540 1.8700 0.1523 0.5847 0.7713 2.8647 3.1250 3.2527 3.2603 3.2700 3.2973 0.2213
SD 0.0115 1.0830 0.0811 0.0185 0.0796 0.0912 0.0331 0.0180 0.0468 0.0241 0.0603 0.0299
Adjusted x 1.7160 -0.0017 0.4307 0.6173 2.7107 2.9710 3.0987 3.1063 3.1160 3.1433
% Viability 54.59 -0.05 13.70 19.64 86.24 94.52 98.58 98.82 99.13 100.00
(b) CVDE assay, plate 2
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Column 1 2 3 4 5 6 7 8 9 10 11 12
Controls Test Dilutions isolate Penicillin – MIC dilutions µ/ml Controls
Row Blank Growth 32.00 16.00 8.00 4.00 2.00 1.00 0.50 0.25 YES 1.57% Blank
B 0.1350 3.2790 3.3000 3.3280 3.2580 3.3520 3.2810 3.2800 3.2780 3.2440 3.2330 0.2110
C 0.1320 3.2510 3.3700 3.3050 3.2630 3.2360 3.3270 3.2980 3.3080 3.3040 3.2760 0.2030
D 0.1480 3.2980 3.2820 3.2540 3.3000 3.2820 3.3510 3.2420 3.3110 3.3060 3.2680 0.3330
Mean 0.1383 3.2760 3.3173 3.2957 3.2737 3.2900 3.3197 3.2733 3.2990 3.2847 3.2590 0.2490
SD 0.0085 0.0236 0.0465 0.0379 0.0229 0.0584 0.0356 0.0286 0.0182 0.0352 0.0229 0.0729
Adjusted x 3.1377 3.1790 3.1573 3.1353 3.1517 3.1813 3.1350 3.1607 3.1463 3.1207
% Viability 100.00 101.32 100.63 99.93 100.45 101.39 99.92 100.73 100.28 99.46
Test Dilutions isolate Penicillin – strong dilutions mg/ml
Row Blank YES 3.13% 3.00 1.50 0.75 0.38 0.19 0.09 0.05 0.02 Growth Blank
E 0.1860 3.1410 2.3060 3.1270 3.2590 3.2840 3.2640 3.3010 3.2260 3.3270 3.3280 0.2120
F 0.1450 3.1420 2.3990 3.1590 3.2960 3.3500 3.2810 3.3190 3.3240 3.3280 3.2380 0.2370
G 0.1270 3.2910 2.3900 3.1310 3.3430 3.2820 3.2510 3.2980 3.3030 3.2580 3.3190 0.2060
Mean 0.1527 3.1913 2.3650 3.1390 3.2993 3.3053 3.2653 3.3060 3.2843 3.3043 3.2950 0.2183
SD 0.0302 0.0863 0.0513 0.0174 0.0421 0.0387 0.0150 0.0114 0.0516 0.0401 0.0496 0.0164
Adusted x 3.0387 2.2123 2.9863 3.1467 3.1527 3.1127 3.1533 3.1317 3.1517 3.1423
% Viability 96.70 70.40 95.04 100.14 100.33 99.06 100.35 99.66 100.30 100.00
(c) CVDE assay, plate 3
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